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ABSTRACT
The single largest cause of compound attrition during drug development is due to
inadequate tools capable of predicting and identifying protein interactions. Several tools have
been developed to explore how a compound interferes with specific pathways. However, these
tools lack the potential to chronically monitor the time dependent temporal changes in
complex biochemical networks, thus limiting our ability to identify possible secondary signaling
pathways that could lead to potential toxicity. To overcome this, we have developed an in silico
neuronal-metabolic model by coupling the membrane electrical activity to intracellular
biochemical pathways that would enable us to perform non-invasive temporal proteomics. This
model is capable of predicting and correlating the changes in cellular signaling, metabolic
networks and action potential responses to metabolic perturbation.
The neuronal-metabolic model was experimentally validated by performing biochemical
and electrophysiological measurements on NG108-15 cells followed by testing its prediction
capabilities for pathway analysis. The model accurately predicted the changes in neuronal
action potentials and the changes in intracellular biochemical pathways when exposed to
metabolic perturbations. NG108-15 cells showed a large effect upon exposure to 2DG
compared to cyanide and malonate as these cells have elevated glycolysis. A combinational
treatment of 2DG, cyanide and malonate had a much higher and faster effect on the cells. A
time-dependent change in neuronal action potentials occurred based on the inhibited pathway.
We conclude that the experimentally validated in silico model accurately predicts the changes
in neuronal action potential shapes and proteins activities to perturbations, and would be a
iii

powerful tool for performing proteomics facilitating drug discovery by using action potential
peak shape analysis to determine pathway perturbation from an administered compound.
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CHAPTER-1: INTRODUCTION
1.1. Proteomics
A good understanding of the factors affecting disease progression is essential for
commencing treatments and making therapeutic monitoring decisions. The study of disease
progression in humans has been accomplished through several approaches as listed in Figure 1
and includes genomics, transcriptomics and proteomics.

Figure 1: Biochemical contexts of different studies for disease progression

Deoxyribonucleic acid (DNA) contains all the necessary information required to build and
maintain the cell. Great progress has been made to understand the structure of a DNA in
identifying the genetic abnormalities caused in a specific disease condition [1]. Genes are
expressed in varying combinations and nearly 21,000 genes have been identified and
sequenced [2]. The complete set of DNA in a single cell of an organism is referred to as genome.
Genomics is the study of structure and function of genomes. DNA transcribes into ribonucleic
acid (RNA), followed by translation into a protein.
All genome sequences are now available and researchers are trying to determine the
molecular and functional properties of each gene to understand the role of gene products in
complex biological processes. The transcriptome is the set of all RNA molecules that include
1

messenger RNA (mRNA), ribosomal RNA (rRNA), transfer RNA (tRNA), and other non-coding
RNA produced in the cells. The analysis of mRNA has become popular in recent years [3].
Several methods such as serial analysis of gene expression and DNA microarray technology are
applied. However, the quantification of mRNA does not reflect the cellular proteins. Several
factors including pH, hypoxia and drug administration define the expression and activity of
proteins. The proteins interact and work in conjunction to maintain a functional biological
system. Cells respond to stimuli by regulating the level and activity of cellular proteins the cell
responds to any stimuli. Cellular processes are mediated through a large network of proteinprotein interactions that are spatially and temporally regulated in the cell. A poor correlation
has been shown between mRNA and protein expression levels [4].
Proteomics is the study of the expression, function and interactions of proteins in the
proteome on a large scale [5]. The term proteomics was coined by Marc Wilkins during the
1990’s, redefining the thought process of a biological working system. Proteomics offers a
comprehensive analysis of a specific proteome, including abundances, variations and
modifications in order to understand cellular processes. The phenotype of the cell is
determined by the proteins that carryout cellular activities [6]. Each protein such as the
membrane receptor, ion channel, transcription factor, kinases or chaperones has a specific
function. Malfunction of the definitive proteins is the major cause of disease and serves as an
indicator for the disease. Proteins are also the primary targets for several drugs [6]. Therefore,
a logical step is to study the structure and functional properties of the working parts of the
biological systems at different levels. Such a study would provide a comprehensive global
comparison between different cell types, tissues, organs and the entire organism. More
2

importantly the study of proteomics enables us to grain a deeper insight into the mechanism of
disease progression which could eventually help in developing a therapy.
Proteome is the expressed protein complement of a genome and represents the subset of
all the gene products. A proteome is more complex than a genome, since any protein that is a
product of a single gene can exist in multiple forms in the same cell or different types of cells
due to post translational modifications. A proteome may vary with time and cellular
requirements. For example, exposure of a cell to elevated temperatures causes an increase in
expression of heat shock proteins. These changes affect the structure and function of the
proteins. The survival of the cells is dictated by the gene expression and activity of their
corresponding proteins. The proteome of the cell can comprise all the different forms of
proteins and is complicated to study. Protein metabolism, the production and degradation of
proteins is responsible for regulating the rate of cellular processes. Proteins after synthesis
undergo major biochemical changes due to post translational modifications. Proteins are also
involved in the energy metabolism networks in a cell. The life time and expression of proteins
also varies, as some proteins may rapidly degrade, are only expressed in certain situations or a
few may even last for a life time [7]. Proteins are synthesized and released into the cytosol or
other compartments from the ribosomal machinery. There are two major mechanisms by
which cells degrade proteins, namely, the lysosome and the proteasome. The degradation of
cytosolic and nuclear proteins occurs within the proteasomes. In lysosome degradation, the
entire protein enters the lysosome, followed by protein disassembly and degradation. The
proteasome mechanism, unlike the lysosome system, is equipped to achieve metabolic balance.
The rate of protein synthesis is determined by factors such as the amount of messenger RNA
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(mRNA) and the rate of degradation by ubiquitination. Both lysosome and proteasome
mechanisms are irreversible and do not respond to the rate of mass action kinetics of their
products [7]. Posttranslational modification (PTM) is a step in protein biosynthesis where
polypeptide chains undergo folding, cutting and other processes before becoming an active
mature protein. Protein phosphorylation is a PTM of proteins in which a serine, a threonine or a
tyrosine residue is phosphorylated by a protein kinase by the addition of a covalently bound
phosphate group. Protein phosphorylation regulates protein functions by turning the control
on/off during cell cycle, cellular signaling cascades and other cellular processes [1]. Proteins
undergo wear and tear upon exposure to free-radicals and other biological agents leading to
protein damage. External factors including environmental agents such as radiation, chemicals
and drugs can lead to protein modification followed by inactivation. It is critical to maintain a
balance between protein synthesis and degradation. The steady state of the cell reflects the
ratio of the equilibrium constant between these two processes. Wheatley et al. has shown that
30 - 90% of all proteins are defective and improperly folded even after transferring to the
endoplasmic reticulum [8]. When a change in the protein concentration occurs, either due to
altered physiological process or an onset of a disease condition, a new steady state
concentration is achieved by the cell [7].
The human genome project led to the classification of proteins encoded by the human
genome and enabled the classification of genes based on their functions [2]. Table 1 lists the
classification of proteins into functional categories based on human genome. The expression of
different genes is required for the synthesis of different proteins in different functional
categories. Proteins associated with intermediary and nucleic acid metabolism account for
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about 15% of proteins in the proteome.
Table 1: Classification of proteins into functional categories based on human genome

Functional category

% Genes

Functional category

% Genes

Cell adhesion

1.9

Ion channel

1.3

Hydrolase

4.0

Motor

1.2

Carrier protein

0.7

Structural

1.0

Transcription factor

6.0

Protooncogene

2.9

Nucleic acid enzyme

7.5

Calcium binding

0.1

Signaling molecule

1.2

transporters

1.7

Receptor

5.0

Immunoglobulin

0.9

Kinase

2.8

Extracellular matrix

1.4

Regulatory molecule

3.2

Cytoskeletal

2.8

Transferase

2.0

Chaperone

0.5

Synthase

1.0

Lyase

0.4

Oxidoreductase

2.1

Ligase

0.2

Isomerase

0.5

Intracellular transporter

1.1

Miscellaneous

4.3

Unknown

41.7
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The proteins involved in protein synthesis and turnover are about 15-20%. The signaling and
DNA binding proteins constitute 20-25% of the proteins. Around 41.7% of the function of the
genome is still unknown and determining their functionality is a challenge. It is important to
identify and quantify huge variations in the protein profiles that are observed in different cell
types.
Proteomics focuses on the interactions between multiple proteins as a part of a largescale analysis and should be performed at a much higher level [1].The information from the
functional characterization of a proteome will help us gain new insights into biology and
medicine. Recent advances in the development of proteomic tools have allowed the evaluation
of systemic changes in protein expression in responses to perturbations to a biological system
[5]. In addition, proteomic biomarkers deliver a more reliable result when compared to
traditional biomarkers since multiple interacting protein species are evaluated simultaneously
in response to metabolic perturbation [5]. Proteomics is applied to characterize the behavior of
the entire system rather than a single protein. Proteomics is a potential tool for drug discovery
with an inception to identify novel biomarkers.

1.2. Applications of proteomics
Proteomics technology is advancing rapidly and could revolutionize our fundamental
understanding of how a cell ‘works’ by identifying the responses to both internal and external
stimuli. The major applications of proteomics are performing mining, profiling including steady
state determination, mapping interaction and identifying protein modifications/functions [1].
These applications enable scientists to perform pathway analysis which involves examining
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thousands of proteins simultaneously involved in several pathways.
Protein mining is the identification of all the proteins present in the sample followed by
cataloging to determine how levels have changed in an experiment. Protein mining is
performed to resolve numerous proteins and uses tools such as mass spectrometry (MS) in
combination with software to determine the identity of the protein. Several approaches, each
offering a set of advantages, have been adapted for protein mining and build a database. By
combining the database and software tools, the protein of interest could be studied which
otherwise could only be achieved by performing gene-expression analysis [1].
The largest application of proteomics is in profiling protein expression. Protein profiling
facilitates the identification of the state of proteins in a biological sample or a cell exposed to
physical/chemical stimuli and is mainly performed to compare the states of proteins in healthy
vs. diseased cells. Protein profiling is an advanced form of protein mining and the obtained
information could lead to identification of drug targets. Protein profiling is mostly conducted by
employing two dimensional gel electrophoresis (2D-GE). Cancer proteomics relies on protein
profiling to compare the transformed and non-transformed cells directly. Many novel tumor
biomarkers and clues for cancer development have been identified. Protein profiling has been
performed on several tissues such as breast, bladder, esophageal and prostate [3]. Protein
microarrays are now widely used and are the fastest method to profile a protein.
Mapping the protein-protein interactions enable us to understand how protein
interactions occur in living systems. The study of protein-protein interactions allows us to
simultaneously assess the status of all the proteins in a pathway. Most of the cellular processes
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occur in close association with other proteins. The process of cell growth, cell death and cell
cycle are all regulated by signaling pathways through protein complexes. The interactions
between protein networks dictate cellular functions such as cellular signaling and metabolic
pathways. A majority of information has been obtained by performing in-vitro studies using
single and purified proteins with a yeast two-hybrid system. Most proteomic techniques offer
the ability to characterize multiple proteins interactions by pairing them. Multiple protein
complexes have been identified and their role in cellular pathways has been determined.
Protein-protein interaction is one of the most resourceful and demanding application of the
pharmaceutical industry.
Identification of protein modifications allows us to map the structural and functional
changes in proteins. Proteins undergo PTM in response to extracellular and intracellular signals.
In addition, exposure to environmental hazards generates reactive species that may modify
proteins. MS is a powerful tool for analyzing protein modifications. Antibodies are widely used
for detecting protein modifications but with this method the precise sites where the
modifications occur cannot be determined. Simultaneous characterization of the modified
regulatory proteins during a signaling cascade is important. Analysis of protein function is
performed to understand the molecular mechanisms underlying the biochemical process
occurring in the cell. It includes the study of how proteins interact with other compounds or
metabolites. The interactions of proteins occur at multiple stages such as with a single pathway,
whole cells, tissues or an entire organism [9]. It is important to understand all these functions
as several disease conditions arise as a consequence of alterations in protein functions.
Furthermore, all the physiological functions such as signaling networks, energy production and
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consumption of the cells are dependent upon the activity of the proteins.

1.3. Tools for proteomics
Several tools have been developed to systematically characterize and obtain a
comprehensive profile of the functions in biological systems. Biochemical assays have
reproduced some of the cellular pathways outside the cell but do not address the interactions
with the myriad of other pathways within the cell [10]. Early stages of proteomics have heavily
relied on biochemical assays but it is a very low throughput technology. Biochemical assays
were also involved in studying gene regulation, especially the interactions between nucleic
acids and proteins [11].
Imaging using high-throughput microscopic screening instruments have generated a
large set of images by incubating cells with one or more fluorescent probes [12]. However, it is
a difficult task to derive the patterns that link the generated images back to the biochemical
reactions. Although fluorescent probes have supplied a wealth of information, they suffer from
several draw backs such as toxicity due to photobleaching and triggering a cascade of signaling
pathways due to the interaction of the probe with cellular proteins or metabolites. Live cells
when exposed to an excitation light may be subjected to photodynamic effect, causing cellular
damage by direct contact with molecular oxygen [13]. The optical resolution affected by the
noise and photobleaching could alter the image quality leading to altered intracellular protein
levels. Imaging is a powerful tool with high resolution and even small objects are identified.
However, the images needs to be interpreted carefully as few images could be exaggerated and
may not appear according to scale [13].
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MS is the workhorse for performing proteomics and offers high sensitivity to detect
digested or intact proteins [14]. Current modifications allow targeting the protein modification
of interest such as phosphorylation, oxidation and ubiquination [15]. MS requires the proteins
or peptides to be in gas phase for analyzing them. MS is used to detect and quantify proteins in
biological matrix but is not yet capable of separating the complex protein mixtures from the
unprocessed biological matrix [16]. Matrix assisted laser desorption/ionization (MALDI) is
employed where the sample is dissolved into a matrix followed by exposure to laser [3]. The
major advantage of MALDI is that no purification of the sample in 2D-gel is required to separate
the proteins. A disadvantage of MALDI is that the matrix aids ionization and desorption when
hit with a short laser pulse and can also cause a drift in the protein mass.
2D-GE is widely used and allows the separation of numerous proteins in a single
experiment. 2D-GE can also determine the extent of a proteins expressions and changes in their
expression levels from sample to sample. Several drug targets have been identified employing
2D-GE technique. Separated proteins may be identified using MS or by using antibodies. A
multidimensional 2D-GE offers an advantage over the traditional gel electrophoresis by
allowing the separation of several samples in a single experiment by comparing the controls
with the diseased samples [15]. As an alternative to 2D-gel for protein quantification, isotopecoded affinity tags (ICAT) have been developed. ICAT relies on labeling proteins obtained from
different sources with chemicals of different isotope composition. The application of different
labels allows quantifying the difference using a mass spectrometer. The ICAT method also
enables the detection of low concentration of proteins. The major drawback of profiling using
the ICAT method is that the proteins must contain cysteine residues and these must be spaced
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far enough apart for the proteases to cleave them. Liquid chromatography (LC) has advanced in
the recent years and offers an advantage of separating proteins in the liquid phase. LC can be
coupled to MS (LC-MS) for identifying and further characterizing the sample. The volume of
sample required for LC is in the nanoscale, making it more useful to do proteomics in a
microfluidic device. The major disadvantage of LC is that during the separation of small
volumes, the flow rates are restricted [15].
Protein microarrays (PMAs) are powerful tools for capturing and measuring multiple
proteins in a high throughput fashion for the study of potential biomarkers but are expensive
[16]. In this method, cells are typically lysed and exposed to protein arrays along with specific
antibodies. PMAs are designed specifically to ‘catch’ the protein of interest and characterize it.
PMAs can be used in combination with other approaches to identify a specific protein. The
changes in protein concentrations, modifications and interactions can all be studied using
PMAs. Another major advantage of PMAs is that a specific set of proteins such as all the
mitochondrial proteins can be targeted for analysis [15].
Nanoproteomics (NP) addresses the current limitations in selectively reaching a target
protein in vivo by applying physical and biological barriers to detect low concentration targets
[17]. NP offers rapid and miniaturized assay, real time analysis, low sample consumption and
high sensitivity. However, the toxicity and biocompatibility of these techniques needs to be
studied further [18].
Several reagents such as antibodies have been developed and characterized to improve
proteomics but are limited to capturing and detecting a specific protein. Many other methods
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such as immunoblotting, analytical ultracentrifugation, surface plasma resonance (SPR) and
circular dichrosim are also employed to perform proteomics [15]. All these tools are excellent
and powerful to perform proteomics but are incompetent to chronically monitor the
interactions non-invasively.

1.4. Challenges in proteomics
The biggest challenge for proteomics lies in the proteome’s complexity. A single gene
encodes multiple proteins. The human genome contains 21,000 protein encoded genes that
generate an estimated 250,000 to one million different proteins in a human cell [19]. The
genome is a static blueprint of a cell whereas the proteome is dynamic and dependent on
varying extracellular stimuli [20]. PTM leads to protein variability, causing different expression
profiles and polymorphism that makes it difficult to detect [16]. The isolated proteins during
cellular interactions must be in their native forms for an accurate analysis. In spite of the
availability of several new advanced technologies, detection of low levels of proteins in a
complex biological mixture still remains a challenge. Few eukaryotic cells have a low to high
protein ratio of 1:106, making it difficult to analyze and track the changes in the sample. Also, it
is difficult to identify transcription factors, protein kinases and regulatory proteins as they are
expressed in low number. Further purification or extractions methods may be employed to
isolate the protein of interest from the proteome [3]. Also, certain protein extraction and
separation techniques are skill-based and remain difficult to automate [21].
Most of the methods including 2D-GE or performing biochemical assays are not highthroughput. Performing an MS may require a substantial amount of time for data acquisition,
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processing and analysis [3]. Quantification of hundreds of proteins can be achieved by
performing MALDI time-of-flight MS (MALDI-TOF MS) but not all proteins in the sample can be
detected, yielding a low-resolution analysis. A higher resolution of the sample can be obtained
by using a MS/MS but it would require significant time and resources to interpret data.
Performing a wide dynamic range of analysis has been another limitation of MS/MS [19]. Most
of these systems are invasive, thereby activating other signaling pathways which lead to cellular
apoptosis. Moreover, these systems detect only the end-point, cost ineffective, lack the
capability for chronic monitoring of cellular functions interactions and are limited to the
pathways being analyzed. Instead, a study of the entire biological system as a single entity is
necessary and would provide profound insights.

1.5. Systems biology driven proteomics
Systems biology employs a centralizing approach to characterize biological systems, where
the interactions described mathematically to establish a computable model. Systems biology
aims to increase our understanding and predicting the behavior of a biological system. The key
utilities of model building are (1) to organize information from different sources into a cohesive
model, (2) to determine what species and interactions play a vital role a specific pathway of
interest or the entire cell, (3) identification of new inter-dependencies on cellular process and
(4) to learn all the quantitative features on a large scale. System biology based tools are now
widely used to perform drug discovery due to the physiological relevance of results and the
ability to perform high content screening. These tools aid in analyzing cellular pathways
providing a deeper understanding of several biochemical processes including metabolic
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pathways [22].
Most biological systems behavior cannot be limited to a single molecule or pathway instead
they result due to the interactions occurring at different levels among different cellular
compartments. Modeling of the reconstructed system, if possible at different levels, would
allow performing simulations and predicting hypothesis. The earlier stages of the developed
systems could be small containing few proteins representing a signaling pathway and
eventually lead to a whole-cell model [23]. Since systems biology is hypothesis driven, the
model is validated by perturbations and validating with the experimental datasets. A dynamic
analysis of the changes in the model enables the identification of changes in protein activity. In
modeling biological systems, cellular networks are divided into signaling, regulatory and
metabolic that responds to perturbations and alters cellular activities. Currently, a biological
system is best characterized using metabolic models [24]. The basis of reconstruction and
development of cellular networks is well documented and have also received much interest.
Analysis of these networks can be aimed at performing a quantitative or qualitative analysis
[25]. For example, a boolean network can be implemented to perform quantitative and kinetic
models for quantitative analysis of cellular signaling pathways.
Proteomics was identified as an essential discipline for building precise network models
[23]. Proteomic analysis and Systems Biology have come closer during the past decade and
present a promising approach to unveil functions of proteins in complex cellular networks.
Proteomic analysis by employing systems biology would be a powerful tool. It has become
obvious that protein analysis needs to be performed on a large- scale as the rate of drug
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attrition has increased. The complex dynamics of proteins makes it difficult to study. Proteins
are the actual effectors for maintaining cellular hemostasis by driving the cellular pathway and
cannot be simply be studied by looking at a gene, mRNA or in fact a single protein. A large
amount of experimental data is being generated using several tools such as PMAs, imaging and
LC-MS/MS [24]. The data obtained from all the proteomic tools can be integrated into a single
system for further analysis. Proteomic tools can be applied to study the protein-protein
interactions and protein functions as a result of perturbations in biological process on a large
scale. Most of the limitations and challenges of the proteomic tools could be addressed by
coupling existing tools and data to systems biology driven models. However, none of the
current standalone tools or tools coupled to systems biology can monitor the cellular pathways
or the dynamic changes that a protein undergoes in response to perturbations [23].

1.6. Motivation
A system capable of determining temporal profiles of living cells to perturbations of a
compound as it interacts with a cell over a period of time providing a rich set of information
that could be captured non-invasively would be beneficial [26,27]. Such system would provide
insight into the mechanistic details of cellular pathways, predict the response of proteins
interactions in cellular systems to multiple perturbations beyond those from which models are
derived and guide the design of perturbations for a desired response. Tools based on
monitoring the state and activities of the excitable cells are frequently used to quantify the
physiological responses to external stimuli [28,29].
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Neurons exhibit an action potential (AP) that gives complex information about the
internal/external environment of excitable cells. The AP shape contains a significant amount of
information, as it is dependent on concerted action of ion channels located on cell membrane
that are tightly regulated by receptors and intracellular messenger systems [30,31]. Ion
channels are regulated by all common intracellular mechanisms including phosphorylation and
second-messenger dependent systems [32] as intracellular ions play the significant role of
second messengers in cells [33]. The membrane electrical activity is highly dependent on the
state, physiology and pathophysiology of the cells [34]. The AP generation and shape are
determined by Na+, K+, Ca2+, ATP, other second messenger dependent channels and pumps [3537]. Calcium [38], sodium [39], and potassium [40] channel modulators have been shown to
affect the shape of cellular action potentials [27].
Cellular metabolism and membrane electrical properties are tightly integrated. The
changes in AP are characteristic to the biochemical pathway affected by chemical or biological
entities [26,27,41]. Deconvolution is the quantitative determination of underlying ionic currents
of AP which would not only enable the detection of altered pathways but also potentially
differentiate

compounds

with

different

mechanisms

of

actions

[27,41].

Cellular

electrophysiology is the gold-standard technique for measuring ionic currents of an excitable
cell and the electrical components in the cell membrane, including primary ion channels. The
information obtained from the system is highly complex in nature and needs to be
deconvoluted using an in silico tool to gain a deeper understanding on the dynamics of the
physiological processes [26].
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1.7. Previously developed models
Previously developed models of cellular pathways in cells have been effective in
modeling pathways and enhancing drug discovery. Techniques for network modeling of cellular
pathways span a wide spectrum of complexity. Models of signaling pathways have been
reconstructed by combing and analyzing information available in the public domain, including
DNA sequence data, protein sequence data, literature, pathways recorded in public databases,
gene expression data, mass spectrum data and metabolic profiles. However, these networks
often have delivered several false positives or false negatives due to noise and incomplete data.
The great majority of cell models were also tailored towards one or two specific cell
activities, mostly carbon flux, respiration, signaling, gene activation and electrophysiology.
Computational models incorporating ion channels to represent whole-cell AP models relate the
changes in membrane potential to the sum of inward and outward ionic currents. They typically
consisted of 10-70 differential equations with multiple parameters. Gleeson et al. introduced
NeuroML, which offers a multilayer approach of electrophysiological features from individual
cells with selected ion channels to morphologically reconstructed multi-compartment neurons
forming networks with others [42]. However, the modeled neurons were limited to their
electrophysiological function since metabolic events were not included. Lewis et al. modeled
complex signaling interactions between astrocytes and motor neurons by including metabolic
pathways for each cell type [43]. Zhou et al. published their comprehensive work on the
electrophysiological activity of cardiac myocytes and influences of the mitochondrial TCA cycle
[44]. Masson et al. explored the link between electrical activity and insufficient metabolic
energy by merging the classical Hodgkin-Huxley conductance model [45]. Their model provided
17

theoretical basis to study the dependence of cellular bioenergetics on membrane electrical
activity. The metabolic model was not detailed enough to perform analysis of cellular pathways.
Cortassa et al. developed a computational model by integrating cardiac electrophysiology,
contraction and mitochondrial bioenergetics to obtain a greater insight into their interactions
and dependencies [46]. The model lacked the detailed glycolytic and pentose phosphate
pathway along with the deconvolution module to predict the responses of action potentials.
Experimentally validated models have already been developed which are coupled to the
electrophysiological properties of the cell membrane to complex intracellular pathways [47,48].
These models have been used to predict the physiological changes in the intracellular
mechanisms such as gene expression, activation of secondary messenger systems and
phosphorylation [49]. Several publications from leading groups in systems biology are all
extraordinary milestones towards large-scale and whole-cell modeling. A first ‘real’ whole-cell
model of Mycoplasma genitalium was built by combining all the molecular components to
study the unexplored cellular behavior [50]. However, experimentally validated computational
models including all major functions and organelles of mammalian cells, especially neurons, are
currently not available.
A popular way to develop more complex and comprising models is to extend existing
pathway models with further reactions and species or in some cases the combination of two or
more existing models. The latter approach comes with challenges as the employed models
were usually proposed by different groups, which used different time frames, units, and often
worked with pathways of different cell types if not species. In our previous work, we have
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demonstrated the use of neuronal cells as sensor elements for toxin detection [27,41]. The
interrupted AP showed differences we believe could vary depending upon the pathway being
inhibited by a compound, protein or gene.

1.8. Objectives of dissertation
The objective of this dissertation is to develop and experimentally validate an insilico tool
that would predict action potential time-series by enabling chronic monitoring of intracellular
networks and intracellular proteins activities.
To achieve the aforesaid objectives the following tasks have been performed
1. The basal metabolism of NG108-15 cells has been determined by performing
biochemical measurements.
2. The NG108-15 cellular metabolic model was reconstructed and experimentally validated
by employing the biochemical measurements.
3. A neuronal module for deconvolution of neuronal action potentials was constructed and
the electrophysiological parameters were extracted.
4. The effects of inhibition of cellular proteins involved in energy producing metabolic
pathways were evaluated by measuring the biochemical and electrophysiological
changes in NG108-15 cells.
5. A coupled neuronal-metabolic model including the sub-cellular compartment was built
to generate a series of action potentials followed by predicting the changes in
intracellular ion concentrations and protein activities.
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6. An experimental validation of neuronal-metabolic model was performed by simulating
multiple scenarios of inhibiting cellular proteins involved in cellular bioenergetic
pathways for predicting protein activities and action potential time-series.
7. An in-depth analysis of predicted temporal activities of cellular proteins during
metabolic perturbations was carried out to evaluate the model predictive capabilities.

1.9. Dissertation outline
This dissertation describes development and experimental validation of neuronal
metabolic model.
Chapter 2 provides the theory behind the cellular metabolic pathways and general
approach for model development is discussed. The ionic basis of membrane electrical
properties, cellular electrophysiological techniques and the theory behind Hodgkin-Huxley
model are explained.
Chapter 3 describes the experimental methods employed in measuring the effects
metabolic inhibitors. This chapter includes details of the modifications of surfaces, cell culture,
biochemical assays and patch clamp electrophysiology protocols that were utilized.
Chapter 4 illustrates the development of neuronal-metabolic model. The coupling of
different intracellular pathways including the metabolic reactions was explained. The chapter
also includes the reconstruction and a detailed description of biophysical components involved
in neuronal module. The integration of both the modules followed by methodologies employed
for parameter estimation is described. The chapter also included a detailed description on how
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experimental conditions were simulated
Chapter 5 provides a discussion on the results obtained from the model. The basal
metabolic properties of NG108-15 cell are presented. The calibration of model to steady state
using the experimental data is explained. The deconvolution of action potentials to extract the
ion channel parameters has been described in detail. Also, a discussion on how the neuronalmetabolic model was simulated to steady state and perturbations induced were estimated is
provided. The experimental validation of simulated results for all the drugs and drug
combinations including the characteristic analysis of action potential time series data is
presented. The predicative capabilities of the model are demonstrated in this chapter.
Chapter 6 concludes the dissertation by outlining the outcomes from the model and the
future work involved in developing the model is discussed in detail.
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CHAPTER-2: THEORY

In this chapter the cellular metabolism and membrane electrical properties were reviewed.
An understanding of the fundamental theory behind the biochemical and biophysical
interactions occurring during cellular function is a prerequisite. The core cellular pathways
involved in energy metabolism followed by describing the basics of modeling and kinetic
analysis are presented. The second half of the chapter describes the characterization of
membrane electrical properties following the description of the measurement techniques and
their mathematical basis.

2.1. Cellular Metabolism
Cellular metabolism plays a vital role in cellular functions. The metabolic reactions can be
categorized into two broad categories, namely degradation and synthetic pathways. The
biochemical reactions occurring in a pathway are organized, localized and regulated in a cell
[51]. The rates of intracellular enzymes i.e., regulatory proteins dictate cellular activities. The
protein activities are modified in a cell to maintain a favorable environment for obtaining highly
efficient cellular processes. At steady state, a cell requires carbon for biosynthesis and ATP for
cellular functions [51]. These requirements are met by central metabolic pathways that include
glycolysis, pentose phosphate pathway (PPP), mitochondria and endoplasmic reticulum.

2.1.1. Glycolysis and PPP
The glycolytic pathway is one of the core metabolic process during which one molecule
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of glucose is converted into two molecules of pyruvate by producing ATP. Glycolysis is also
known as the Embden-Meyerhof pathway that has two phases [51]. In phase one, conversion of
glucose into fructose-1,6-bisphosphate is catalyzed by hexokinase (HK), phosphogluccose
isomerase (PGI) and phosphofructokinase (PFK). HK and PFK consume two molecules of ATP to
mediate conversions. During the second phase of glycolysis, fructose-1,6-biphosphate is further
metabolized into pyruvate by consuming two ADP molecules and produces four molecules of
ATP. The fate of pyruvate is dependent on cellular oxygen utilization. In hypoxia conditions,
pyruvate generated gets converted into lactate and is transported by monocarboxylate
transporters (MCT) [52]. In contrast, during normoxia pyruvate enters the mitochondria and
gets further metabolized to generate ATP. Additionally, the glycolytic enzymes such as HK,
glyceraldehyde 3-phosphate dehydrogenase (GAPDH) and enolase have been shown to be
multifunctional as they play a role in cellular transcription [52].
The pentose phosphate pathway (PPP) is an alternative pathway for metabolizing
carbon entering glycolysis. The end product of PPP, ribose-5-phosphate, is utilized in the
synthesis of nucleic acids. PPP generates NADPH that is utilized for ATP production. The activity
of PPP differs from cell-to-cell. For example, muscle cells lack PPP as they utilize carbohydrates
for energy generation whereas red blood cells lack mitochondria forcing the cell to completely
rely in PPP for NADH generation [53]. On the other hand, neurons, which are of interest here,
have been shown to possess active PPP [54]. The PPP and glycolysis are interconnected. The
enzyme transketolase in PPP mediate the conversion of xylulose-5phosphate to glyceraldehyde3-phosphate. The produced glyceraldehyde-3-phosphate enters the second phase of glycolysis
directly to generating pyruvate and ATP [52].
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2.1.2. Mitochondria
Mitochondria are considered as the power house of the cell. Two major mitochondrial
pathways namely, the TCA cycle and electron transport chain generate ATP.

Pyruvate

generated during glycolysis is transported into mitochondria by monocarboxylate transporters
present on the mitochondrial membrane. Pyruvate is converted into mitochondrial acetyl-CoA
which acts as the starting point for the TCA cycle. The acetyl group from Acetyl-CoA is
transferred to oxaloacetate to generate citrate. A series of cyclic reactions convert citrate to
oxaloacetate by performing two decarboxylations and four steps of oxidation to form malate
followed by regenerating oxaloacetate. The ATP production from the TCA cycle occurs during
the conversion mediated by succinyl-CoA lyase [53]. The TCA cycle generated NADH and FADH2
are transported by succinate dehydrogenase (SDH) to the electron transport chain for ATP
production. The TCA cycle generates precursors for biosynthesis of several amino acids. The
major sites of regulations of TCA cycle were citrate synthase, isocitrate dehydrogenase and αketoglutarate dehydrogenase. The TCA cycle is also sensitive to the buildup of metabolites by
lowering its activity [53].
The electrons generated in glycolysis are transported into mitochondria by the malateaspartate shuttle (MAS) or glyceraldegyde-3-phosphate shuttle (G3P). The expression and
efficiency of these shuttles varies in different cell types [51]. MAS and G3P transport 6 and 3
electron equivalents respectively. The electrons from NADH and FADH2 are passed into the
inner mitochondrial membrane by complexes I, III and IV. The electrons then move towards
oxygen and protons from the cytosol are consumed to increase the pH in the mitochondrial
membrane creating a potential difference. The protons move through F 1F0-ATPase to
24

synthesize ATP. The mitochondrial ATP is transferred into the cytosol by the adenine nucleotide
transporter [53].

2.1.3. Endoplasmic reticulum
The endoplasmic reticulum (ER) has several functions including folding and transport of
proteins. The ER also acts as stress modulator by altering intracellular calcium levels. The
intracellular calcium levels in a cell are maintained at low concentrations when compared with
sodium and potassium concentrations. The low calcium concentrations are necessary as several
proteins get activated or deactivated from calcium binding. Thus, cellular calcium
concentrations must always be maintained in homeostasis and in check to avoid activation of
unwanted signaling cascades [55]. The intracellular calcium concentrations are maintained by
two mechanisms, buffering and sequestering. Buffers are calcium-binding proteins that absorb
95-99% of free cytosolic calcium [55]. Calcium sequestering usually occurs in the ER.
The ER consists of three major channels that mediate calcium fluxes. The
sarco/endoplasmic calcium ATPase (SERCA) pump moves cytosolic calcium into the ER against
the concentration gradient by consuming cellular ATP. To generate feedback and maintain
homeostasis, cells have inositol triphosphate (IP3) and ryanodine (RyR) receptors. A negative
and positive feedback is obtained from channels when calcium is bound to them. These
receptors have been shown to control several cellular processes such as cell cycle and
membrane electrical activity [55].
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2.1.4. Metabolic alterations in cancer cell
Cancer cells have exhibited aerobic glycolysis i.e., higher glycolytic activity compared to
normal cells even in the presence of sufficient oxygen. This phenomenon was first described by
Otto Warburg in the year 1930. The prime cause for metabolic alterations was due to lowered
mitochondrial activity and was resolved by Warburg in 1956. This effect of cells possessing
aerobic glycolysis was termed as the ‘Warburg effect’. The Warburg effect was considered as
one of the prominent symptoms in cells with altered metabolic activities. Researchers have
rationalized this effect to describe (a) defective mitochondria, (b) adaption to hypoxia, (c)
oncogenic signaling and (d) overexpression of cellular proteins [52].
Impaired mitochondrial function forces the cell to depend on glycolysis for ATP
generation. Mitochondrial damage was assumed as low levels of ATP were being produced.
Analysis of mitochondrial DNA (mtDNA) levels revealed high mutations in cancer cells [52].
Several factors such as reactive oxygen species (ROS) and low levels of chaperones could cause
mutations [52]. Hypoxia has been shown to directly modulate energy metabolism. Tumors have
been shown to have a restricted supply of oxygen creating a hypoxic environment that would
increase glucose utilization and lactate production leading to acidification. It’s well established
that inhibiting glycolytic activity with 2-deoxy-glucose (2DG), Oxamate or 3-bromopyruvate has
a significant effect on cancer cells [52,56,57].
The enzymes that play a vital role in TCA cycle dependent ATP production are fumarate
hydratase (FH) and succinate dehydrogenase (SDH). Studies have showed that inhibiting SDH
caused accumulation of succinate and suppresses the TCA cycle activity [52]. SDH is an
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important enzyme as it is involved in both the TCA cycle and electron transport chain. A loss in
SDH activity would arrest mitochondrial energy metabolism completely. Cancer cells have been
shown to possess increased ROS levels. It is possible that increased ROS levels may lower or
inhibit ROS-sensitive enzymes [52].

2.1.5. Metabolic Modeling
Metabolic modeling employs systemic integration of experimental knowledge into a
mathematical framework that enables the prediction of dynamic behavior in cellular
machinery. Currently metabolic models are largely validated based on constrained-based
approaches. Most metabolic models are usually aimed at the identification of molecular targets
for controlling cellular activities. Models based on ordinary differential equations (ODEs) have
been successful at determining cellular fluxes, metabolite concentrations and protein activities.
An ODE for a certain component (C) is usually represented by determining the rate of
production (𝑣𝑝𝑟𝑜𝑑𝑢𝑐𝑡𝑖𝑜𝑛 ) and consumption (𝑣𝑐𝑜𝑛𝑠𝑢𝑚𝑝𝑡𝑖𝑜𝑛 ) as shown in equation 1.
𝑑
[𝐶] = 𝑣𝑝𝑟𝑜𝑑𝑢𝑐𝑡𝑖𝑜𝑛 − 𝑣𝑐𝑜𝑛𝑠𝑢𝑚𝑝𝑡𝑖𝑜𝑛
𝑑𝑡

(1)

The rate of production and consumption depends on kinetics of proteins involved in
pathways. The basic kinetic method that describes the activity of most proteins is MichaelisMenten kinetics. Proteins are complex and so it their activity. A biochemical determination of
protein activities and estimation of their kinetics has enabled the derivation of kinetics of
specific proteins or a common kinetic equation for describing a set of proteins [58,59].
Several tools, such as Pathways Tools [60], have been developed to implement and
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model the kinetics of a set of proteins. The initial conditions were usually estimated using
experimental data. The numerical equations can then be solved using an ODE solver. Due to a
large interest in model development, a Systems Biology Markup Language (SBML) has been
developed to exchange models of different biochemical networks [61]. Parameter estimation
currently is one of the biggest challenges in systems biology. An increase in the number of
interactions exponentially increases the parameter estimation space. To overcome this several
strategies have been proposed. A toolbox (COBRA) in MATLAB has been developed by
constraint-based modeling for quantitative prediction of cellular networks [62]. The model
predictions obtained from COBRA have delivered the best set of parameters and when
evaluated the model predications were accurate [62].

2.2. Cellular electrophysiology
The flow of ions across the membrane creates a voltage difference called biopotential.
The changes in the biopotential may occur due to several factors such as temperature, pH, ionic
concentrations or extrinsic current [63]. Cellular electrophysiology is the study of membrane
electrical properties of a cell. The goal of performing electrophysiology is to detect electrical
signals generated by excitable cells such as neurons, muscle, cardiac, pancreatic and sensory
neurons. Cellular electrophysiology involves measuring changes in voltage or current across the
membrane. A voltage clamp recording is performed to measure changes in sodium and
potassium currents by holding voltage constant and a current clamp is obtained by holding
current constant thereby measuring changes in membrane potential.
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2.2.1. Ionic basis of action potentials
Cells at rest have a certain potential called a resting membrane potential, due to
difference in ionic concentrations across the membrane. The intracellular potassium
concentration is about 10-14 times higher compared to the extracellular potassium
concentration leading to a negative reversal potential. The concentrations of sodium and
calcium are very low intracellular and high extracellularly generating a positive reversal
potential. The plasma membrane contains ‘open’ potassium channels that allow the passage of
potassium ions. The resting membrane potential is mainly determined by the movement of
potassium ions since it is occurring down the concentration gradient through the open
potassium channels. The resting membrane potential of a typical cell is about -60 mV to -70 mV
and the reversal potential of potassium is close to the resting potential. A change in resting
membrane potential always changes the intracellular potassium concentration and reversal
potential [64].
An action potential (AP) represents changes in cellular membrane potentials generated
when a required strength of electric current is passed through the membrane of an electrically
excitable cell. Different cells exhibit action potentials of different shapes including a variation in
AP amplitude and time course. The time course of AP’s varies from 1 ms in neurons to 5s in
cardiomyocytes [63]. AP is a cyclic process where membrane depolarization, hyperpolarization
and resting membrane potential cycle are a result of alterations in ion permeability.
During an AP, an initial depolarization changes the conformation of voltage-gated
sodium channels and allows an influx of sodium ions. The propagation of this AP depolarizes the
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adjacent region thereby opening voltage-gated sodium channels and increasing the sodium
influx. A combination of factors established due to differences in ionic concentrations and
resting membrane potential drives sodium ions into the cell. As more sodium ions enter the
cell, the membrane is depolarized, further causing a larger influx of sodium and the
permeability of sodium in that specific region increases. But when the reversal potential of
sodium matches the cellular membrane potential, the sodium influx ceases [64]. During the
closure of voltage gated sodium channels, voltage gated potassium channels open leading to an
increased potassium permeability. The potassium efflux causes the membrane to repolarize
back to the resting membrane potential. The voltage-gated calcium channels are also opened
simultaneously with potassium channels and closed upon reaching resting membrane potential.
Upon reaching the resting membrane potential the sodium, potassium and calcium ion
channels close [64].
Action potentials cause characteristic changes in membrane potentials by rearranging
ionic balances across the membrane. The movement of ions across the membrane generates a
change in voltage. Although the changes in voltage are significant, the actual number of ions
that move across the membrane are very small compared to number of ions in the total volume
of the cytosol. The ionic fluxes during AP were measured initially by performing an experiment
on giant squid axons. The movement of ions across the membrane was characterized by using
radioactive sodium and potassium. It was found that depending on the size of a neuron, during
single AP generation about one potassium ion per 300,000 in the cytosol is exchanged for
extracellular sodium. So the changes in the total cytosolic ionic concentrations during an AP are
negligible [64].
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2.2.2. Measurement techniques
Several techniques such as patch-clamp, extracellular recordings and planar patch clamp
are employed for performing cellular electrophysiology. Each technique offers a set of
advantages and disadvantages. Both intracellular and extracellular recordings have been
performed to study membrane activity. During patch clamp electrophysiology, the recordings
are usually performed by patching cell using a sharp electrode to measure changes in
membrane potential. Several variations in patch clamp techniques have been exercised
depending on the study. An on-cell patch is performed where patch membrane is kept intact
and currents are measured without disturbing intracellular pathways. Another variation is an
inside-out patch. During an inside out-patch, the cell is patched and pipette is withdrawn
quickly to exposing intracellular contents of the cell to external environment. A whole-cell
patch is the most common patch employed during patch clamp electrophysiology. Patch clamp
techniques enables measurements of single ion channel properties. The principle behind patch
clamp relies on the high-resistance seal formed between sharp electrode and cell membrane.
The resistance of the seal varies from patch-to-patch but usually a giga-ohm seal is necessary to
maintain a stable patch. During a whole-cell patch, a small surface of the cell membrane is
drawn into the pipette, and by applying suction the membrane is broken enabling access into
the whole-cell. A ground electrode lies in the extracellular chamber acting as a reference
electrode. The electrodes are connected to an amplifier for detecting and measuring changes
across cellular membrane. An outside-out patch is formed by patching a cell and slowly
withdrawing the pipette along with a bleb of cellular membrane containing the ion channel of
interest. The activity of ion channels in the bleb can then be measured. Perforated patch clamp
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employs rupturing the cell membrane by incorporating a small amount of antibiotic. A giga-ohm
seal is formed during perforated patch by just touching pipette to the membrane. Since the
membrane is not ruptured, a long term measurements can be performed.
Patch clamp electrophysiology is the gold standard for measuring membrane electrical
activity. It is a short term and technique driven. To overcome this microelectrode arrays have
been developed and are capable of measuring electrical activity over long periods. Optical
measurement systems based on changes in emitted fluorescence signal upon incorporation of a
dye are also used. The fluorescent probes are voltage sensitive and emit fluorescence when a
change in voltage occurs. The changes in fluorescent intensities need to be tracked and
processed for quantifying. To perform high throughput electrophysiology, the planar patch
clamp technique has been developed. During planar patch clamp, cells are suspended in a
solution and added to a chip containing micro pipettes. Suction is applied in the micropipettes
to create a seal followed by record membrane electrical activities.

2.2.3. Hodgkin-Huxley model
Hodgkin & Huxley’s mathematical description of AP formalism is the most widely used to
describe an AP and relies on the opening and closing of channels, selectively allowing ions to
move across the membrane [65]. A series of voltage clamp experiments were performed and
the experimental data was fitted to obtain sodium conductance of voltage gated sodium
channels consisting of activation ‘m’ and inactivation ‘h’ gates. The potassium conductance was
also determined which consisted of a single activation gate ‘n’. The ionic conductances were
obtained from,
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𝑔𝑁𝑎 = 𝑔𝑚𝑎𝑥 𝑚3 ℎ

(2)

𝑔𝐾 = 𝑔𝑚𝑎𝑥 𝑛3

(3)

Where 𝑔𝑚𝑎𝑥 is the maximum conductance of ion channel. The exponents on m, n and h were
determined by obtaining a fitting of the model to experimental data. The gating variables were
postulated and determined for voltage-gated time constants i.e., τm , τh and τn. The leak
conductances were incorporated to account for small conductances in the membranes. The
ODE’s for the HH model are given by,
𝐶 𝑑𝑉
= −𝑔𝑁𝑎 𝑚3 ℎ(𝑉𝑚 − 𝑉𝑁𝑎 ) − 𝑔𝐾 𝑛4 (𝑉𝑚 − 𝑉𝐾 ) − 𝑔𝑙𝑒𝑎𝑘 (𝑉𝑚 − 𝑉𝑙𝑒𝑎𝑘 ) + 𝐼𝑎𝑝𝑝
𝑑𝑡

(4)

𝑑𝑛
= 𝛼𝑛 (1 − 𝑛) − 𝛽𝑛 𝑛
𝑑𝑡

(5)

𝑑𝑚
= 𝛼𝑚 (1 − 𝑚) − 𝛽𝑚 𝑚
𝑑𝑡

(6)

𝑑ℎ
= 𝛼ℎ (1 − ℎ) − 𝛽ℎ ℎ
𝑑𝑡

(7)

The model could mimic the neuronal dynamics accurately but were computationally
inefficient for parameter estimation and model simulation [66]. To create a more accurate
estimation of parameters, a functional form for the voltage dependence of the rate constants
that takes into account more realistic effect of the electrical field on the ion channel protein
was developed by Destexhe et al. [67]. Mohan et.al have developed a linear thermodynamic
formalism that was then used to describe the voltage and time dependence of the ionic
conductance, which eliminated the need for ‘guessing’ the function for the voltage-dependence
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of rate constants and the same form could be used for characterization of all ion channels [27].
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CHAPTER-3: EXPERIMENTAL METHODS

In this chapter, the methodology implemented to perform experiments is described in
detail. NG108-15 cells, a neuroblastoma-glioma hybrid neuronal cell line were used for
developing and charactering the model. The NG108-15 cell line was developed by fusing a
mouse N18TG2 neuroblastoma cell with a rat C6-BU-1 glioma cell in the presence of an
inactivated Sendai virus. The NG108-15 cells line was developed in 1971 by Bernd Hamprecht
[68]. These cells do not form synapses and possess functional properties of neurons making
them ideal for performing high-throughput drug screening and pathway analysis. A
combination of biochemical and electrophysiological measurements were performed to
characterize and develop the model.

3.1. Surface modification
Glass coverslips (22 mm × 22 mm, Thomas Scientific) were coated with N-1[3(trimethoxysilyl) propyl] diethylenetriamine (DETA) according to previously published protocols
[10]. The protocol involved cleaning coverslips using a mixture (1:1) of hydrochloric acid and
methanol followed by soaking it in concentrated H2SO4 for 30 min. The cover slips were rinsed
with deionized (DI) water for 30 min, immersed in boiling in deionized water for 30 min, rinsed
with acetone and placed in an oven at 70 oC for 20 min to allow drying. The cleaned surfaces
were treated with a 0.1% (v/v) mixture of organosilane in toluene to form a thin film of DETA
(United Chemical Technologies., Bristol, PA). The DETA coated coverslips were heated to a
temperature just below the boiling point of toluene, rinsed with toluene, reheated to a
35

temperature just below the boiling point again and then oven dried [27]. The DETA surface was
analyzed using contact angle measurements and X-ray photon spectroscopy (XPS) [69].

3.2. Preparation of culture medium and patching Solutions
3.2.1. Culturing and differentiation medium
NG108-15 culturing medium was prepared by adding 50ml of 10% fetal bovine serum
(FBS) (Gibco, NY, USA ) and 10ml of hypoxanthine-aminopetrin thymidine (HAT) medium
supplement (Sigma-Aldrich Corp, St.Louis, USA) to 500ml of Dulbecco’s modified eagle’s
medium (DMEM, Gibco). The differentiation medium was prepared by adding 10 ml of B27
(Gibco) to 500ml of DMEM (Gibco) media. The prepared medium was sterilized by filtration and
stored at 4 oC.

3.2.2. Intracellular patch solution
Intracellular

solution

was

prepared

by

dissolving

4-(2-hydroxyethyl)-1-

piperazineethanesulfonic acid (HEPES) and ethylene glycol tetraacetic acid (EGTA) in water. The
mixture was sonicated to ensure that EGTA is completely dissolved. Following sonication, NaCl,
KCl, MgCl2 and CaCl2 were added to the solution. DI water was added to make up the volume to
50 mL. The osmolarity of the solution was verified using an osmometer (Fiske) and adjusted to
280-290 mOsm by adding HEPES. The pH of the solution was adjusted to 7.2 at room
temperature. The prepared solution was aliquoted into 1mL vials and stored at 4 oC. The
osmolarity was checked prior to performing the experiment. The composition of the solution is
listed in Table 2.
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Table 2: Composition of intracellular patch solution

Compound

Concentration (mM)

Sodium chloride

10

Potassium chloride

140

Magnesium chloride

2

Calcium chloride

0.5

Ethylene glycol tertaacetic acid

1

HEPES buffer

10

3.3. NG108-15 cell culture
The NG108-15 cell line (passage number: 16) was obtained from Dr. M. W. Nirenberg,
National Institute of Health (NIH) and was sub-cultured according to previously published
protocols [27,41]. A vial of NG108-15 cells stored under liquid nitrogen was thawed and
immediately resuspened in 9ml of culturing medium. The medium with the cells was
centrifuged at 1000 RPM for 5 min. The supernatant was removed and the cells were
resuspened in 1ml of fresh culturing medium. A cell count was performed using tryphan blue in
a hemocytometer. During resuspension, cells were mixed slowly to avoid cell damage and care
was also taken to avoid bubbles. The suspension containing cells was then added to a T-75 flask
(Corning, NY, USA) containing 20ml of fresh differentiation medium. The flask was placed in a
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standard cell culture incubator at 37 oC for 72 hours to achieve 90% confluency (Figure 2).

Figure 2: A representative image of NG108-15 cells after reaching 90% confluency on Day 3.

DETA coated cover slips were sterilized by rinsing with ethanol in a biosafety hood. The
coverslips were allowed to dry in the hood and transferred to 6-well plates (Corning, NY)
followed by the addition of 3ml of fresh differentiation media. The plates were placed in the
incubator for 20 min. Cells were collected from the T75 flask by removing the culturing media
and adding 10ml of fresh differentiation media. The flask was tapped to detach the cells. The
medium with cells was centrifuged for 5 min at 1000 RPM. The supernatant were removed and
resuspened in 1ml of fresh differentiation medium. Cell count was performed using tryphan
blue in a hemocytometer. The cell mixture was diluted and plated at different densities. Cells
were plated at 4×105 cells per well for patch clamp electrophysiology and 8×105 to 1×106 cells
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per well for biochemical assays. A half media change was performed every 2 days. The
morphology of cells was examined every day and experiments were performed after 4 days
(Figure 3).

A

B

C

D

Figure 3: Differentiation of NG108-15 cells. The morphology of cells on DETA coated coverslips on DIV-1 (A), 3 (B), 4
(C) and 5 (D) is shown at 10x

3.4. Biochemical assays
The basal metabolism of the NG 108-15 cells was determined by performing biochemical
assays on day four. The rate of glucose uptake, lactate production, ATP and ADP concentrations
were determined.
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3.4.1. Glucose assay
The differentiation medium was taken out from the 6 well plate and 1ml of fresh
differentiation medium or differentiation medium containing drug was added. Samples were
collected every 20 min and the glucose concentration was analyzed using a colorimetric assay
kit. (Biovision, Inc; Catalog #K606-100). A sample of 4 µL was diluted by adding 16µL of assay
buffer solution and 2µL of the diluted sample was further diluted to total volume of 50µL/well.
The glucose standard curve was prepared by diluting the glucose standard to 1nmol/µL
by adding 10µL of the glucose standard to 990µL of glucose assay buffer. Various volumes,
namely 0, 2, 4, 6, 8 and 10 µL of the above solution were added into each well individually. The
volume was adjusted to 50µL/well with glucose assay buffer to generate 0, 2, 4, 6, 8 and 10
nmol/well of the glucose standard.
Enough reagents for the number of assays to be performed were pre-mixed. For each
well, a total 50µL reaction mix was prepared by adding 46µL glucose assay buffer, 2µL glucose
probe and 2µL glucose enzyme mix. Then 50µL of glucose reaction mix was added to each well
to obtain 100µL per well. The plate/reaction was then placed in an incubator at 370C for 30 min.
The absorbance was measured at 570nm using a Synergy HT mulitwell plate reader (BioTek
Instruments, Inc.). A calibration curve was performed simultaneously and the background was
corrected using the blank (Figure 4).
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Figure 4: Glucose assay standard curve

The concentrations of the samples were determined by the following equations:

𝐶=

𝑆𝑎 × 𝐷
𝑆𝑣

(8)

Where, C = Actual concentration from the graph; Sa = Sample amount (in nmol) from standard
curve; Sv = Sample volume added to the sample wells; D = Dilution factor
Calculation of Flux per minute per cell (Fmc),

 C 2  C1  1 
 
 T 2  T1  Cc 

𝐹𝑚𝑐 = 

(9)

Where, C2 = Concentration of glucose present at time (T2), C1 = Concentration of glucose
present at time (T1) and Cc = Cell count.
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3.4.2. Lactate assay
Samples were collected every 20 min and the lactate concentration was analyzed using
a colorimetric assay kit (Biovision, Inc; Catalog #K606-100). Samples were collected
simultaneously while performing the glucose assay. A sample of 4 µL was diluted by adding
16µL of assay buffer solution and 2µL of the diluted sample was further diluted to total volume
of 50µL/well.
The lactate standard curve was prepared by diluting the lactate standard to 1nmol/µL by
adding 10µL of the lactate standard to 990µL of lactate assay buffer and it was mixed well.
Various volumes, namely 0, 2, 4, 6, 8 and 10 µL of the above solution were added into each well
individually. The volume was adjusted to 50µL/well with glucose assay buffer to generate 0, 2,
4, 6, 8 and 10 nmol/well of the lactate standard.
Sufficient reagents for the number of assays to be performed were pre-mixed. For each
well, a total 50µL reaction mix was prepared by adding 46µL lactate assay buffer, 2µL lactate
probe and 2µL lactate enzyme mix. Then 50µL of lactate reaction mix was added to each well so
that each well totaled 100µL in volume. The plate/reaction was then placed in the incubator at
370C for 30 min. The absorbance was measured at 570nm using as Synergy HT mulitwell plate
reader (BioTek Instruments, Inc.). A calibration curve was performed simultaneously and the
background was corrected using the blank (Figure 5).
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Figure 5: Lactate assay standard curve

Calculation of the Unknown concentration using linear trend:

𝐶=

𝑆𝑎 × 𝐷
𝑆𝑣

(10)

Where, C = Actual concentration from the graph; Sa = Sample amount (in nmol) from standard
curve; Sv = Sample volume added to the sample wells; D = Dilution factor
Calculation of Flux per minute per cell (Fmc),

 C 2  C1  1 
 
 T 2  T1  Cc 

𝐹𝑚𝑐 = 

(11)

Where, C2 = Concentration of glucose present at time (T2), C1 = Concentration of glucose
present at time (T1) and Cc = Cell count.
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3.4.3. ATP assay
On day 4, differentiation medium was replaced with the either fresh or drug containing
medium. Cells were incubated and samples were collected for every 20 min and 60 min. Cells
were rinsed twice and collected by trypsinization. The detached cells were resuspended in
extracellular solution and cell count was performed. Cells were centrifuged and 100uL of ATP
assay buffer was added to the cells followed by adding 20 µL of PCA and 5 µL of neutralization
solution (Deproteinizing Sample Preparation Kit, Biovision, Inc, Catalog#: K808-200). The sample
was then frozen until all the remaining samples were collected. 50 µL of the sample was
analyzed using the ATP assay kit (Biovision, Inc; Catalog #K354-100).
The ATP standard curve was prepared by diluting the ATP standard to 1nmol/µL by
adding 10µL of the ATP standard to 990µL of ATP assay buffer. Various volumes, namely 0, 2, 4,
6, 8 and 10 µL of the above solution was added into each well individually. The volume was
adjusted to 50µL/well with ATP assay buffer to generate 0, 2, 4, 6, 8 and 10 nmol/well of the
ATP standard.
Reagents for the number of assays to be performed were pre-mixed. For each well, a
total 50µL reaction mix was prepared by adding 44µL ATP assay buffer, 2µL ATP probe, 2µL ATP
developer min and 2µL ATP converter. Then 50µL of ATP reaction mix was added to each well
so that each well totaled 100µL in volume. The plate/reaction was then placed in the incubator
at 370C for 30 min. The absorbance was measured at 570nm using as Synergy HT mulitwell
plate reader (BioTek Instruments, Inc.). The calibration curve was performed and the
background was corrected by subtracting the value from the 0 lactate control from all readings
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(Figure 6).
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Figure 6: ATP assay standard curve

Calculation of the ATP concentration(C) using linear trend:

𝐶=

𝑆𝑎 × 𝐷
𝑆𝑣

(12)

Where, C = Actual concentration from the graph, Sa = Sample amount (in nmol) from standard
curve, Sv = Sample volume added to the sample wells, D = Dilution factor, Total cell volume =
number of cells × cell volume.
Dilution factor (D) was calculated as,

𝐷=

𝑇𝑜𝑡𝑎𝑙 𝑐𝑒𝑙𝑙 𝑣𝑜𝑙𝑢𝑚𝑒
𝑇𝑜𝑡𝑎𝑙 𝑐𝑒𝑙𝑙 𝑣𝑜𝑙𝑢𝑚𝑒 + 𝑃𝐶𝐴 + 𝑁𝑒𝑢𝑡𝑎𝑙𝑖𝑧𝑎𝑡𝑖𝑜𝑛 𝑠𝑜𝑙𝑢𝑡𝑖𝑜𝑛
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(13)

3.4.4. ADP assay
An ADP assay was performed in parallel with the ATP assay. On day 4, differentiation
medium was replaced with either fresh or drug containing medium. Cells were incubated and
samples were collected for every 20 min and 60 min. Cells were rinsed twice and collected by
trypsinization. The detached cells were resuspended in extracellular solution and cell count was
performed. Cells were centrifuged and 100µL of ADP assay buffer was added to the cells
followed by adding 20µL of PCA and 5µL of neutralization solution (Deproteinizing Sample
Preparation Kit, Biovision, Inc, Catalog#: K808-200). The sample was then frozen until all the
remaining samples were collected. 50uL of the sample was analyzed using the ADP assay kit
(Biovision, Inc; Catalog #K355-100).
The ADP standard curve was prepared by diluting the ADP standard to 1nmol/µL by
adding 10µL of the ADP standard to 990µL of ADP assay buffer and it was mixed well. Various
volumes, 0, 2, 4, 6, 8 and 10 µL, of the above solution was added into each well individually. The
volume was adjusted to 50µL/well with ADP assay buffer to generate 0, 2, 4, 6, 8 and 10
nmol/well of the ADP standard.
Required quantity of reagents for the number of assays to be performed was pre-mixed.
For each well, a total 50µL reaction mix was prepared by adding 44µL ADP assay buffer, 2µL
ADP probe, 2µL ADP developer min and 2µL ADP converter. Then 50µL of ATP reaction mix was
added to each well so that each well totaled 100µL in volume. The plate/reaction was then
placed in the incubator at 370C for 30 min. The absorbance was measured at 570nm using as
Synergy HT mulitwell plate reader (BioTek Instruments, Inc.). The calibration curve was
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performed and the background was corrected by subtracting the value from the blank from all
readings (Figure 7).
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Figure 7: ADP assay standard curve

Calculation of the ADP concentration(C) using linear trend:

𝐶=

𝑆𝑎 × 𝐷
𝑆𝑣

(14)

Where, C = Actual concentration from the graph; Sa = Sample amount (in nmol) from standard
curve; Sv = Sample volume added to the sample wells; D = Dilution factor; Total cell volume =
number of cells × cell volume.
Dilution factor (D) was calculated as,
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𝐷=

𝑇𝑜𝑡𝑎𝑙 𝑐𝑒𝑙𝑙 𝑣𝑜𝑙𝑢𝑚𝑒
𝑇𝑜𝑡𝑎𝑙 𝑐𝑒𝑙𝑙 𝑣𝑜𝑙𝑢𝑚𝑒 + 𝑃𝐶𝐴 + 𝑁𝑒𝑢𝑡𝑎𝑙𝑖𝑧𝑎𝑡𝑖𝑜𝑛 𝑠𝑜𝑙𝑢𝑡𝑖𝑜𝑛

(15)

3.5. Patch clamp electrophysiology
Patch clamp electrophysiology was performed on the NG108-15 cells to collect
parameters for the model. Whole cell recordings were performed to assess changes in cellular
membrane electrical activity. The instrumentation and the methodology to record cellular
electrical activity are described in the following sections.

3.5.1. Instrumentation
The experimental setup for performing patch clamp electrophysiology is shown in figure
2A. It consists of a a Zeiss Axioscope 2 FS plus upright microscope (Figure 8B) which was
mounted on a Gibraltar platform with motors for movement in X and Y directions (Figure 8B).
The whole system was mounted on a vibration-isolation table to avoid unwanted vibrations
during recording. A Faraday cage was also installed round the system and grounded to protect
the interior against external electric fields and electrostatic discharges. Micromanipulators
were used to precisely manipulate the patch pipette at a micrometer resolution. The pipette
holder was attached to the headstage (Figure 2B) and was also equipped with a flexible tube to
control pressure.
The electrodes were prepared using a Shutter 97 pipette puller (BF150-86-10; Sutter,
Novato, CA) as shown in Figure 8B. The voltage clamp and current clamp measurements were
performed on a Multiclamp 700B amplifier (Axon Instrument, Foster City, CA, USA) as shown in
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Figure 2C. An Axon Digidata 1322A (Figure 8C) interface was used to filter the signals at 2 kHz
and digitized at 20 kHz. The probe from Axon Digidata 1322A was connected to the
micromanipulators and pipette holder. All data acquisition was performed using pClamp 10
software (Axon Instruments, Foster City, CA, USA).

A

B

C

D

Figure 8: Set up of the electrophysiology rig having the microscope mounted on a gibraltor stage (A). Pipette puller
(B), Amplifier (C), micromanipulator (D) is also shown
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3.5.2. Whole cell recordings
Whole-cell patch recordings were performed on the stage of a Zeiss Axioscope 2 FS Plus
upright microscope (Axiovert 200, Carl Zeiss, Göttingen, Germany). The recordings were
obtained at room temperature (21-25 oC) in the recording chamber containing differentiation
medium. The recording chamber was continuously perfused with the differentiation medium.
To investigate the effect of the drugs on action potential, metabolic inhibitors were added to
the medium. Patch pipettes (4–6 MΩ resistance) were prepared from borosilicate glass with a
Sutter P97 pipette puller and filled with intracellular solution.
The cell to be patched was observed under a 40X objective. The electrode was
positioned till the tip was bright on the monitor and immerse in the patch chamber (Figure 9).
The pipette offset was compensated. The objective was lowered followed by the electrode until
one could see the electrode was above the cell (Figure 10). The Seal Resistance was recorded
and the electrode was pushed towards the cell membrane. The pipette then touched the cell
and an increase of 0.5mohms was observed. The initially applied pressure was removed and
gentle suction was applied by mouth. If required, constant pressure was applied to form a seal.
The image of the cell was saved. A holding potential of -70mV (in Multiclamp) was applied to
form the gigaohm seal. The leakage current on the amplifier was less than 30pA. The gigaohmseal formed was recorded and the pipette capacitance (fast & slow) was compensated. A short
slight suction ‘Kiss’ was applied to open the cell membrane and the capacitive transient was
observed. The membrane resistance was recorded and the seal test window was switched off.
The membrane potential was checked by switching to I=0 mode. The whole cell
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parameters (click Auto) followed by leak subtraction (auto) were compensated. The stability of
the patch was checked by clicking on membrane test and results were saved. The gain and
Bessel were set to 5 and 3 respectively. The ionic currents were measured in voltage clamp
mode using 10mV voltage steps from a holding potential of -85mV. By holding the voltage
constant the changes in current was measured in voltage clamp mode. A p/6 protocol was
implemented upon compensating for the whole cell capacitance and series resistance. The
access resistance of the patched cells was less than 20 MΩ. Experimental parameters such as
membrane resistance, membrane capacitance, resting membrane potential and injected
stimulus current were noted. The protocol in clampex was then initiated. The membrane test
was again performed and the results were saved.

Figure 9: An image showing the glass electrode, ground electrode, patching chamber, objective lens on an
electrophysiology rig
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The action potentials were recorded by switching to IC mode and by compensating for
bridge balance. The holding current was adjusted to get a membrane potential of -70mV. A 2
ms depolarizing current injections was injected to initiate action potentials. The perfusion
system was switched to add the drug. The APs were continuously recorded until either the
patch was lost or the cell could no longer generate an AP. The membrane test was checked and
results were saved.

Figure 10: Picture of NG108-15 cell during electrophysiological recording

A voltage clamp recording was again performed at the end to see the effects of drugs on
VC recording. All the recordings were corrected for a junction potential that developed during
the interface between the patch electrode and the bath solution. The Multiclamp 700B files
were also saved for extraction of any other parameters, if necessary. Data was saved and
imported into MATLAB using a custom code for parameter estimation.
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CHAPTER-4: MODEL DEVELOPMENT

The neuronal-metabolic model was built in a top-down approach by integrating the
ensemble metabolic model to a modified Hodgkin Huxley based neuronal module. The models
were implemented with physiological compartments, including physiological volumes. The
metabolic compartments were nested in the cytosolic volume and the total cellular volume was
nested in the extracellular volume. The compartments were implemented as volumetric ratios
as shown in Table 3.
Table 3: Volumetric ratios of nested cellular compartments

Compartment

Volumetric ratio

Reference

Total Intracellular volume

1

Estimated

Bulk cytosolic space

0.65

[70]

Sub-cellular space

0.02

[70]

Mitochondria

0.05

[71]

Endoplasmic reticulum

0.1

Estimated

Others (Nucleus, Lysosomes)

0.28

Estimated

A modular approach was utilized during model reconstruction. The model development was
completed in 3 major developmental stages, (1) reconstruction of a neuronal metabolism, (2)
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development of neuronal module and (3) the integration of models for predicting effects of
metabolic perturbations. Each of these modules is described in the following sections.

4.1. Reconstruction of metabolic model
The metabolic module for NG108-15 cells includes the core metabolic pathways for
carbon metabolism and cellular bioenergetics and was reconstructed by combining glycolysis
[72], mitochondria [59] and endoplasmic reticulum [73,74] modules. The model was
reconstructed in MATLAB Simbiology. Simbiology allows for rapid expansion of the model by
facilitating the addition of other cellular processes through Systems Biology Markup Language
(SBML). It also provides access to several solvers for simulation of dynamic models of cellular
process. The equations can be programmed directly in MATLAB but Simbiology enables us to
implement it in a graphic user-interface (GUI) by creating a diagram for visualization. The data
can be imported and exported easily from Simbiology. Moreover, it is backed up by the entire
MATLAB suite which can help perform various analyses using any custom code. A detailed list of
reactions, fluxes, parameters and metabolite concentrations are depicted in the Appendix.

4.1.1. Glycolysis model
The glycolysis module was adapted from a comprehensive model of energy and redox
metabolism for human erythrocytes [58]. This mathematical model converts glucose to lactate
through a series of 13 reactions, from hexokinase to lactate dehydrogenase via 2,3biphosphoglyceate shunt involving 19 reactants (Figure 11). Glycolysis requires oxidized
Nicotinamide adenine dinucleotide (NAD+) and reduced Nicotinamide adenine dinucleotide
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(NADH). The NADH is utilized by the cells and is recycled back to NAD+. Several reactions are
capable of performing this conversion and one of them is the lactate dehydrogenase (LDH) that
converts pyruvate into lactate. The lactate is then transported out of the cell via the
monocarboxylate transporters (MCT). The MCT’s are also equipped to transport pyruvate.

Figure 11: Glycolytic module consisting of glycolysis, pentose phosphate pathway and glutathione
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In addition, the glycolytic module also contains ten other reactions that include
glutathione oxidation, glutathione reduction and pentose phosphate pathway (PPP). The
glutathione reduction and oxidation dictates the conversion of Nicotinamide adenine
dinucleotide phosphate (NADPH) to NADP thereby influencing the lactate dehydrogenase
enzyme activity. The glutathione process has been lumped together into a generalized reaction.
A sink for phosphoribosylpyrophosphate (PRPP) has been included for the consumption of
carbon entering the PPP to avoid the accumulation of intracellular metabolites. The ATP
dependent exchangers were incorporated and calibrated to match the activities obtained from
the neuronal module. A generalized ATP consumption reaction has been implemented to
represent all the other ATP utilizing pathways. The total adenine concentration has been
maintained constant by including the conservation condition and an adenine kinase reaction
that mediates the conversion of ADP to AMP and ATP [72]. The total adenine nucleotides
including the NAD+ and NADH, NADP and NADPH and FAD+ and FADH2 were held constant. The
temporal behavior of the metabolite concentration is based on ordinary differential equations.
All the rate equations have a general form as described in equation 16,

𝑐 + 𝑖𝑗

𝑣 = 𝑉𝑚𝑎𝑥 × 𝑟(𝑋) × (∏ 𝑥𝑖
𝑖

−

1
𝑐−
∏ 𝑥𝑖 𝑖𝑗 )
𝑞

(16)

𝑖

Where c+ and c- are the positive and negative elements of the stoichiometric matrix, q is the
equilibrium constant and r(X) is the regulatory function for saturation, allostery, etc [58]. Earlier
models have described the HK, PFK, PK, DPGM, DPG, G6PD, 6PGD and GSSR to be completely
irreversible. An increase of backward fluxes by several orders of magnitude due to high
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accumulation of metabolites was avoided by using rate equations based on equation 16. The
equilibrium constants and kinetic equations were taken from several other sources [58]. The
equations for AK, PGK and enolase were based on data from previously published results [58].
AK and PGK were considered to have a random BiBi mechanism. PGM and enolase are based on
an UniUni mechanism [58].

4.1.2. Mitochondrial model
The mitochondrial model was adapted from a cardiac mitochondrial metabolism model
and consists of 22 reactions involving 27 reactants [59]. The total mitochondrial volume was set
to be 5% of the total cell volume [71]. The model incorporates the main mitochondrial
electrophysiological and metabolic process including the oxidative phosphorylation and matrixbased process in mitochondria (Figure 12). The reaction rates of the enzymes in the TCA cycle
namely, citrate synthase, isocitrate dehydrogenase, α-ketoglutarate dehydrogenase and malate
dehydrogenase have been implemented as described and implemented as described by
Cortassa et al [59]. Sensitivity to calcium is also incorporated for IDH and KDGH. The TCA cycle
in the model can be divided into two pathways, the tricarboxylate (oxaloacetate to αketoglutarate) and the dicarboxylate (α-ketoglutarate to oxaloacetate) pathway. Acetyl-CoA
and oxaloacetate react and produce α-ketoglutarate (αKG), NADH, and CO2. αKG serves as a
substrate of the dicarboxylate pathway producing OAA that resupplies and initiates the
tricarboxylate pathway.
The mitochondrial model involves the complete oxidation of acetyl CoA to generate
NADH and ATP. Acetyl CoA is the point of convergence for carbohydrate, amino acid and fatty
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acid metabolism. The oxidation of acetyl CoA produces NADH and FADH2, which are oxidized to
propel oxidative phosphorylation. The model includes both the explicit electrical gradient (ΔΨ m)
and the proton gradient across the mitochondrial inner membrane established by oxidative
phosphorylation. The protons from NADH and FADH2 are oxidized pumping protons across the
mitochondrial inner membrane establishing a proton motive force and proton gradient. The
large ΔΨm of the inner mitochondrial membrane determines the electrochemical transport of
ions across, including calcium influx and efflux. The proton motive forces drive the
phosphorylation of matrix ADP to ATP by F1F0-ATPase. The F1F0-ATPase activity accounts for the
reversibility of the enzyme when the ΔµH collapses.

Figure 12: Diagram showing mitochondrial module in Simbiology

The Adenine Nucleotide Transporter (ANT) transports the ATP from the inner
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membrane of the mitochondria to the cytosol and reaction was implemented. The model also
incorporates a proton leak that influences the mitochondrial membrane potential and proton
motive force that follows a thermokinetic formulation. The mitochondrial membrane potential
is determined by,
dΔΨm 𝑉𝐻𝑒 + 𝑉𝐻𝑒(𝐹) − 𝑉𝐻𝑢 − 𝑉𝐴𝑁𝑇 − 𝑉𝐻𝑙𝑒𝑎𝑘 − 𝑉𝑁𝑎𝐶𝑎 − 2𝑉𝑢𝑛𝑖
=
dt
𝐶𝑚𝑖𝑡𝑜

(17)

Where, 𝑉𝐻𝑒 , 𝑉𝐻𝑒(𝐹) , 𝑉𝐻𝑢 , 𝑉𝐴𝑁𝑇 , 𝑉𝐻𝑙𝑒𝑎𝑘 , 𝑉𝑁𝑎𝐶𝑎 𝑎𝑛𝑑 𝑉𝑢𝑛𝑖 are the rates of NADH oxidation, FADH2
oxidation, F1F0-ATPase , adenine nucleotide transporter, sodium-calcium exchanger and calcium
uniporter. The redox (Ares), phosphorylation (AF1) potentials and the proton motive force (ΔµH)
are the driving forces. The coefficients in the equations and the rate constants of are obtained
from Cotrassa et.al [59]. In addition, the model considers the explicit dependence of the TCA
cycle dehydrogenases on mitochondrial calcium concentration. The influx of calcium through
the Ca+2 uniporter and the Na-dependent Ca+2 efflux driven by Na+/Ca+2 antiporter determines
the mitochondrial calcium concentration. The phosphate transport into the mitochondria also
has the general form described in equation 16.

4.1.3. Endoplasmic reticulum Model
The endoplasmic reticulum (ER) model was included to study the effect of calcium on
cellular dynamics. The ER model consists for the IP3 receptor, sarcoplasmic reticulum calcium
ATPase (SERCA) and a calcium leak (Figure 13). These pumps were implemented as described in
Chen et.al [74]. The activation/inhibition of the general plasma membrane receptor has been
coupled with the activation of phospholipase C (PLC), which converts phosphatidylinositol 4,559

biphosphate (PIP2) to inositol 1,4,5-triphosphate and diacylglycerol (DAG). The rate equation
for the hydrolysis of PIP2 and IP3 and DAG by PLC was implemented using Michaelis-Menten
kinetics and multiplied by its Boolean value. Therefore, when the Boolean value is zero, the
reaction rate is zero, and when the Boolean value is one, the reaction rate is given by equation
18,
[𝑃𝐼𝑃2 ]
𝑣 = 𝑉𝑚 ∗ (
)
𝐾𝑚 +[𝑃𝐼𝑃2 ]

(18)

Figure 13: Implemented endoplasmic reticulum module in Simbiology

A simple rate equation was implemented for IP3 and DAG consumption, which used
mass action kinetics IP3 then, activates IP3R calcium channels on the endoplasmic reticulum
membrane, through which endoplasmic reticulum calcium is released into the cytosol. While
the flux of calcium to and from the mitochondria has been addressed by the implementation of
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the mitochondrial metabolism model [59], the ER calcium flux has been addressed by
implementing reactions as described in Marhl et al. [73]. The IP3 calcium channel kinetics was
modified as described by Chen et al and includes a dependence of IP3 that was absent in the
channel reaction rate as described by Marhl et al.

4.1.4. Ensemble metabolic model
The glycolysis and the mitochondrial model were coupled by including the reactions for
pyruvate transport into mitochondria followed by conversion of acetyl Co-A by pyruvate
dehydrogenase (Figure 14). The rate equation for pyruvate transport into mitochondrial space
had the general form previously described in equation 16,

𝑣 = 𝑉𝑚𝑎𝑥 ([𝑃𝑦𝑟]𝑐𝑒𝑙𝑙 −

[𝑃𝑦𝑟]𝑚𝑖𝑡𝑜
)
𝐾𝑒𝑞𝑃𝑇

(19)

Where, 𝐾𝑒𝑞𝑃𝑇 is the equilibrium constant for pyruvate transport, [𝑃𝑦𝑟]𝑀𝑖𝑡𝑜 and [𝑃𝑦𝑟]𝑐𝑒𝑙𝑙 are
the concentrations of pyruvate in the mitochondria and cytosol. The rate equation for pyruvate
dehydrogenase was implemented using the irreversible mass action kinetics as described by
Nazaret et al. [75] and is shown below.

𝑣 = 𝐾𝑃𝐷𝐻 ([𝑃𝑦𝑟]𝑀𝑖𝑡𝑜 −

[𝐴𝑐𝐶𝑜𝐴]𝑚𝑖𝑡𝑜
) [𝐶𝑜𝐴]𝑚𝑖𝑡𝑜 [𝑁𝐴𝐷]𝑚𝑖𝑡𝑜
𝐾𝑒𝑞𝑃𝐷𝐻

(20)

Where, 𝐾𝑃𝐷𝐻 is the Michaelis constant for PDH, 𝐾𝑒𝑞𝑃𝐷𝐻 is the equilibrium constant for PDH,
[𝑃𝑦𝑟]𝑀𝑖𝑡𝑜 , [𝐴𝑐𝐶𝑜𝐴]𝑚𝑖𝑡𝑜 , [𝐶𝑜𝐴]𝑚𝑖𝑡𝑜 and [𝑁𝐴𝐷]𝑚𝑖𝑡𝑜 are the concentrations of pyruvate, AcetylCoA, CoA and NAD in mitochondria.
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Figure 14: Reconstructed NG108-15 metabolic model in MATLAB Simbiology

The Glycerol-3 Phosphate (G3P) shuttle for transferring the NADH equivalents into the
mitochondria was incorporated using irreversible mass action kinetics. The shuttle is
irreversible and not as efficient as the malate-aspartate shuttle (MAS). It can generate only 1.5
ATP compared to 2.5 ATP transferred by MAS [51]. The reducing equivalents of NADH are
transferred to glycerol-3 phosphate which is converted to dihydroxyacetone phosphate on the
mitochondrial membrane by mitochondrial glycerol-3phosphate dehydrogenase. Thus the
reducing equivalents are transferred to FAD to form FADH2 in the mitochondria which are
further oxidized to generate the required proton motive force for ATP production.
The cytosolic ATP and ADP levels are linked to the mitochondrial Adenine Nucleotide
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Transporter activity. The ATP consumption by the ATP-dependent pumps was incorporated and
matched to the activity of that obtained in the neuronal module. The generalized ATPase
reaction was also included to represent all the other ATP consuming processes in the cell. The
general ATPase reaction will further be categorized upon incorporation of other modules and
ATP dependent reactions. The mitochondrial calcium uptake and release was tied to the
cytosolic calcium concentration. The cytosolic calcium concentration is again dependent on the
calcium fluxes from the endoplasmic reticulum and the neuronal module. The phosphate
transport into the cell and mitochondria was implemented based on equation 16.
The cellular volume of NG108-5 cells was calculated using the equation of volume for a
sphere. A radius of 22.5µm was used and is within the experimentally observed range published
by American Type Culture Collection (ATCC) and also in agreement with the cell volume
reported by Dubois el al. [76].

4.1.5. Parameter estimation for metabolism model
The rate equations in the metabolic model contain several parameters such as Vmax, Km,
Ki etc. The values of the parameters are dependent on mutations, binding of effectors, lack of
cofactors, etc.. In the glycolytic module only specific parameters such as the maximum activity
Vmax is considered to alter as it reflects the concentration of the enzymes and the structural
modifications of the enzyme [58]. The Vmax’s for the set of glycolytic, PPP, pyruvate transport
and lactate transport reactions were scaled directly. The mitochondrial module has no Vmax’s
but instead the mitochondrial enzyme concentration (E) is altered directly.
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The flux of all the reactions in the metabolic reaction was obtained by forcing the model
to a steady state. The steady state fluxes were set to obey the flux balance condition as shown
below to represent the conservation of mass for reaction system. In steady state, the
dependent change of metabolic concentrations in equation 21 is zero. The sundials solver was
used with an absolute tolerance of 1.0e-8 and a relative tolerance of 1.0e-5. Sundials solver was
recommended by MATLAB for running simulations that use rules and events.
𝑟

𝑟

∑ 𝑁𝑖𝑗 𝑉𝑗 = ∑ 𝑁𝑖𝑗 (𝑉𝑗
𝑗=1

(+)

− 𝑉𝑗

(−)

)=0

(21)

𝑗=1

Optimization was performed using built-in MATLAB optimization routines. The function
‘fmincon’ computes a constrained minimum of a function by varying the variables within
specific bounds. Metabolites fluxes have been included as constraints in FBA. The fluxes of
glucose uptake and lactate release were constrained during parameter estimation. The
intracellular levels of ATP and ADP were also constrained during flux balance analysis by
applying sum of squared residuals.
Model optimization was carried out by applying the weighted least squares fitting
method. The least square method minimizes the summed square of residuals. The residuals are
the difference between simulated values and experimental values,
𝑟𝑛 = 𝑆𝑛 − 𝐸𝑛

(22)

The fit was improved by incorporating an additional scaling factor (weight) in the fitting
process. The error estimate with weighted least-squares regression was determined by
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𝑠𝑠𝑟 = ∑ 𝑤(𝑟)2

(23)

𝑛

Where, the simulated flux is given by 𝑆 and the experimental flux by 𝐸. The influence of
parameter estimate is response is determined by weight 𝑤. An arbitrary weight has been
implemented to prioritize parameters during estimation. The algorithm implemented during
parameter extraction is shown in Figure 15.

Figure 15: Flowchart for estimation of metabolic model parameters
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4.2. Development of neuronal module
The neuronal module was implemented on the cell membrane (Figure 16). The ions
move from the extracellular space to the sub-cellular space and from the subcellular space to
the bulk cytosol. A modified Hodgkin-Huxley formulation based on incorporating a
thermodynamic approach was employed to implement the neuronal module. The rate of
change in membrane potential (Vm) was determined using,
𝑑𝑉
− 𝐼𝑖𝑜𝑛 + 𝐼𝑠𝑡𝑖𝑚
=
𝑑𝑡
𝐶𝑚

(24)

Where, Cm is the membrane capacitance, Istim is the stimulus current and Iion is the sum of all the
ionic currents.

Figure 16: Schematic representation of neuronal module
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The total ionic current 𝐼𝑖𝑜𝑛 and the leakage current 𝐼𝐿 were defined as,
𝐼𝑖𝑜𝑛 = 𝐼𝑁𝑎 + 𝐼𝐾 + 𝐼𝐶𝑎 + 𝐼𝐾𝐴𝑇𝑃 + 𝐼𝑁𝑎𝐾𝐴𝑇𝑃𝑎𝑠𝑒 + 𝐼𝑁𝐶𝑋 + 𝐼𝐶𝑎𝐴𝑇𝑃𝑎𝑠𝑒 + 𝐼𝐿𝑁𝑎 + 𝐼𝐿𝐾
(25)

+ 𝐼𝐿𝐶𝑎 + 𝐼𝐿𝐺𝑒𝑛

Where, 𝐼𝑁𝑎 , 𝐼𝐾 𝑎𝑛𝑑 𝐼𝐶𝑎 is the current generated from the voltage gated sodium, potassium and
calcium channels, 𝐼𝐾𝐴𝑇𝑃 is from ATP-dependent potassium channel, 𝐼𝑁𝑎𝐾𝐴𝑇𝑃𝑎𝑠𝑒 is from the
sodium-potassium exchanger, 𝐼𝐶𝑎𝐴𝑇𝑃𝑎𝑠𝑒 is from the calcium pump, 𝐼𝑁𝐶𝑋 is from the sodium
calcium exchanger. 𝐼𝐿𝑁𝑎 + 𝐼𝐿𝐾 𝑎𝑛𝑑 𝐼𝐿𝐶𝑎 are the specific ionic leakages for sodium, potassium and
calcium ions. 𝐼𝐿𝐺𝑒𝑛 represents the general leak. The method for determination of all the ionic
currents is described in the following sections.

4.2.1. Voltage gated channels
The voltage gated sodium, potassium and calcium ion channels were implemented using
the thermodynamic formulation [27]. These gates are controlled and activated by changes in
membrane potential. A simple two state (open/close) formalism is adapted to describe the
channel activation and inactivation. The voltage gated ionic currents are given by

𝐼𝑁𝑎 = 𝑔𝑁𝑎 𝑚3 ℎ(𝑉𝑚 − 𝑉𝑁𝑎 )

(26)

𝐼𝐾 = 𝑔𝐾 𝑛4 (𝑉𝑚 − 𝑉𝐾 )

(27)

𝐼𝐶𝑎 = 𝑔𝐶𝑎 𝑒 3 (𝑉𝑚 − 𝑉𝐶𝑎 )

(28)

Where 𝑔𝑁𝑎 , 𝑔𝐾 , 𝑔𝐶𝑎 , 𝑉𝑁𝑎 , 𝑉𝐾 and 𝑉𝐶𝑎 are maximum ion channel conductance and reversal
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potentials of sodium, potassium and calcium respectively. The dynamics of gating variables 𝑚,
ℎ, 𝑛, and 𝑒 with their steady state values 𝑚∞ , ℎ∞ , 𝑛∞ , and 𝑒∞ as and the respective voltage
dependent time constants 𝜏’s are given by,
𝑑𝑚 𝑚∞ − 𝑚
=
𝑑𝑡
𝜏𝑚

(29)

𝑑ℎ ℎ∞ − ℎ
=
𝑑𝑡
𝜏ℎ

(30)

𝑑𝑛 𝑛∞ − 𝑛
=
𝑑𝑡
𝜏𝑛

(31)

𝑑𝑒 𝑒∞ − 𝑒
=
𝑑𝑡
𝜏𝑒

(32)

The voltage dependent steady state parameters and their respective time constants were
determined using the general formula,

𝑚∞ =

𝜏𝑚 =

1
1+𝑒

−𝑧𝐹(𝑉𝑚 −𝑉1/2 )/𝑅𝑇

𝐴
𝑒 (𝑧𝐹𝜉/𝑅𝑇)(𝑉𝑚−𝑉1/2 ) cosh(𝑧𝐹(𝑉𝑚 − 𝑉1/2 )/2𝑅𝑇)

(33)

(34)

Where, 𝑧 is relates to the number of moving charges during the opening and closing of the ion
channels, 𝑉1/2 is the half activation/inactivation potential of an ion channel; 𝐴 is related linearly
to the activation or inactivation time constant, 𝜉 is the asymmetric position of the moving
charge in the cell membrane, 𝑅 is real gas constant, 𝐹 is Faraday’s constant, 𝑇 is temperature,
𝑅𝑚 is membrane resistance and 𝑉𝑚 is the resting membrane potential.
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The reversal potentials were calculated as follows,

[𝑁𝑎]𝑜𝑢𝑡
𝑉𝑁𝑎 = 59.16 log10 (
) = 65 𝑚𝑉
[𝑁𝑎]𝑖𝑛

(35)

[𝐾]𝑖𝑛
) = − 85 𝑚𝑉
[𝐾]𝑜𝑢𝑡

(36)

𝑉𝐾 = 59.16 log10 (

𝑉𝐶𝑎 =

[𝐶𝑎]𝑜𝑢𝑡
59.16
log10 (
) = 124 𝑚𝑉
[𝐶𝑎]𝑖𝑛
2

(37)

Where the Na+, K+ and Ca+2 are the intracellular and extracellular ionic concentrations. The
resting membrane potential was back calculated from the experimental holding potentials
using the reversal potentials and the maximum ionic conductance using equation 38.

𝑉𝑚 =

𝑔𝑁𝑎 𝑉𝑁𝑎 + 𝑔𝑘 𝑉𝐾 + 𝑔𝐶𝑎 𝑉𝐶𝑎 + 𝑔𝑙𝑒𝑎𝑘 𝑉𝑙𝑒𝑎𝑘
𝑔𝑁𝑎 + 𝑔𝐾 + 𝑔𝐶𝑎 + 𝑔𝑙𝑒𝑎𝑘

(38)

4.2.2. ATP dependent potassium channel
An ATP-dependent potassium channel was incorporated and is activated when the
cellular ATP decreases. The equation has been adapted from Cunningham et al. [77] and is
defined as,
𝐼𝐾𝐴𝑇𝑃 = 𝑔𝐾𝐴𝑇𝑃 𝑧(𝑉𝑚 − 𝑉𝐾 )

𝑧=

1
[𝐴𝑇𝑃] 𝛾
1+(
)
𝑘12

(39)
(40)

Where, 𝑔𝐾𝐴𝑇𝑃 is the maximum conductance of z is the gating variable, [ATP] is the ATP
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concentration, k12 is 0.06, 𝑉𝐾 is the reversal potential of potassium and the hill coefficient (𝛾) is
1.

4.2.3. ATP dependent sodium-potassium pump
The sodium potassium exchanger has been implemented as described by Kager et al.
[78] to restore the balance for sodium and potassium ions. The pump contributes an
electrogenic factor as it transports 3 Na+ in exchange for 2 K+ by consuming ATP. The ATP
dependence was incorporated for ATP consumption and to determine its activity based on
changes in intracellular ATP levels [79].

𝐴𝑝𝑢𝑚𝑝

𝐾𝑚𝐾 −2
𝐾𝑚𝑁𝑎 −3
𝐾𝐴𝑇𝑃 −1
= ((1 +
) ) × ((1 +
) ) × ((1 +
) )
[𝐾𝑜 ]
[𝑁𝑎𝑖 ]
[𝐴𝑇𝑃]

(41)

𝑁𝐾𝐴
𝐼𝐾𝐴𝑇𝑃𝑎𝑠𝑒 = −2 ∗ 𝐼𝑚𝑎𝑥
∗ 𝐴𝑝𝑢𝑚𝑝

(42)

𝑁𝐾𝐴
𝐼𝑁𝑎𝐴𝑇𝑃𝑎𝑠𝑒 = 3 ∗ 𝐼𝑚𝑎𝑥
∗ 𝐴𝑝𝑢𝑚𝑝

(43)

The pump is modeled using the above modified rate equation where 𝐾𝑚𝐾 is 3.5 mM/L, 𝐾𝑚𝑁𝑎 of
𝑁𝐾𝐴
10 mM/L and 𝐾𝐴𝑇𝑃 = 5 mM [78,79]. 𝐼𝑚𝑎𝑥
is the maximal flux generated by the pump to

compensate the leaks and other pumps to obtain a steady state at rest. The literature reported
𝑁𝐾𝐴
value for 𝐼𝑚𝑎𝑥
is 0.013 mA/cm2[78].

4.2.4. Sodium-calcium exchanger
The sodium calcium exchanger (NCX) transports 3 Na+ in exchange for Ca+2 and is
electrogenic. The exchanger was implemented using the formulation as described by
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Courtemanche et al. [80,81].
𝐾𝑏 = 𝑒 (

𝐾𝑞𝑎 =

𝐴𝑁𝐶𝑋 =

Where, 𝐾𝑚𝑁𝑎

𝛾 𝑉𝑚 𝐹
)
𝑅𝑇

(44)

(𝛾−1) 𝑉𝑚 𝐹
(
)
𝑅𝑇
𝑒

([𝑁𝑎]3𝑖 × [𝐶𝑎]𝑜 × 𝐾𝑏 ) − ([𝑁𝑎]3𝑜 × [𝐶𝑎]𝑖 × 𝐾𝑞𝑎 )
3
(𝐾𝑚
+ [𝑁𝑎]3𝑜 ) (𝐾𝑚𝐶𝑎 + [𝐶𝑎]𝑜 ) (1 + 0.1𝐾𝑞𝑎 )
𝑁𝑎

(45)

(46)

𝑁𝐶𝑋
𝐼𝑁𝑎𝑁𝐶𝑋 = −3 ∗ 𝐼𝑚𝑎𝑥
∗ 𝐴𝑁𝐶𝑋

(47)

𝑁𝐶𝑋
𝐼𝐶𝑎𝑁𝐶𝑋 = 2 ∗ 𝐼𝑚𝑎𝑥
∗ 𝐴𝑁𝐶𝑋

(48)

𝑁𝐶𝑋
is 87.5 mM, 𝐾𝑚𝐶𝑎 is 1.38 mM, 𝐼𝑚𝑎𝑥
is the maximal flux, and the voltage

dependence parameter 𝛾 is 0.35.

4.2.5. ATP dependent calcium pump
The ATP dependent calcium pump has been incorporated as described by Kager et al.
[81]. The ATP dependence was incorporated to calculate ATP consumption.

𝐴𝐶𝑎𝑎𝑡𝑝

𝐾𝑚𝐴𝑇𝑃 −1
𝐾𝑚𝐶𝑎 −1
= ((1 +
) ) × ((1 +
) )
[𝐶𝑎𝑖 ]
[𝐴𝑇𝑃]
𝐶𝑎𝑎𝑡𝑝
𝐼𝐶𝑎𝐴𝑇𝑃𝑎𝑠𝑒 = 𝐼𝑚𝑎𝑥
∗ 𝐴𝐶𝑎𝑎𝑡𝑝

(49)

(50)

𝐶𝑎𝑎𝑡𝑝
Where, 𝐾𝑚𝐶𝑎 is 6.9 µM [81] and 𝐾𝑚𝐴𝑇𝑃 is 2.5 mM (estimated). 𝐼𝑚𝑎𝑥
is the maximal flux for the

Ca-ATPase pump and is estimated to simulate steady state.
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4.2.6. Leakages
Specific ionic leakages were implemented as described by Kager et al. [78].

𝐼𝐿𝑁𝑎 = 𝑔𝑙𝑒𝑎𝑘𝑁𝑎 (𝑉𝑚 − 𝑉𝑁𝑎 )

(51)

𝐼𝐿𝐾 = 𝑔𝑙𝑒𝑎𝑘𝐾 (𝑉𝑚 − 𝑉𝐾 )

(52)

𝐼𝐿𝐶𝑎 = 𝑔𝑙𝑒𝑎𝑘𝐶𝑎 (𝑉𝑚 − 𝑉𝐶𝑎 )

(53)

𝐼𝐿𝑔𝑒𝑛 = 𝑔𝑙𝑒𝑎𝑘𝑔𝑒𝑛 (𝑉𝑚 − 𝑉𝑙𝑒𝑎𝑘 )

(54)

The 𝑔𝑙𝑒𝑎𝑘𝑁𝑎 , 𝑔𝑙𝑒𝑎𝑘𝐾 and 𝑔𝑙𝑒𝑎𝑘𝐶𝑎 are the maximum leak conductance of sodium, potassium and
calcium ions. The maximum leak conductance and reversal potential for general leak are
determined by choosing the holding potentials of -85 and -80 mV. At these potentials the cell is
hyperpolarized and has no significant contribution from the voltage gated ion channels. The
maximum leak conductance of leakage is,

𝑔𝐿𝑒𝑎𝑘𝑔𝑒𝑛 =

(5 − 𝑅𝑚 ) (𝐼85 − 𝐼80 )
(5 𝑅𝑚 )

(55)

The 𝐼85 𝑎𝑛𝑑 𝐼80 are the total ionic currents at the holding potential of -85 and -80 mV. 𝑅𝑚 is the
membrane resistance. The leakage reversal potential was determined using,
𝑉

𝑉𝑙𝑒𝑎𝑘 =

𝑚
𝐼𝑖𝑜𝑛𝑖𝑐
+ 𝑉𝑚
𝑔𝑙𝑒𝑎𝑘𝑔𝑒𝑛
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(56)

𝑉

𝑚
𝐼𝑖𝑜𝑛𝑖𝑐
= 𝐼𝑁𝑎 + 𝐼𝐾 + 𝐼𝐶𝑎 + 𝐼𝐾𝐴𝑇𝑃 + 𝐼𝑁𝑎𝐾𝐴𝑇𝑃𝑎𝑠𝑒 + 𝐼𝑁𝐶𝑋 + 𝐼𝐶𝑎𝐴𝑇𝑃𝑎𝑠𝑒 + 𝐼𝐿𝑁𝑎

(57)

+ 𝐼𝐿𝐾 + 𝐼𝐿𝐶𝑎
The reversal potential for leakage was calculated based on the fact that the membrane current
at resting membrane potential was zero. The membrane resistance and resting membrane
potential were experimentally determined.

4.2.7. Ionic concentrations
The ionic currents were converted into chemical units to determine the changes in the
ionic concentrations. Ionic concentration was obtained by multiplying ionic current in 𝑝𝐴 with a
surface factor (𝐹𝑆 ). The surface factor was determined by,

𝐹𝑆 =

𝐹𝑆 =

𝐶𝑢𝑟𝑟𝑒𝑛𝑡
𝐹𝑎𝑟𝑎𝑑𝑎𝑦 ∗ 𝐶𝑒𝑙𝑙 𝑉𝑜𝑙𝑢𝑚𝑒
10−12

(58)

𝑚𝑜𝑙 𝐶
𝑠

𝐶
96485 𝑠 ∗ (50 × 10−15 ) 𝑚3

𝐹𝑆 = 2.073 × 10−7

𝑚𝑜𝑙
𝑚3 𝑚𝑠

The model was compartmentalized and the diffusion of ions was considered to take place from
the center of the sub-cellular space to the center of the bulk cytosolic space. The diffusion of
ion (I) is given by [70],
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𝐽𝐼(𝐶1 −𝐶2 ) = 𝐷𝐼(𝐶1 −𝐶2 ) 𝐴

[𝐼]𝐶1 − [𝐼]𝐶2

(59)

𝛥𝑥𝐶1 −𝐶2

Where, the ion diffuses a distance (x) through area (A) from the center of one compartment
(C1) to another compartment (C2). The parameters (Table 4) were obtained from the Rabbit
ventricular myocyte [70]. The diffusion distance of 0.45 from the subcellular space to middle of
the bulk cytosolic space was calculated assuming a length of 1.8 m. The distance determines
the transfer functions for the ionic fluxes between compartments. The lumped nature of the
compartments was thereby adjusted to the physical geometry [70].
Table 4: Parameters for flux determination

Parameter

Value

Reference

Cell length

100 µm

[70]

Cell radius

10 µm

[70]

Sub-cellular space depth

45 nm

[70]

Area (Subcell - bulk)

3.01 × 10-6 cm2

[70]

DNa (Subcell - bulk)

1.09 × 10-5 cm2/s

[82]

DK (Subcell - bulk)

1. 96 × 10-5 cm2/s

[83]

DCa (Subcell - bulk)

1.22 × 10-6 cm2/s

[82]

Distance (𝛥𝑥)

0.5 µm

[70]
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The changes in the subcellular space and bulk cytosol sodium concentration was determined
using the equation,
𝑡𝑜𝑡𝑎𝑙
𝑑
−𝐼𝑁𝑎
𝐹𝑆 + 𝐽𝑁𝑎 ([𝑁𝑎]𝐵𝑢𝑙𝑘 − [𝑁𝑎]𝑆𝑢𝑏𝑐𝑒𝑙𝑙 )
[𝑁𝑎]𝑆𝑢𝑏𝑐𝑒𝑙𝑙 =
𝑑𝑥
𝑉𝑆𝑢𝑏𝑐𝑒𝑙𝑙

(60)

𝑑
𝐽𝑁𝑎 ([𝑁𝑎]𝑆𝑢𝑏𝑐𝑒𝑙𝑙 − [𝑁𝑎]𝐵𝑢𝑙𝑘 )
[𝑁𝑎]𝐵𝑢𝑙𝑘 =
𝑑𝑥
𝑉𝐵𝑢𝑙𝑘

(61)

The changes in the subcellular space and bulk cytosol potassium concentration was determined
using the equation,
𝑑
−𝐼𝐾𝑡𝑜𝑡𝑎𝑙 𝐹𝑆 + 𝐽𝐾 ([𝐾]𝐵𝑢𝑙𝑘 − [𝐾]𝑆𝑢𝑏𝑐𝑒𝑙𝑙 )
[𝐾]𝑆𝑢𝑏𝑐𝑒𝑙𝑙 =
𝑑𝑥
𝑉𝑆𝑢𝑏𝑐𝑒𝑙𝑙

(62)

𝑑
𝐽𝐾 ([𝐾]𝑆𝑢𝑏𝑐𝑒𝑙𝑙 − [𝐾]𝐵𝑢𝑙𝑘 )
[𝐾]𝐵𝑢𝑙𝑘 =
𝑑𝑥
𝑉𝐵𝑢𝑙𝑘

(63)

The changes in the subcellular space and bulk cytosol calcium concentration was determined
using the equation,
𝑡𝑜𝑡𝑎𝑙
𝑑
−𝐼𝐶𝑎
𝐹𝑆 + 𝐽𝐶𝑎 ([𝐶𝑎]𝐵𝑢𝑙𝑘 − [𝐶𝑎]𝑆𝑢𝑏𝑐𝑒𝑙𝑙 )
[𝐶𝑎]𝑆𝑢𝑏𝑐𝑒𝑙𝑙 =
𝑑𝑥
𝑉𝑆𝑢𝑏𝑐𝑒𝑙𝑙

(64)

𝑑
𝐽𝐾 ([𝐶𝑎]𝑆𝑢𝑏𝑐𝑒𝑙𝑙 − [𝐶𝑎]𝐵𝑢𝑙𝑘 )
[𝐶𝑎]𝐵𝑢𝑙𝑘 =
𝑑𝑥
𝑉𝐵𝑢𝑙𝑘

(65)

𝑡𝑜𝑡𝑎𝑙
𝑡𝑜𝑡𝑎𝑙
Where, 𝐼𝑁𝑎
, 𝐼𝐾𝑡𝑜𝑡𝑎𝑙 and 𝐼𝐶𝑎
are the total specific currents generated by the movement of

sodium, potassium and calcium respectively. 𝑉𝑆𝑢𝑏𝑐𝑒𝑙𝑙 and 𝑉𝐵𝑢𝑙𝑘 are the volumes of the subcompartments.
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4.2.8. Parameter estimation for electrophysiological recordings
The coupled ordinary differential equations were numerically integrated in MATLAB
using a built-in differential equation solver ‘ode15s’ to solve a set of differential equations. A
relative tolerance of 10-5 and an absolute tolerance of 10-6 were used. A custom graphical user
interface (GUI) was created in MATLAB for parameter estimation and all the ion channels of the
neuronal module including the leakage correction were incorporated.
The experimentally measured voltage clamp and current clamp were imported into
MATLAB for deconvolution. The initial fitting parameters were obtained from the previously
published average values [27,78]. The potassium currents in the voltage clamp recordings were
fitted followed by calcium and sodium currents. A simultaneous fit was then performed on the
voltage gated ion channels to obtain a first estimate for ion channel parameters. Using the
obtained ion channel parameters and to avoid numerous solutions considering the large set of
parameters being fitted, a second optimization was performed to extract a quasi-unique set of
parameters by fitting the simulated action potentials to experimental measurements. The
fittings were not sufficiently optimized to balance the ionic concentrations and could not
produce a steady state. So, a third optimization routine was performed by optimizing the
activities of pumps, exchangers and specific leakages. The 𝐼𝑚𝑎𝑥 for ion exchanges and 𝑔𝑚𝑎𝑥 for
specific ionic leakages were determined. The action potential time series data was then fitted
to further validate the experimental action potentials. The second and third steps of the
optimization routines were repeated to fit the experimental recordings.
The optimization was performed using built-in MATLAB optimization routines. The
76

function ‘fmincon’ computes a constrained minimum of a function by varying the variables
within specific bounds. This was carried out in combination with the sum of squared residuals
(ssr) as described in the following equation,
𝑠𝑠𝑟 = ∑(𝑆(𝑡𝑛 ) − 𝐸(𝑡𝑛 ))2

(66)

𝑛

Where, the simulated value is given by 𝑆 and the experimental value by 𝐸 at time 𝑡𝑛 .

4.3. Integration of neuronal and metabolic models
The model was numerically integrated using MATLAB (2014a) in a modular approach. It
was modeled and simulated using a desktop computer running Windows 7 on a 2.95GHz Intel
Core2-Quad CPU and 8GB RAM. The obtained results were analyzed and plotted in MATLAB.
The neuronal module and the metabolic model were coupled to form the neuronalmetabolic model. The models were interfaced to exchange the intracellular ATP, ionic
concentrations and the membrane potentials. Additional ATP consumption reactions such as
NaK-ATPase and Ca-ATPase were incorporated into the metabolic model. The activity of these
reactions was matched to that of the neuronal model. The metabolic model can sense only the
bulk cytosolic concentrations. The neuronal module coupled to the deconvolution algorithm
extracted the ion channel parameters which were then imported into the neuronal-metabolic
model. The neuronal module calculates currents and the changes in the ionic concentrations.
The obtained concentrations were fed into the metabolic model. The metabolic model was
simulated following the determination of the metabolic activity. The new metabolite and ionic
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concentrations were again feed into the neuronal module.
The action potential was simulated for every one second. The ionic exchangers usually
restored the ionic balances within a few milliseconds. Stimulating an action potential every one
second gives the ionic exchanges ample time to restore ion balances. The model was simulated
to simultaneously generate a series of action potentials and run the metabolic model to
determine the intracellular fluxes and changes in ionic concentrations. The model also
predicted the changes in intracellular protein activities and metabolic concentrations. To
simulate drug effects, the event created in Simbiology was turned ‘on’ and the model was
simulated. The simulation results were compared to the experimentally determined values.

4.4. Simulating experimental conditions
To simulate the drug effects an event was created in the metabolic model (SimbiologyMATLAB) to introduce a drug effect that inhibits the enzyme activity. The inhibitors tested
(Table 5) only bind and inhibit the enzymes in the metabolic pathway. The inhibitors do not
bind to ion channels, so the ion channel parameters were held constant while fitting the drug
induced time-series data. The only parameters allowed to change are the reversal potentials for
the ion channels and cellular ATP concentrations in the neuronal module. So when fitting the
effects of ion channel inhibitors, the ion channel parameters can be changed as they bind to the
ion channel directly, thereby modifying its properties.
The Vmax of the targeted enzyme was reduced, using a scaling factor. The scaling factor
allows a function for the dose-response curve, describing the effect of a compound on the
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enzyme [84]. The scaling factor ‘b’ typically relates the drug concentration [D] according to,

𝑏=

1
[𝐷] 𝑛
1 + (𝐼𝐶 )
50

(67)

Where IC50 is the drug concentration at which a 50% reduction in the enzyme activity is
observed, which n is the Hill coefficient of the dose-response curve and is often assumed to be
one as one drug molecule is necessary to inhibit the enzyme [84]. The IC50 values were obtained
by fitting the model to metabolic experimental data.
The neuronal-metabolic model was simulated to predict the changes in cellular
metabolism and action potentials. The specific Vmax’s or the enzyme concentration that were
reduced to simulate the drug effects are listed below.
Table 5: List metabolic inhibitors and their targets

Drug

Enzyme

2DG

Hexokinase

Cyanide

Mitochondrial Oxidative Phosphorylation

Malonate

Succinate Dehydrogenase

2DG + Cyanide

Hexokinase and Oxidative Phosphorylation

2DG + Malonate

Hexokinase and Succinate Dehydrogenase
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CHAPTER-5: RESULTS

The results obtained from the experiments and computational model are analyzed in this
chapter. The basal metabolism was evaluated for calibrating the metabolic model to steady
state. The core energy producing metabolic pathways namely glycolysis, mitochondrial TCA
cycle and the electron transport chain were inhibited using 2DG, cyanide and malonate. A
combinational inhibition of these pathways was also performed to experimentally validate the
metabolic and electrophysiological responses. The neuronal-metabolic model was simulated to
predict the metabolic fluxes and action potential time-series. The simulation data was
compared to the experimental measurements. The results presented in this chapter
demonstrate the predictive capabilities of the model.

5.1. Bioenergetics of NG108-15 cells
The NG108-15 cells were obtained by fusing mouse N18TG2 neuroblastoma and rat C6BU-1 glioma cells in presence of sendai virus. During the fusion process reprogramming of core
cellular metabolic pathways may occur. The reprogramming of cellular metabolic pathways
impacts cellular functions and bioenergetics. To characterize and quantify NG108-15 cellular
bioenergetics, the basal metabolism was determined by measuring the glucose utilization,
lactate secretion, cellular ATP and ADP levels.

5.1.1. Glucose and lactate flux
The carbon flux was determined by measuring glucose uptake and lactate release. The
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glucose uptake was found to be 495.19 + 63.72 pM/hr/cell and is in close range to that found in
glioblastoma cells previously [85]. The lactate flux was determined to be 851.05 + 74.72
pM/hr/cell. The rates of lactate production are consistent with the expected flux for glioma
cells [86]. The measurement of carbon flux revealed that 85% of the carbon entering the cell
was ending up as lactate and only 15% of carbon is being utilized by other pathways in the cell.
The glycolytic and lactate fluxes remained steady over time (Figure 17). The carbon flux was
compared to Murine hybridoma cell line. Murine hybridoma cell had a glucose uptake of 380
nmol/hr/106 cells and a lactate release of 630 nmol/hr/106 cells indicating a carbon flux of 83%
into lactate production [87].

Figure 17: Measured glucose uptake (O) and lactate output (□) flux of NG108-15 cells

Lactate excretion causes the cell to waste three carbons that can either be incorporated
into macromolecular precursor biosynthesis or get utilized in ATP production [88]. The
increased lactate excretion elevates carbon uptake and simultaneously increases the pentose
phosphate pathway activity. The elevated carbon utilization and lactate production regardless
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of the availability of oxygen suggests the presence of aerobic glycolysis. This phenomenon was
found by Otto Warburg and termed as ‘the Warburg effect’. The effect was mostly found in
cancer cells with lower mitochondrial respiration rates. This elevated glycolysis helps the cell to
maintain higher proliferation rates or in differentiation mode enables the cell to produce
neuronal process faster compared to primary neurons. Moreover, a sufficient amount of energy
for maintaining cellular functions is produced by glycolysis in cancer cells.

5.1.2. ATP and ADP concentrations
Cellular ATP levels act as an indicator of cellular health and any disruption in cellular
pathways may lead to impaired cellular bioenergetics. The assay kits measure the total cellular
ATP and ADP levels including free and Mg-bound ATP/ADP. The intracellular ATP and ADP levels
in NG108-15 cell were found to be 0.22 + 0.03 mM and 0.11 + 0.02 mM respectively. The ATP
and ADP levels were stable over time (Figure 18) matching the literature reported values [89].

Figure 18: Measured intracellular ATP (O) and (□) ADP levels in NG108-15 cells
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A literature search on intracellular ATP levels in different cell lines has shown that they
possess lower levels (Table 6). Furthermore, most cell lines depend on aerobic glycolysis, an
inefficient pathway for ATP production. The alterations in cellular bioenergetic pathways
produce different metabolites supporting rapid cell growth and proliferation [88]. Normal cells
utilize the nutrients efficiently and cell lines have no selective pressure to optimize their
metabolism for ATP production. Glycolysis is an inefficient mode of ATP generation compared
to mitochondrial pathway. The intracellular ATP/ADP ratio is also maintained at steady state
and determines which pathway the cell adapts for ATP production. A lower ATP/ADP ratio has
been shown to favor glycolysis and a higher ratio would favor mitochondrial ATP production
[88]. A slight change in cellular ATP/ADP or ADP/AMP ratio may impair cellular homeostasis and
trigger apoptosis [90].
Table 6: Literature reported cellular ATP levels in different cell lines

Cell type

Origin

ATP

ADP

(nmol/106 cells)

(nmol/106 cells)

ATP/ADP
ratio

Reference

HeLa

Cervical cancer cells (glycolysis dominated)

5.2

1.64

3.2

[91]

BSC-40

Kidney epithelial cell line (oxidative phosphorylation
dominated)

9.47

1.08

8.8

[91]

SH-SYSY

Human dopaminergic neuroblastoma cell line

1.33

0.24

5.5

[92]

NG108-15

Hybrid neuroblastoma and glioma cell

8 - 10

-

-

[89,93]

NG108-15

Hybrid neuroblastoma and glioma cell

10 + 0.83

5.13 + 0.44

1.9

Measured
values
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5.2. Deconvolution of Electrophysiological Recordings
5.2.1. Thermodynamic dependent Hodgkin-Huxley Model
To deconvolute the electrophysiological recordings the neuronal model was constructed
in a modular approach. The basic voltage gated ion channels were modeled by incorporating
the thermodynamic dependences and simulated using previously published ion channel
parameters [27]. The voltage clamp and the current clamp recordings were simulated for a
NG108-15 cell.

Figure 19: Voltage clamp simulation. (A) The voltage steps protocol used during a voltage clamp recording. (B)
Simulated voltage clamp recording for NG108-15 cell

During a voltage clamp recording, the voltage was held constant at different ‘steps’
(Figure 19A) and the changes in the current were recorded (Figure 19B). The voltage
dependence on the ionic current is demonstrated by plotting the current-voltage relationship
(Figure 20). The properties of NG108-15 cells were demonstrated by varying the current during
incremental impositions of voltage or the responses of voltage to current injections through a
whole-cell patch. The IV-curve for NG108-15 defines the input resistance.
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Figure 20: IV Curve for NG108-15 cell showing the changes in sodium (green), potassium (blue) and total current
(red) at different voltages

The current clamp recording was also simulated to generate an action potential using
the same parameters by application of a stimulus current (Figure 21).

Figure 21: Simulated current clamp recording showing an action potential
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The activation and inactivation of gates determines the generation of action potentials. The
probabilities during NG108-15 action potential are shown in the Figure 22. At rest, the
activation variable for sodium (m) is small and inactivation variable (h) for sodium is large. The
activation of potassium (n) and calcium (e) are also small. When a stimulus is applied, the
membrane depolarizes causing an increase in m leading to the peak in action potential. The
activation of potassium gate (n) also increases and h decreases. The activation of the calcium
gate (e) also takes place during the action potential generation. The gates h and n slowly return
to their initial state when compared to other gates where as other gates act rapidly (Figure 22).

Figure 22: The activation and inactivation of voltage gated ion channel gates during an action potential

5.2.2. Modeling ionic exchangers, pumps and leaks
The ATP dependent potassium channel (KATP) has emerged as an important ion channel
especially in neurodegenerative diseases and acute brain ischemia adapting to changes in
metabolic activity. The probability of activation and inactivation depends on the intracellular
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ATP levels directly coupling the metabolic activity and membrane electrical activity. The
channel was modeled and simulated to visualize the changes in action potential peak shape due
to changes in cellular ATP concentration (Figure 23).

Figure 23: Effect of cellular ATP levels on action potential peak shape

The resting membrane potential is mainly determined by the ionic pumps and leakages.
The sodium and potassium ion leaks are counterbalanced by the Na/K-ATPase pump. The ATP
dependent sodium potassium exchanger is a major pump responsible for maintaining sodium
and potassium homeostasis. The current generated by moving three sodium ions out and two
potassium ions against the concentration gradients has been added to the respective total
specific ionic currents. At rest, the pump balances the sodium (Figure 24) and potassium (Figure
25) fluxes of the ion channels and leaks. A stoichiometric balance of intracellular potassium and
sodium ions was not achieved by Na/K-ATPase pump alone. Additional ionic pumps have been
incorporated to maintain cellular ionic concentrations (Figure 26).

87

Figure 24: Restoration of intracellular sodium concentration by Na/K-ATPase pump. (A) Without Na/K-ATPase and
(B) with Na/K-ATPase

Figure 25: Restoration of intracellular potassium concentration by Na/K-ATPase pump. (A) Without Na/K-ATPase
and (B) with Na/K-ATPase

Figure 26: Rationale for implementation of other ionic pumps
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Figure 27: Sodium-calcium exchanger currents mediated by changes in membrane potential

Figure 28: Remodeled the IV curve for sodium calcium exchanger showing the exchanger activity for different
calcium concentrations

The sodium calcium exchanger (NCX) activity is dependent on the membrane potential
and intracellular calcium concentration. NCX exchanges one calcium ion for three sodium ions
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and has an electrogenic contribution to the membrane electrical properties. At rest, the
exchanger activity is reversed transferring three sodium ions out and one calcium ion thereby
generating a very small sodium and calcium current (Figure 27). The membrane depolarization
reverses the pump activity again resulting in an outflow of calcium and influx of sodium [81]. A
shift in curve representing the calcium influx and efflux is observed (Figure 27). The pump
activity depends on the intracellular calcium concentration. Two intracellular calcium
concentrations were used to model validate the exchanger activity (Figure 28). The slope of the
curve varies with the increased calcium concentration leading to a faster extrusion of
intracellular calcium ions. The activity from Courtemanche et al. [80] and Kager et al. [81] has
been reproduced to validate NCX and adapted into the neuronal module.
The ATP dependent calcium pump (Ca-ATPase) transports intracellular calcium ions
against the concentration gradient by consuming intracellular ATP. The pump activity increased
with an accumulation of intracellular calcium (Figure 29). Kager at al. have assumed an
unlimited availability of cellular ATP and modeled the pump [81]. Since ATP could be a limiting
factor in the model, ATP dependence has been incorporated so that the pump could lower the
extrusion of calcium ions upon lowering the intracellular ATP levels. The ATP dependence has
been modeled to match the Ca-ATPase activity previously reported by Kager et al. (Figure 30).
The activity of pump is made very sensitive to intracellular ATP levels so a slight decrease in ATP
concentration would lower the pump activity and lead to an accumulation of intracellular
calcium.
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Figure 29: Calcium dependence on Ca-ATPase pump

Figure 30: ATP dependence on Ca-ATPase pump

Specific ionic leakages were implemented to represent all the other sodium, potassium
and calcium ion channels [78]. The ions diffuse long the diffusion gradient and the ionic
exchangers restore the altered intracellular levels. All the equations were implemented and the
steady state was simulated using the experimental holding potential. The holding potential was
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varying due to the experimental conditions. The resting membrane potential was calculated as
shown in Figure 31A. The sodium, potassium and calcium ionic concentrations were at steady
state when the model was simulated for 40 min (Figure 31). The parameter estimation for Imax
of all the pumps and conductance for leakages was performed to simulate steady state. Model
was compartmentalized by incorporating the ionic fluxes of subcellular space and bulk cytosol.
The fluxes were simultaneously determined while generating the action potential.

A

B

D
A
C

Figure 31: Calibration of the neuronal module to simulate steady state. (A) The resting membrane potential (red
line) of the cell is determined based on holding potential (blue line). The changes in (B) sodium, (C) potassium and
(calcium) concentrations are simulated
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5.2.3. Extraction of electrophysiological parameters
NG108-15 cells were observed to be fully differentiated on day-4 in serum-free
differentiation medium and were patched to record their electrophysiological activity (Figure
32). Voltage clamp and current clamp data were imported into Matlab and fitted using the
custom graphical user interface. The curves were fitted after an initial 0.1ms delay to eliminate
the effect of experimental artifacts. The voltage clamp recordings were fitted initially and an
agreeable fit was obtained to the sodium, potassium and calcium ion channel data (Figure 32).

Figure 32: Simulated (red) voltage clamp were fitted to an experimental (blue) recording

Ion channel parameters were then automatically fitted using the fitting algorithm that
converged in less than 4 minutes. Weighted least square error function was applied to quantify
the difference between the simulated and the experimentally recorded data [27]. The
implemented error function is:
Least square: ELsquare = ∑(𝑆(𝑡𝑛 ) − 𝐸(𝑡𝑛 ))2
𝑛
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Weighted least square: E𝑊Lsquare =ELsquare if tn <30ms and EWLsquare =5 ×ELsquare if tn ≥30ms

Figure 33: Simulated (red) action potentials were fitted to experimental (blue) action potential recording

The action potentials (Figure 33) were evoked with a short 2 ms current injection in
current clamp mode at holding potential. The following parameters were obtained from the
patch-clamp recordings and used in the modeling: membrane resistance, resting membrane
potential, membrane capacitance and injected current. The maximum conductance of the
leakage current was calculated form the resting membrane potential in the model. The earlier
averaged ion-channel parameters were used as initial values for AP fitting. Using the voltage
dependent sodium, potassium and calcium ion channels, ATP-dependent potassium channel,
ATP-dependent exchangers, sodium-calcium exchanger and specific leakages an excellent fit to
the entire AP was obtained (Figure 33). The first action potential was fitted simultaneously with
the voltage clamp recording and the extracted parameters were fed into the coupled neuronalmetabolic model.
The model showed a sharp rise in the subcellular ionic concentrations of sodium (Figure
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34), potassium (Figure 35) and calcium (Figure 36) ions. However, the bulk cytosolic
concentrations did not change significantly.

Figure 34: Simulated changes in subcellular and bulk cytosolic sodium concentration during action potential

Figure 35: Simulated changes in subcellular and bulk cytosolic potassium concentration during action potential

These results were observed to be in agreement with the physiological observations. It is well
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known that during action potential generation and propagation, the ionic concentrations close
to the membrane change rapidly causing the membrane potential to alter. The bulk
intracellular ionic concentrations do not change significantly. The ion channels on the plasma
membrane only sense the ionic concentrations close to the membrane and act rapidly to
restore the ionic balances.

Figure 36: Simulated changes in subcellular and bulk cytosolic calcium concentration during action potential

The sodium and calcium buffering takes place in the cell [70]. To keep the model simple,
buffering systems have not been included. A sudden rise in ionic concentration leads to an
increased activity of the exchangers and pumps to extrude and restore the intracellular ionic
concentrations. The diffusion of ions takes place from the subcellular space to the bulk cytosol
initially and when the pumps are reestablishing the sub-cellular concentrations, the bulk
cytosolic concentrations also slowly reached the initial values.
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5.2.4. Statistical analysis
Ion channel parameters were extracted by fitting the voltage clamp recoding and the
initial action potential of a total of forty nine data sets. Several fitting parameters were applied
in fitting the action potentials. Each dataset produced a different set of parameters. Statistical
analysis was performed to determine the variations in fitting parameters. A box plot has been
created to visualize the skewness of parameters and to identify outliers. The box plot of
voltage-gated sodium channel parameters is shown in Figure 37.

Figure 37: Box plot for voltage gated sodium channel parameters

The maximum conductance of sodium channel has a wide range and is much higher
than the conductance of other ion channels. These conductances are unique for a particular cell
to support its cellular functions. The variations in voltage thresholds and time constants for
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channel activation and inactivation vary the ion channel conductance [94]. Moreover the
location where the cells are patched can also cause variations. The activation and inactivation
parameters are used to fit the exponential and sigmoidal functions of Hodgkin-Huxley model.
No large change was found in these parameters while fitting it to the experimental data. The
estimated half-activation potential was -43.41 + 6.47 mV and was agreement with that found in
neuronal models. The experimentally determined half-activation potential from central neurons
is -60 mV [95]. The variations could be due to the different resting membrane potentials of the
cells (Figure 41C).

Figure 38: Box plot for voltage gated potassium channel parameters

The box plot of potassium channel parameters showed the variability in activation
amplitude, half-activation potential and the maximum conductance (Figure 38). The half98

activation potential of cortical pyramidal neurons was found to be -24.5mV and was close to
the fitted result of -16.04 + 9.62 mV for NG 108-15 cells [96]. The activation time constant
(Act_amp) has a higher standard deviation but the box plot shows that 25% of the values are in
the 3rd quartile close to 22 ms. The maximum conductance (gmax) for voltage gated potassium
channel is very low compared to the sodium channel.

Figure 39: Box plot for voltage gated calcium channel parameters

Similarly, the calcium parameters showed slight variations (Figure 39). The activation
time constant and half-membrane potential had a few outliers. The fitted gmax of voltage gated
calcium channel for NG108-15 cells is 6.77 + 3.69 mS and is in agreement with the earlier
reported values [27]. Few recordings had a higher calcium conductance causing a ‘hump’ in
action potential. The calcium entering the cell acts as serves as secondary messenger during AP.
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A list of all the ion channel parameters with the standard deviations is given below in Table 7
and 8.
Table 7: Average electrophysiological parameters for NG108-15 cells obtained from fitting to voltage clamp and
current clamp recordings. Data are mean + SD (n = 49)

Ion channel Parameters

Sodium

Potassium

Calcium

Leak

Conductance (g)

241.21 + 104.08

14.62 + 7.43

6.77 + 3.69

3.24 + 2.34

Reversal potential (VRev)

67.85

-85.61

124.05

- 53 + 86

Activation exp (m,n,e)

3

4

3

-

Inactivation exp (h)

1

-

-

-

Activation q (q)

14.92 + 8.97

1.61 + 0.42

1.71 + 1.67

-

Half activation potential (V1/2)

-43.41 + 6.47

-16.04 + 9.62

-25.41 + 14.44

-

Act.assim (ξ)

-0.43 + 0.08

-0.04 + 0.22

-0.17 + 0.05

-

Act.Ampl (A)

0.83 + 0.77

35.39 + 30.38

32.19 + 18.29

-

Inactivation q (q)

-4.66 + 0.4

-

-

-

Inact. Half-activation

-73.9 + 7.07

-

-

-

Inact. Assim

0.36 + 0.04

-

-

-

Inact.Ampl

4.95 + 4.38

-

-

-
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Table 8: Activities of exchangers and leaks

NaK-ATPase

Ca-ATPase

NCX

K-ATP

Na leak

K leak

Ca leak

Imax

1520 + 351

1700 + 147

502 + 55

-

-

-

-

Conductance

-

-

-

2.54 + 1.98

0.39 + 0.21

4.2 + 1.6

0.12 + 0.2

The Imax’s for the exchangers also varied from cell to cell as the membrane potential,
capacitance and fluxes varied (Table 8). The fitted Imax for Na/K-ATPase is close to that reported
in the literature for neurons [78,79]. The Ca-ATPase was slightly higher than the Na/K-ATPase as
NG108-15 cells have higher intracellular calcium levels similar to cancer cells. The cellular
resting membrane potential was determined based on separation of potassium ions since the
cellular membrane has higher permeability towards potassium. The potassium leak
conductance is higher compared to the sodium and calcium leak conductances.

Figure 40: Box plot for (A) leakage currents and (B) maximum conductance of ATP dependent potassium channel
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The maximum conductance and reversal potential for general leak have also been analyzed
(Figure 40A). The implementation of ion channels in the model lead to a decrease in leakage
conductance. The maximum conductance of the ATP dependent potassium channel was 2.54 +
1.98 (Table 8) and is higher than that of primary cortical neurons [77]. The sensitivity of KATP
channel varies from cell to cell [97]. A decrease in cellular ATP level causes the KATP channel to
activate and prevents the potassium ions to move across the membrane. The experimental
membrane resistance is 0.64 + 0.30 GΩ and the membrane capacitance which is indicative of
the cell size is 69.19 + 37.87 pF. The resting membrane potential (RMP) of the patched cells was
-43.88 + 5.99 mV with 25% of the recordings in the third quartile showing a RMP of -47 mV
(Figure 41C). The resting membrane potential of NG108-15 cell has been reported to range
from -33.2 to -47 mV [98,99].

Figure 41: Box plot for experimentally obtained (A) membrane resistance, (B) membrane capacitance and (C)
resting membrane potential
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5.3. Steady state analysis
Modeling cellular metabolic pathways integrates all the information into a functional
networking model that simulates all the intracellular interactions. The aim is to construct and
validate the model to predict cellular protein activities, fluxes, metabolite concentrations and
action potentials at steady state.

5.3.1. Forcing metabolic model to steady state
The method for reconstructing large models is to obtain a validated model and
recalibrate it to match the experimental data for the cell type of our interest. The cellular
pathways possess a very complex feedback and feed-forward interactions that control the
overall flux and must be maintained continuous check [100]. This means that the relative ratios
of kinetic constants are important and any disruptions in the balance will render the model
causing an accumulation of intracellular metabolites. In reality, cell controls the flux by
adjusting protein concentrations. Metabolic genes are typically located in blocks within the
genomes and are expressed together. In our model, we are essentially altering the V max of the
reactions to mimic the changes in protein concentration within a cell as a means of controlling
flux [58,72,101].
The glycolytic model derived from red blood cell [72] was more favorable as it utilizes
glucose as the primary source of carbon. This is important because glucose is the major source
of carbon in brain and neuronal glycolysis is regulated by hexokinase [54]. In addition, the
glycolytic model consists of the PPP that is active in brain [54]. Red blood cells lack
mitochondria forcing them to completely rely on glycolysis for carbon and ATP [102]. Since the
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glycolytic module from red blood cells has higher a glycolytic activity, we have lowered the V max
of the glycolytic enzymes between 1-100% to match the experimentally measured data
[58,101]. Similarly, the mitochondrial model obtained from cardiac cell provides 90% of the
energy from mitochondrial oxidative phosphorylation and is highly active [103]. The TCA cycle
activity was lowered by altering the enzyme concentrations. The total concentration of the TCA
cycle metabolites was conserved [59] to match the experimental data.
The ensemble metabolic model was calibrated by scaling a set of pathways
simultaneously. At steady state, the rate of production and consumption of all metabolic
concentrations is balanced and equals zero. A fitting algorithm was written to fit the model to
experimental data in a modular approach. The fitting algorithm scaled the pathways by
computing the range of possible fluxes for each pathway that enables a close-to-optimal fit with
the experimental data. The fitting algorithm also iteratively performed the metabolic flux
analysis while constraining the flux through each pathway. The metabolic model was
constrained to match the glucose and lactate flux to 495 and 851 pM/hr/106 cells respectively.
The total cellular ATP and ADP levels were constrained to 220 and 110 µM. The reassembled
model attained steady state after running it for 120 min (Figure 42 and Figure 43).
The initial concentrations of all species in the metabolic model were then changed to
run the model in steady state from beginning. The overall adenosine pool was kept constant.
The ATP/ADP and ATP/AMP ratios were 2.2 and 5 respectively. The Na/K-ATPase and CalciumATPase activity were tied matched to the activities obtained from the neuronal module and
later integrated in the coupled model.
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Figure 42: Simulating glucose uptake and lactate release to steady state

Figure 43: Simulated steady state of intracellular adenosine levels
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The metabolic flux analysis of NG108-15 cells showed that 83.09 % of carbon ends up in
lactate production, 14.76% enters the mitochondrial TCA cycle, 2.02% is used by pentose
phosphate pathway (PPP) for PRPP synthesis and 0.13% is secreted out of cells as pyruvate
(Figure 44). The activity of pentose phosphate pathway in cancer cells or cell lines has been
shown to vary depending on the cellular activity that ranges from 0.1 % to 11% and considering
that NG108-15 cells were in differentiation stage 2% seems to be reasonable. The transport of
pyruvate into extracellular space is very less as most of it got converted into lactate or entered
mitochondria.

Figure 44: Fate of carbon in NG108-15 cell

Analysis of the ATP production by NG108-15 cell showed that 81.3% of ATP is being
produced by glycolysis and only 18.7% of ATP is being contributed by the mitochondria towards
the total cellular ATP concentration (Figure 45). Due to the increased carbon flux through
glycolysis, NG108-15 cells produced more ATP from glycolysis and less from mitochondria. The
total concentrations of ATP and ADP represented in the figure include free and magnesium
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(Mg)-bound ATP and ADP. The total magnesium concentration has been held constant in the
model.

Figure 45: ATP Production by different pathways in NG108-15 cell

During steady state, the rate of ATP production is equivalent to ATP utilization. The
analysis of ATP utilization revealed that 45% of total cellular ATP is used back in glycolysis to
mediate the conversions by hexokinase and phosphofructokinase enzyme (Figure 46). Although
the net production of ATP is more by glycolysis, 45% is a significant amount that is being used
back. A higher utilization of ATP by glycolysis also enables the cells to consume more glucose
which would be available for both glycolysis and pentose phosphate pathway. The ATP
dependent sodium-potassium and the ATP-dependent calcium exchangers consumed 17 and
11% of the total cellular ATP respectively. The PPP and AK consumed less than 2% of the total
ATP levels. The general ATPases representing all the other ATP-dependent process consumed
26% of the ATP (Figure 46).
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Figure 46: ATP utilization by different cellular processess in NG108-15 cell

NG108-15 cells lack glutamate [104] indicating the absence or a non-functional malateaspartate-shuttle. The other shuttle capable of transferring the high-energy electrons
generated in the glycolytic pathway into mitochondria and simultaneously active in brain could
be the Glyceraldehyde-3-phosphate shuttle (G3P shuttle) [102]. The G3P shuttle transfers four
high-energy electrons from the cytosol to mitochondrial electron transport chain by the flavin
nucleotides. The efficiency of G3P shuttle is lower compared to malate-aspartate shuttle (MAS).
MAS transfers six high-energy electrons into mitochondria. The activity of NAD/NADH recycling
was compared as it determines the activity of glycolysis and mitochondria. The glycolytic lactate
dehydrogenase has recycled 93% of NAD/NADH and 7% was recycled by mitochondria (Figure
47). The lower mitochondrial recycling of NAD/NADH demonstrates that not too many
electrons are entering the mitochondria leading to a lower mitochondrial membrane potential
generation. This lowered membrane potential reduced the drive for ATP synthase and resulted
in lower mitochondrial ATP production.
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Figure 47: Predicted NAD/NADH recycling between glycolytic lactate dehydrogenase (LDH) and glycerol-3phosphate (G3P) shuttle

5.3.2. Simulating neuronal-metabolic model to steady state
Cellular membrane properties are sensitive to changes in cellular metabolism especially
in neurons. So, the calibrated metabolic model was coupled to neuronal module for building
the neuronal-metabolic model. The coupled model was simulated to steady state and the
activities of ATP-dependent pumps were matched. The extracted parameters (Table 7 and
Table 8) including ion pumps and leaks parameters were exported into the neuronal-metabolic
model for simulating steady state. The neuronal-metabolic model is simulated to continuously
generate action potentials and predict the changes in the intracellular ionic concentrations. The
model-generated action potentials were in good agreement with the experimentally obtained
recordings (Figure 48A). The coupled model was simulated for 80 min and only the first 1000
action potentials generated a time span of 12 min are shown here.
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Figure 48: Simulated (red) and measured (blue) action potentials of NG108-15 cell

The sub-cellular ionic concentrations of all ions change rapidly during AP generation and
reaches back to a steady state. Moreover, the bulk cytosolic concentrations have increased
slightly and reached steady state. Simulating multiple action potentials also caused the sub
cellular sodium (Figure 49- blue), potassium (Figure 50- red) and calcium (Figure 51- pink)
concentrations to spike along with the action potential. The exchangers sensed a rapid increase
in subcellular ionic concentration and extruded increased concentrations from the cell to
restore ionic balance. A certain amount of ions also diffused into the cell increasing intracellular
concentrations. The altered concentrations sodium (Figure 49 – green), potassium (Figure 50 green) and calcium (Figure 51- gold) were also determined. The change in bulk concentration is
small and usually assumed to be negligible. The metabolic model senses changes in bulk
cytosolic concentrations and alters the metabolic activity. The rate change of concentrations
usually varies by the membrane electrical activities and cell types [105].
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Figure 49: Predicted changes in subcellular and bulk cytosolic sodium concentrations during action potentials

Figure 50: Predicted changes in subcellular and bulk cytosolic potassium concentrations during action potentials
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Figure 51: Predicted changes in subcellular and bulk cytosolic calcium concentrations during action potentials

The fluxes obtained from the neuronal-metabolic model was also extracted and
compared to the experimentally determined values. An excellent fit was obtained to glucose
and lactate flux (Figure 52). The intracellular ATP and ADP levels were also in agreement with
the measured values (Figure 53).

Figure 52: Compared glucose (blue) and lactate (red) flux obtained from neuronal-metabolic model (solid line) to
experimental values (dotted line)
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Figure 53: Compared ATP (blue) and ADP (red) flux obtained from neuronal-metabolic model (solid line) to
experimental values (dotted line)

The low levels of intracellular pyruvate levels were predicated by the model (Figure 54). The
lower pyruvate levels enable cells to avoid cell death by inhibiting the HDAC1/HDAC3 [106]. The
extracellular and mitochondrial levels of pyruvate levels are low compared to the cytosolic
levels. However, most of the pyruvate ended up as lactate due to elevated glycolysis.

Figure 54: Predicted extracellular (green), mitochondrial (red) and cytosolic (blue) pyruvate concentrations
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Phosphoribosyl pyrophosphate (PRPP) in pentose phosphate pathway is a precursor for
several biomolecules. The predicted PRPP levels are in close range to that found in B16
melanoma cells [107]. PRPP transfers a high energy phosphate for the phosphorylation of
purines bases and synthesis of purines, pyrimidines and pyridine nucleotides.
A proton gradient is established across inner mitochondrial membrane as a result of
transport of electrons by cytochrome complexes. The mitochondrial membrane potential of
NG108-15 cells was found to be -122 mV (Figure 55) and was in range as with the other
neuroblastoma cell lines [108]. This potential difference drives the ATP synthesis by F1F0ATPase
pump. The redox mechanisms have a huge effect on the cellular metabolic activities. The
metabolic activities, ATP levels and redox levels are tightly integrated into the model. The redox
mechanism is sensitive to alterations in glycolytic enzyme activities. The intracellular metabolite
concentrations are dependent on changes in protein activities.

Figure 55: Predicted mitochondrial membrane potential of NG108-15 cell

The metabolite concentrations and flux rates in the model were at steady state and the
protein functions were dependent on the maximum activity of the enzymes. The activities of
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these enzymes lie mostly at plateau. An increase or decrease in protein activity will determine
the metabolite concentration and will also restore the model back to original steady state upon
perturbations in metabolite levels. The stability of metabolic activity is not only due to the
stoichiometry of metabolites but due to regulatory protein mechanisms.

5.4. Perturbing glycolysis
The first rate limiting step in glycolysis is the ATP dependent conversion of glucose to
glucose-6-phosphate (G6P). The phosphorylation converts non-ionic form of glucose to anionic
G6P. G6P act as the entry point for PPP and glycolysis. Several studies have shown that
hexokinase plays a crucial role in initiating and maintain high glycolytic rates in rapidly
proliferating cells [52]. To inhibit the glycolytic pathway, cells were treated with 2-Deoxyglucose (2DG). The molecular structure of 2DG is similar to glucose and the cell transports it
through the glucose transporters. 2DG is an effective glycolytic inhibitor as it not only competes
with cellular glucose for phosphorylation but also directly decreases cellular ATP levels by
consuming ATP during the conversion to 2-deoxyglucose-6-phosphate (2DG6P). The metabolite
2DG6P cannot be further metabolized down the glycolysis and get accumulated in the cell
[105]. Moreover, neuronal cells lack glycogen stores and they depend on glycolysis as a source
for carbon and energy production making glycolytic inhibition more pronounced.
To determine and experimentally validate the metabolic perturbations induced by
glycolysis, the NG108-15 were exposed to 2DG followed by determining the metabolic activity
and electrophysiological changes. To mimic the experimental conditions, the hexokinase
enzyme was inhibited in the neuronal-metabolic model using an event in Simbiology.
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5.4.1. Analysis of carbon flux
The scaling factor ‘b’ for inhibiting the hexokinase activity was estimated by predicting
the IC50 values. The simulated lactate flux was initially fitted to experimentally measured values
(Figure 56– red line) for determining the scaling factor (and IC50). The rapid decline of glucose
flux during the first 20 min shows that NG108-15 cells are sensitive to 2DG treatment due to
elevated glycolytic activity. A 60 min exposure to NG108-15 cells decreased the lactate flux by
68%. The lactate flux has remained constant after 60 min and reached a plateau. The lactate
flux obtained from the metabolic model gave a good fit to experimental measurements. The
model predicted a decline in glucose flux upon inhibiting hexokinase activity (Figure 56 - blue
line). A 60 min exposure of 2DG leads to a 61% decrease in glucose flux into the cell. The model
predicts that a prolong exposure of 2DG has further lowered the glycolytic flux. The glucose
uptake rates were not determined as the assay kit was detecting both glucose and 2DG.

Figure 56: Predicted glucose uptake and lactate flux of 2DG compared to experimental data
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The metabolic flux analysis of carbon usage by NG108-15 cell upon exposure to 2DG is
shown in Figure 57. The amount of carbon that ended up as lactate decreased from 83% to
66%. The overall carbon flux into all the pathways decreased. But due to lowered carbon usage
by glycolysis during 2DG treatment, the mitochondrial carbon usage has increased from 15% to
33%. (Figure 44 and 57).

Figure 57: Carbon flux analysis of NG108-15 cell exposed to 2DG

The cellular pyruvate levels were also analyzed to examine the amount and rates of
pyruvate flux into different pathways. Inhibition of glycolysis reduced the cytosolic pyruvate
flux significantly and provoked a decrease in transport of pyruvate into mitochondria (Figure
58). Moreover, an external supply of pyruvate could have significantly delayed the effect of
glycolysis inhibition [105].
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Figure 58: Predicted pyruvate flux during simulating the effects of 2DG

5.4.2. ATP production and utilization
The exposure of 2DG decreased carbon flux into the cell resulting in a lowered cellular
ATP levels. The model predicted intracellular ATP (Figure 59) and ADP levels (Figure 60) were in
agreement with the experimentally measured ATP and ADP levels. Since the adenosine level in
the model is conserved, a decrease in ATP and ADP levels caused the cellular AMP levels to rise
(Figure 61). The conversion of ATP, ADP to AMP is mediated by the enzyme Adenylate kinase
(AK). After 20 min, the cellular ADP level predicted by the model decreased faster compared to
the experimental measurements. It may be due to the production of adenosine by cells or other
mechanisms that are currently not accounted in the model. The overall trend of changes in the
adenine nucleotide predicated by the model is in good agreement with the experimentally
determined values.
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Figure 59: Predicted (solid line) and experimentally (O-dotted line) measured ATP production exposed to 2DG

Figure 60: Predicted (solid line) and experimentally (O-dotted line) measured ADP production exposed to 2DG
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Figure 61: Predicted (solid line) AMP levels exposed to 2DG

The ATP production by individual pathways exposed to 2DG were analyzed. The over all
ATP production by both glycolysis and mitochondria has decreased. But the percent amount of
ATP produced by glycolsyis has lowered from 81% to 60% (Figure 62). The mitochondrial ATP
production has increased from 19% to 40%. The increase in mitochondrial activity is due to the
inhibitoion of glycolysis which focred the cell to rely on mitochondrial ATP generation to meet
its cellular requirments.
The usage of ATP by difference cellular pathways was also evaluated simulaneously
(Figure 63). The total ATP usage by cellular pathways went down. The ATP utilized in glycoslysis
ishas reduced from 46% to 41%. The ATP consumption by general ATPases, NaK-ATPase, PPP
and AK were 29%, 11%, 18% and 1% respectively. The lowered carbon influx into mitochondria
has decreased the generation of protons necessary for maintaining the required mitochondrial
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membrane potential for driving ATP synthase. The simulated mitochondrial membrane
potential (ΔΨ) changed from -120mV to -107 mV (Figure 64). The decline in ΔΨ was not
suffieicent enough inhibiting ATP generation infact a higher amount of mitochondrial ATP were
synthesised and transported into cytosol by Adenine nucleotide transloactor (ANT). The ANT is
responsible for exporting ATP from mitochondrial matrix and importing ADP from cytosol.

Figure 62: Predicted ATP production by NG108-15 cell upon exposure to 2DG

Figure 63: Predicted ATP utilization by NG108-15 cell upon exposure to 2DG
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Figure 64: Predicted mitochondrial membrane potential of NG108-15 cell exposed to 2DG

5.4.3. Predicting action potentials and ionic concentrations
The neuronal-metabolic model predicted the changes in action potential peaks shapes
as the cellular metabolism was being affected. The experimentally measured action potentials
exposed to 2DG were compared to model generated action potentials and were in good
agreement (Figure 65). The entire action potential time series was matched to experimental
recordings to validate model predictions. The evaluation of time series data is crucial as most of
the drugs reduced might cause similar effects in AP but the time scale of those effects would be
significantly different.
Inhibiting glycolysis caused a compelling change in intracellular ATP levels. Reduction of
intracellular ATP levels lead to decreased ATP-dependent electrogenic pump activity and also
activated ATP dependent potassium channel. The changes in membrane electrical activity cause
changes in intracellular ionic concentrations. The intracellular accumulation of sodium (Figure
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66) and calcium (Figure 68) followed by a decline in potassium (Figure 67) concentration was
observed.

Figure 65: Predicted (red) action potential time series compared to experimental (blue) recordings when treated
with 2DG

The sodium, potassium and calcium concentrations reached to 13.82, 132.8 and 0.085
mM respectively after 17 min. It has been found that neurons are more sensitive and loose
cellular homeostasis than glial cells upon exposure to metabolic perturbations [105]. The
123

simulation showed the calcium concentration has increased rapidly after 15 min (Figure 68) and
is in agreement with the literature reported changes [105].

Figure 66: Predicted 2DG induced changes in subcellular and bulk cytosolic sodium concentrations

Figure 67: Predicted 2DG induced changes in subcellular and bulk cytosolic potassium concentrations
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Figure 68: Predicted 2DG induced changes in subcellular and bulk cytosolic calcium concentrations

5.5. Perturbing mitochondrial electron transport chain
The mitochondrial electron transport induced perturbations were studied by inhibiting
oxidative phosphorylation reaction using cyanide. Cyanide is a potent reversible inhibitor of
mitochondrial cytochrome oxidase and causes sudden death by acting on central nervous
system. Cyanide predominately inhibits the consumption of oxygen required for ATP
production. Although cyanide inhibition is reversible, a prolong exposure will lower cellular ATP
levels inducing an irreversible damage to cell. The biochemical events during cyanide exposure
have been studied on a wide variety of cells including neurons and NG108-15 cells [89]. To
determine and experimentally validate the metabolic perturbations induced by electron
transport chain, the NG108-15 were exposed to cyanide followed by determining the metabolic
activity and electrophysiological changes.
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To mimic the experimental conditions, the oxidative phosphorylation in the
mitochondria was inhibited in neuronal-metabolic model by creating an event in Simbiology.
Simultaneously, even the contribution of oxidative phosphorylation towards mitochondrial
membrane potential was inhibited.

5.5.1. Analysis of carbon flux
The scaling factor ‘b’ for inhibiting oxidative phosphorylation was estimated by
predicting the IC50 values. The IC50 values were obtained by fitting the simulated lactate flux to
experimental data (Figure 69– red line). The model showed a decreased glucose flux into the
cell upon inhibiting mitochondrial activity (Figure 69 - blue line). The lactate flux obtained from
the metabolic model gave a satisfactory fit to experimental measurements. The experimental
and simulated results showed an initial increase in lactate production by NG108-15 cell.

Figure 69: Cyanide treated simulated glucose uptake and lactate flux compared to experimental data
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The increase in lactate production was due to the inhibition of mitochondrial process
forcing the cell to rely on glycolysis for ATP production. The mitochondrial pyruvate levels have
increased during the first couple of minutes as the mitochondria were unable to metabolize
pyruvate through TCA cycle (Figure 70 – red line). The mitochondrial pyruvate levels have
increased to 203% whereas the cytosolic levels have lowered by 14% after a 5 min exposure to
cyanide. The prolonged exposure has caused the cytosolic pyruvate levels to lower as pyruvate
was used during glycolysis to generate lactate and ATP (Figure 70 –blue line). The reduction in
cytosolic levels of pyruvate caused the mitochondrial pyruvate to be transported back to into
cytosol for ATP generation. The overall cytosolic pyruvate levels were reduced by 35% and the
mitochondrial pyruvate levels were reduced by 24% after 80 min.

Figure 70: Simulated pyruvate fluxes during cyanide treatment

The metabolic flux analysis of carbon utilization showed that carbon utilization by
glycolysis has increased from 83% to 88% upon exposure to cyanide (Figure 71). The
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mitochondrial carbon utilization decreased from 15% to 10%. No significant change in PPP was
observed as the glycolytic metabolites were deplting faster leaving no excess metabolities to
enter PPP. The transport of pyruvate into the extracellular space was less than 1%. These
results indicate a shift in metabolic activity from mitochondria to glycolysis occurs during
hypoglycemia.

Figure 71: Predicted carbon utilization by NG108-15 cells during cyanide treatment

5.5.2. ATP production and utilization
The contribution of ATP production by mitochondrial oxidative phosphorylation was
determined by treating cells with cyanide, a respiratory chain inhibitor. Treatment with cyanide
not only eliminates the utilization of pyruvate but also other endogenous fuels such as amino
acids and fatty acids that may contribute high energy electrons for ATP synthesis [105]. The ATP
production during cyanide treatment was measured and compared to simulated values. The
model accurately predicted change in cellular ATP (Figure 72) and ADP (Figure 73) levels. These
results were in accordance with the cyanide effects tested by Ray et al. [89]. Glycolysis alone
could not maintain the cellular ATP level and the rate of decline in cellular ATP was slow
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compared to 2DG treatment. The AMP levels slightly increased as the cellular ATP and ADP
were converted by AK (Figure 74). A 60 minute exposure of cyanide lowered the cellular ATP
levels to 148 + 29 µM. The ADP levels did not change significantly and remained at 109 + 15 µM
indicating the conversion of cellular ATP to AMP.

Figure 72: Predicted (solid line) and experimentally (O-dotted line) measured ATP production exposed to Cyanide

Figure 73: Predicted (solid line) and experimentally (O-dotted line) measured ADP production exposed to Cyanide

129

Figure 74: Predicted AMP levels exposed to 2DG

The ATP production by individual pathways exposued to cyanide was analyzed. The total
production of ATP by both glycolysis and mitochondria has declined but the percent amount of
ATP produced by glycolsyis has increased from 81% to 85% (Figure 75). The mitochondrial ATP
production has decreased from 19% to 15%. Inhibition of mitochondria has focred the cell to
rely on glycolysis for ATP generation. The ATP generated by glycolysis was sufficient enough for
cellular functions. The ATP utilization by difference cellular pathways was determined (Figure
76). The ATP utilization by glycoslysis has increased from 41% to 49%. The ATP consumption by
general ATPases, NaK-ATPase, Ca-ATPase, PPP and AK was 25%, 15%, 10%, < 1% and < 1%. The
activity of general ATPases decreased by 4%. The carbon influx into mitochondria has decreased
and lower number of protons were generated by TCA cycle.
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Figure 75: Predicted ATP production by NG108-15 cell upon exposure to Cyanide

Figure 76: Predicted ATP utilization by NG108-15 cell upon exposure to Cyanide

Since the activity of glycolytic enzymes has not decreased significaantly, the NAD/NADH
recycling has elevated and electrons are probably being transported into the mitochondria by
the G3P shuttle thereby enabling the maintainence of mitocondrial membrane potetnial. The
simulated mitochondrial membrane potential (ΔΨ) changed from -121 mV to -100 mV within 2
minutes due to usage of the existing electrons and slowly reached back to -110mV as the
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electrons from glycolysis were transferred into mitochondria (Figure 77).

Figure 77: Predicted mitochondrial membrane potential of NG108-15 cell exposed to Cyanide

5.5.3. Predicting action potentials and ionic concentrations
The neuronal-metabolic model generated action potentials and predicted the changes in
action potential peaks shapes as the cellular metabolism was inhibited. The action potential
time series obtained from the model was plotted against the experimental recordings to
validate the model. The measured action potentials matched the simulated action potentials
(Figure 78). A visual analysis showed no change in the action potential peak shapes as the
cellular ion channels and ATP dependent exchangers were functional. The required amount of
ATP was being generated by glycolytic pathway. A detailed analysis of action potential time
series has been performed in chapter 5.9.
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Figure 78: Predicted (red) action potential time series compared to experimental (blue) recordings when treated
with cyanide
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Inhibiting mitochondrial membrane potential has slightly reduced cellular ATP levels.
The electrogenic ATP-dependent exchangers activity were unaffected (Figure 76) and have
been successful at restoring ionic concentrations (Figure 79, Figure 80 and Figure 81). The
sodium, potassium and calcium concentrations reached to 10.78, 138.1 and 0.125 mM
respectively after 17 min. The action potential peak shape has not significantly altered. The
change in intracellular ionic concentrations less initially as the cellular ATP levels were not
lowered. After 17 min of exposure to cyanide, the ATP levels slightly reduced and the
intracellular ionic concentrations were altered. The changes in sodium, potassium and ATP
concentrations lead to a rapid rise in intracellular calcium concentration. The changes in the
subcellular space are swift and achieved equilibrium with the bulk cytosolic concentrations. The
above results obtained from simulating neuronal-metabolic model and experiments suggests
that NG108-15 cells are insensitive to cyanide.

Figure 79: Predicted cyanide induced changes in subcellular and bulk cytosolic sodium concentrations
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Figure 80: Predicted cyanide induced changes in subcellular and bulk cytosolic potassium concentrations

Figure 81: Predicted cyanide induced changes in subcellular and bulk cytosolic calcium concentrations
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5.6. Perturbing mitochondrial TCA cycle and electron transport chain
Succinate dehydrogenase (SDH) was inhibited to investigate metabolic perturbations
induced by mitochondrial TCA cycle and electron transport chain. SDH is the only enzyme that
couples mitochondrial TCA cycle and electron transport chain. SDH is complex-II in the electron
transport chain and does not pump protons directly across inner mitochondrial membrane.
Complex-II transfers reducing equivalents through co-enzyme Q10 that gets re-oxidized by
complex-III in inner mitochondrial membrane. Malonate is a competitive inhibitor of SDH and
causes an accumulation of succinate in mitochondria. Malonate has been shown to induce in
vivo and in vitro neuronal toxicity in a dose-dependent manner [109].
To investigate the metabolic perturbations induced by malonate, NG108-15 cells were
exposed to Malonate followed by determining the metabolic activity and electrophysiological
changes. To simulate experimental conditions, SDH enzyme in TCA cycle was inhibited in the
neuronal-metabolic model by creating an event in Simbiology. The inhibition factor was
predicted by fitting the model to experimental lactate flux. The IC50 values obtained are used
for simulating the neuronal-metabolic model.

5.6.1. Analysis of carbon flux
The carbon flux into the cell has increased upon treating cells with malonate. A 20 min
exposure of malonate has increased the glucose flux into cell by 30% (Figure 82 – blue line). The
increased glycolytic flux subsequently resulted in an elevated lactate flux. The lactate flux was
increased by 22.5% (Figure 82 – red line). The model also predicted an overall increase in
glucose and lactate flux which is in agreement with the experimentally determined values
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(figure 82). The increased glucose and lactate flux were lowered by 10% and 6% respectively
after 60 min exposure. The mitochondrial flux decreased and an increase in cellular glycolysis
was observed indicating that the cell was probably running at its maximum glycolytic capacity.

Figure 82: Simulated glucose uptake lactate release flux compared to experimental data by treating NG108-15 cells
with malonate

The pyruvate flux was analyzed to track the flow of carbon into different pathways over
time (Figure 83). A 9x increase in mitochondrial pyruvate concentration was observed upon a
30 min exposure to malonate. Similarly, the cytosolic pyruvate has also increased as the
pyruvate was not metabolized in TCA cycle leading to a build-up in mitochondria and cytosolic
compartments. The pyruvate levels were slowly reaching back to steady state adjusting to the
perturbations caused by malonate. Due to increased requirement of pyruvate in glycolysis, a
very small amount of carbon is exported out of the cell as pyruvate. Further analysis of the
carbon flux into different pathways was performed. The glycolytic flux has increased by 2%. The
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mitochondrial flux has decreased only by 2% since the pyruvate was getting accumulated in the
mitochondrial compartment as shown in Figure 83. The carbon flux into PPP and extracellular
pyruvate remained unaltered when compared with controls (Figure 44).

Figure 83: Analysis of pyruvate concentrations in cytosol, mitochondria and extracellular compartments during
malonate treatment

Figure 84: Analysis of carbon fluxes for cells exposed to malonate
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5.6.2. ATP production and utilization
The changes in ATP and ADP levels were measured by exposing cells to malonate. The
experimentally determined and simulated results of ATP (Figure 85) and ADP (Figure 86)
measurements were in good agreement. The predicted AMP levels have also increased when
treated with malonate (Figure 88). A 60 min exposure to malonate caused cellular ATP levels to
decline by 22%. The reduction in ATP levels increased the ADP and AMP levels by 37% and 47%
respectively. The adenine nucleotide levels were conserved in the model and their levels are
governed by AK.

Figure 85: Experimental and predicted changes in intracellular ATP concentration during malonate treatment

The rate of decline in ATP production was slightly less compared to cells treated with
cyanide. The protons generated from elevated glycolysis were transferred into the
mitochondria by G3P shuttle. The transferred protons contribute towards the mitochondrial
membrane potential. The mitochondrial membrane potential was reduced from -121 mV to 139

117 mV (Figure 87). The mitochondrial membrane potential has been shown to be lowered by
decrease in the cellular ATP production during malonate treatment in neurons. But due to the
altered metabolic activity the mitochondrial membrane potential was not significantly altered.

Figure 86: Experimental and predicted changes in intracellular ADP concentration during malonate treatment

Figure 87: Mitochondrial membrane potential of NG108-15 cell during treatment with malonate
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Figure 88: Predicted changes in intracellular AMP concentration during malonate treatment

A complete analysis of cellular ATP production and utilization was performed to gain
metabolic insights and identify protein activities. Since the mitochondrial membrane potential
was not altered significantly, the mitochondrial ATP production declined by 2% and
simultaneously the ATP production increased by 2%.

Figure 89: Analysis of ATP production pathways during malonate treatment
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The ATP utilization by glycolysis increased by 7% as glucose uptake was heighted.
Despite a decrease in cellular ATP level, a sufficient amount of ATP was still being synthesised
by the cell to carryout the necessary functions. The ATP utilization flux by Ca-ATPase, NaKATPase, general ATPase, AK and PPP were 10%, 15%, 26%, <1% and <1%.

Figure 90: ATP utilization by different pathways upon exposure to malonate

5.6.3. Predicting action potentials and ionic concentrations
The model generated action potentials (AP’s) were compared to experimentally
determined action potentials. The simulated AP’s were in good agreement with the
experimental recordings (Figure 91). The action potential peak height was maintained as the ion
channels and exchangers were functional. The rate of decline in membrane resistance was
estimated and included in the model during action potential simulation. The action potential
parameters were not altered as malonate does not bind to ion channels and only the reversal
potentials of all ions are allowed to change.
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Figure 91: Simulated (red) and experimental (blue) malonate treated action potential time series
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The neuronal and metabolic modules are driven by changes in the cellular ATP and ionic
concentrations. The model predicted ATP concentrations were analyzed during malonate
treatment. The intracellular sodium concentration increased by 1.7 mM (Figure 92) and
potassium concentration decreased by 18.6 mM (Figure 93). The calcium concentrations did not
change significantly (Figure 94). The subcellular calcium concentrations reached a maximum of
8.48×10-4 mM. The maximum flux of ionic concentrations depends on the fitting parameters
obtained during action potential deconvolution. The intracellular ionic concentrations were
slowly altered and no rapid change was observed as cellular ATP levels were slowly lowered. A
rapid significant decline might have caused intracellular ionic concentrations to rise quickly.

Figure 92: Predicted changes in subcellular (red) and bulk (blue) cytosolic sodium concentrations in NG108-15 cells
exposed malonate
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Figure 93: Predicted changes in subcellular (red) and bulk (blue) cytosolic potassium concentrations in NG108-15
cells exposed malonate

Figure 94: Predicted changes in subcellular (red) and bulk (blue) cytosolic calcium concentrations in NG108-15 cells
exposed malonate
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5.7. Perturbing glycolysis and mitochondrial electron transport chain
Most diseases such as cancer are being treated with some combination of surgery,
radiation and/or multiple drug treatment. Drug treatment mainly involves using drugs that kill
rapidly dividing cells. Cellular pathways in cancer cells are modified and certain pathways are
over expressed. The rationale behind using such treatment is to use a combination of drugs that
inhibit cellular pathways at multiple points. NG108-15 cells are insensitive to mitochondrial
inhibitors, so a combinational treatment with a glycolytic inhibitor was tested to increase the
sensitivity. Cells were treated with 2DG and cyanide simultaneously to induce metabolic
perturbations in glycolysis and the mitochondrial pathways. The metabolic perturbations were
validated by determining the metabolic and neuronal responses.

5.7.1. Analysis of carbon flux
The cellular glucose uptake and lactate production were measured by exposing the cells
to 2DG and cyanide. These drugs significantly inhibited glycolysis and mitochondrial oxidative
phosphorylation and lowered the carbon fluxes in the cell. A rapid decline in cellular glucose
consumption and lactate production was observed within the first 20 min (Figure 95). The
glucose and lactate fluxes were lowered by 66% and 72%, respectively, in 20 min. The decline
was much faster than the standalone treatment of either drug. Prolonged exposure to 2DG and
cyanide has further decreased the carbon fluxes and a complete inhibition of glucose flux was
observed after 80 min. Inhibition glycolysis caused a decline in cytosolic pyruvate
concentrations in 4 min (Figure 96). The pyruvate levels in the mitochondria have rapidly
increased reaching a peak concentration of 0.02 mM.
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Figure 95: Experimental lactate production compared to the model generated lactate and glucose flux during
combinational treatment with 2DG and cyanide

Figure 96: Predicted cytosolic, mitochondrial and extracellular concentrations of pyruvate in NG108-15 cell
exposed to 2DG and Cyanide

147

The increased mitochondrial pyruvate levels were accumulated and transported back to
the cytosol causing the cytosolic pyruvate concentrations to rise. Since carbon influx has been
inhibited, the cellular metabolite levels got exhausted. This expedited depletion of the
glycolytic metabolites forced the carbon flux towards lactate production. The cytosolic pyruvate
decreased as it was converted to lactate and simultaneously the accumulated mitochondrial
pyruvate was transported into the cytosol (Figure 96).
The flux balance analysis of carbon into different pathways was performed (Figure 97).
The global fluxes have decreased and the ratio of carbon fluxes had also changed. The
mitochondrial flux of carbon was lower than the lactate flux. The carbon in glycolysis and the
mitochondria were 94% and 5% respectively. The PPP flux has also been lowered to 0.57%. The
extracellular flux of carbon as pyruvate was less than 0.3%. The combinational treatment had a
larger effect on glycolysis and significantly lowered its activity. Metabolic perturbations induced
by inhibition of glycolysis and mitochondrial respiration had a huge effect on cellular functions.

Figure 97: Flux balance analysis of carbon usage by different pathways during 2DG and cyanide treatment
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5.7.2. ATP production and utilization
The changes in ATP and ADP levels in cells exposed to a combinational treatment of 2DG
and cyanide were assessed by experimental determination at different time intervals. The
simulated ATP (Figure 98) and ADP (Figure 99) concentrations were compared to
experimentally determined values. A 20 min exposure of 2DG and cyanide lowered the ATP
levels to 32%. Prolonged exposure beyond 20 min caused cellular ATP levels to decrease further
down to 18%. The ADP levels increased by 36% during the first 20 min and were decreased by
18%, almost reaching the initial concentrations. The predicted AMP levels increased from 75
µM to 345 µM (Figure 100).

Figure 98: Measured and simulated ATP concentrations in NG108-15 cell exposed to a combinational treatment of
2DG and Cyanide
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Figure 99: Measured and simulated ADP concentrations in NG108-15 cell exposed to a combinational treatment of
2DG and Cyanide

Figure 100: Simulated AMP concentrations in NG108-15 cell exposed to a combinational treatment of 2DG and
Cyanide
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The mitochondrial membrane potential depolarized from -121 mV to -88 mV (Figure
101). An initial small transient was observed lowering the potential to -113 mV due to the
aberrant arrest of mitochondrial respiration by cyanide. As carbon flux was inhibited by
metabolic inhibitors, the generation of protons required to maintain mitochondrial membrane
potential had decreased. This decrease in mitochondrial membrane potential resulted in a
decline in mitochondrial ATP generation mechanisms.

Figure 101: Predicted changes in mitochondrial membrane potential of NG108-15 cell exposed to 2DG and cyanide

The flux balance analysis was perfomed on the ATP production and utilization of
different pathways during treatment with 2DG and cyanide. The analysis indicated an overall
reduction in cellular ATP generation. After 80 min of combinational treatment, the glycolytic
and mitochondrial ATP production were 93% and 7% respectively (Figure 102). The utilization of
ATP by different pathways has shown that only 27% of ATP was used back again in cellular
glycolysis pathway (Figure 103). The reduction in ATP levels have also decreased the conversion
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of glucose by hexokinase. The NaK-ATPase and Ca-ATPase were utilized appromimately 14 and
22% of cellular ATP, respectively, to restore cellular homeostasis. The general ATPases were
utilizing around 36% of ATP. The ATP usage by PPP and AK was lowered and consumed less than
1% of ATP.

Figure 102: Analysis of ATP production by glycolysis and mitochondrial process during 2DG and Cyanide

Figure 103: ATP utilization by different cellular process exposed to 2DG and cyanide

152

5.7.3. Predicting action potentials and ionic concentrations
The model generated action potentials during metabolic perturbation induced by 2DG
and cyanide were significantly altered. The simulated action potentials were compared to the
experimental measurements (Figure 104) and an excellent fit was obtained between them.

Figure 104: Predicted action potentials compared to experimental recordings exposed to 2DG and cyanide
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The action potential peak height decreased and membrane potentials depolarized. The
reversal potentials and cellular ATP concentrations were allowed to change during simulation.
The changes in the subcellular and bulk ionic concentrations were predicted by the model. The
calcium concentration initially increased linearly from 1.25e-4 mM to 2.64e-3 mM, but cellular
ATP concentration did not significantly decrease (Figure 107). But after 8 minutes of exposure
to 2DG and cyanide, a significant reduction in cellular ATP levels caused the calcium
concentration to rise exponentially leading to a rapid influx of sodium and efflux of potassium
ions. The bulk cytosolic sodium concentration increased from 10 mM to 20.4 mM (Figure 105).
The potassium concentration decreased from 140 mM to 84 mM in 17 minutes (Figure 106).
These results were in agreement with the ionic concentration changes found in C6 glioma cells
treated with 2DG and cyanide [105].

Figure 105: Predicted changes in subcellular and bulk cytosolic sodium concentrations during combinational
treatment with 2DG and cyanide
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Figure 106: Predicted changes in subcellular and bulk cytosolic sodium concentrations during combinational
treatment with 2DG and cyanide

Figure 107: Predicted changes in subcellular and bulk cytosolic sodium concentrations during combinational
treatment with 2DG and cyanide
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5.8. Perturbing glycolysis, mitochondrial TCA cycle and electron transport chain
Inhibiting the TCA cycle by malonate had no significant effect on cellular activities as the
required ATP was being generated by glycolysis. The effects of inhibiting glycolysis with 2DG
and the mitochondrial TCA cycle and electron transport chain with malonate were tested.
Malonate inhibits complex-II (SDH enzyme) but does not completely seize the electron
transport chain as the electrons from oxidation of NADH and FADH 2 are directly transported
into inner mitochondrial membrane. The metabolic perturbations that are due to inhibition of
glycolysis and the TCA cycle were evaluated.
To simulate the effect of combination treatment of drugs, both the events representing
the effect of glycolysis and TCA cycle inhibition are turned on. The scaling factors for inhibiting
the pathways were obtained from the earlier obtained fitting data for standalone drugs.

5.8.1. Analysis of carbon flux
The fate of carbon was analyzed to determine the effects of combinational treatment
with 2DG and malonate. The model predicted glucose flux and lactate flux were compared to
the experimental data (Figure 108). The glucose flux was not measured as 2DG and glucose
have a similar molecular structure and the assay kit was unable to distinguish between them.
The glucose uptake and lactate production were lowered to 55% and 51% respectively in 20
min. The declines in carbon flux continued upon prolong exposure. The predicted glucose flux
and lactate flux decreased to 10 and 18%, respectively, after 80 min.
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Figure 108: Simulated glucose and lactate flux compared to experimental lactate flux of NG108-15 cell during
combinational treatment with 2DG and malonate

The cytosolic and mitochondrial pyruvate concentrations decreased over time (Figure
109). Unlike malonate treatment where accumulation of pyruvate was observed, the
combinational treatment caused only a small increase in cytosolic and mitochondrial pyruvate
levels. 2DG inhibited glucose flux which resulted in the transport of carbon to the mitochondria.
The mitochondrial pyruvate slowly decreased as the cytosolic pyruvate was preferably being
converted into lactate. The extracellular pyruvate flux initially remained unaltered but was
completely inhibited after 80 min.
Carbon flux analysis has identified the percent of carbon being used by different
pathways within the cell. Although the total carbon flux decreased, around 91% of carbon was
routed through glycolysis and converted to lactate and only 8% of the carbon entered the
mitochondria. The carbon flux towards the pentose phosphate pathway and extracellular
157

pyruvate were 0.01% and 0.7%. The decrease of carbon flux to PPP was significantly lowered as
the reduction in glycolytic metabolites favored the carbon to route towards lactate generation
by producing ATP for cellular functions.

Figure 109: Predicted pyruvate flux during simulating the effects of combinational treatment of 2DG and malonate

Figure 110: Carbon flux analysis of NG108-15 cell exposed to 2DG and malonate
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5.8.2. ATP production and utilization
The cellular ATP and ADP levels were measured by exposing the cells to 2DG and
malonate simultaneously. The predicted ATP (Figure 111) and ADP (Figure 112) concentrations
were in good agreement with the experimental data. A 40 min exposure to these drugs lowered
the cellular ATP levels to 21%. The model predicted cellular ATP levels declined further after
exposure to 2DG and malonate for 60 min. The experimental results have shown cellular ATP
levels to remain at a plateau probably due to the production of ATP by other endogenous
factors such as fatty acids. The decrease in cellular ATP levels caused the ADP levels to rise
initially. The AMP levels (Figure 113) increased as the cellular ATP levels were decreasing. An
uninterrupted exposure lowered the cellular ADP level, and subsequently increased the
intracellular AMP level.

Figure 111: Measured and simulated ATP concentrations in NG108-15 cell exposed to a combinational treatment
of 2DG and malonate
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Figure 112: Measured and simulated ADP concentrations in NG108-15 cell exposed to a combinational treatment
of 2DG and malonate

Figure 113: Simulated AMP concentrations in NG108-15 cell exposed to a combinational treatment of 2DG and
malonate

The mitochondrial membrane potential became more sensitive when treated with 2DG
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and malonate. Treatment with malonate alone had reduced the mitochondrial membrane
potential by -4 mV, but when the cells were treated with malonate in the presence of 2DG, the
mitochondrial membrane potential depolarized to -32 mV (Figure 114). The reason behind this
significant depletion of the mitochondrial membrane potential was due to lowered transport of
high energy electrons generated during glycolytic inhibition. The G3P shuttle was unable to
transfer the electrons as sufficient electron equivalents were not generated. On the other hand,
malonate has lowered the TCA cycle activity, thereby obstructing the generation and transfer of
electrons. Malonate has been shown to reduce cellular functions by depolarizing the
mitochondrial membrane potential and increasing the oxidative stress in SH-SY5Y
neuroblastoma cells [110].

Figure 114: Predicted mitochondrial membrane potential during treatment combinational treatment with 2DG and
malonate

ATP production and usage by different pathways in NG108-15 cell after 60 min exposure
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to 2DG and malonate was analyzed. The ATP production from glycolysis and the mitochondria
were 96% and 4% respectively (Figure 115). Although the total amount of ATP produced by the
cell decreased to 21%, the glycolytic pathway was still active generating ATP. The low amount
of ATP present in the cell was mainly used by hexokinase (HK), NaK-ATPase, Ca-ATPase and
general ATPases (Figure 116). The activity of the HK enzyme increased due to lowered ATP and
G6P levels. The lowered G6P levels triggered the influx of glucose and, more importantly, 2DG
into the cell. 2DG was preferentially metabolized in the cell leading to an accumulation of
2DG6P, a metabolitite that could not be metabolized futher down the glycolysis pathway. The
next highest ATP consuming process was the NaK-ATPase and Ca-ATPase proteins. These
proteins bind to free-cytosolic ATP and transfer ions across the memebrane to restore ionic
balance.

Figure 115: Analysis of ATP production by glycolysis and mitochondrial process during 2DG and malonate
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Figure 116: ATP utilization by different cellular process exposed to 2DG and malonate

5.8.3. Predicting action potentials and ionic concentrations
The time dependent changes in action potential peak shapes were predicted by the
neuronal-metabolic model. The action potentials generated by the model were plotted against
the experimental recordings (Figure 117). An excellent fit was obtained between the simulated
and experimental recordings. The fit to tail of an action potential was acceptable. A prolonged
exposure to 2DG and malonate has caused the cellular action potentials to alter significantly.
The intracellular ionic concentrations were predicted by the neuronal-metabolic model.
The sodium, potassium and calcium ionic concentrations changed rapidly. The intracellular
sodium reached a peak concentration of 21.1 mM in 18 min (Figure 118). The potassium
concentration decreased to 90 mM in 18 min (Figure 119). The changes in ionic concentrations,
and even cellular ATP levels, have caused a rapid exponential increase in calcium concentration
after 15 min (Figure 120). The calcium concentration increased to 0.92 mM.
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Figure 117: Predicted action potentials compared to experimental recordings exposed to 2DG and cyanide
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Figure 118: Predicted changes in subcellular and bulk cytosolic sodium concentrations during combinational
treatment with 2DG and malonate

Figure 119: Predicted changes in subcellular and bulk cytosolic potassium concentrations during combinational
treatment with 2DG and malonate
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Figure 120: Predicted changes in subcellular and bulk cytosolic calcium concentrations during combinational
treatment with 2DG and malonate

5.9. Distinguishing the effects of metabolic inhibitors
We hypothesized that the rate of change in action potentials would be characteristic to
the pathway being inhibited and their deconvolution would enable the ability to back tract the
effected pathways and allow continuous monitoring of the protein functions. Metabolic
perturbations and changes in cellular proteins activities occur in the cellular network at
different rates. The metabolic inhibitors tested act by lowering the cellular ATP levels, which
cause impaired cellular homeostasis leading to alterations in the membrane electrical activity.
Although the model was able to accurately predict the changes in action potential peaks
shapes based on the pathways being inhibited, an analysis of the characteristic changes would
enable us to gain a deeper insight. To characterize and differentiate the effects of the metabolic
inhibitors, changes in cellular action potential time series and ATP levels were compared.
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5.9.1. Analysis of action potentials
The time dependent changes in action potentials were determined by measuring the
rate of change in the action potential peak amplitude, holding potential, area and half-width at
the peak amplitude. The data were normalized to compare the effects of different inhibitors.
5.9.1.1. Action potential peak height
The normalized rate of change in action potential peak amplitude for different drugs is
shown in Figure 121. The peak height in control recordings remained stable and unaltered. The
mitochondrial inhibitors had the least effect on cellular metabolic activity which was reflected
in the AP peak height.

Figure 121: Normalized action potential peak height of cells exposed to different metabolic inhibitors

Cyanide and malonate lowered the action potential peak height by only 9% and 15%
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respectively whereas 2DG lowered the peak height to 54%. The rate of decline in 2DG treated
and combinational treatment was similar for the first 5 min. Prolonged exposure to the drugs
changed the peak height in a time-dependent manner. The combinational treatment of 2DG
with cyanide and malonate reduced the peak height to 21% and 37%. The reduction in action
potential is due to the reduction in cellular ATP levels. The reduced ATP levels failed to restore
the ionic concentrations, which resulted in huge changes in the intracellular ionic
concentrations. The intracellular accumulation of sodium concentrations reduced the drive for
the sodium ions to enter into the cell, which caused a decrease in sodium current.
5.9.1.2. Holding potential
The membrane potential was altered by injecting the cell initially with a sufficent
current to hyperpolarize the membrane to -70 mV. Although a stimulus pulse was given to
generate action potential. The current required to hold the membrane potential was not
altered during the course of the experiment. The holding potential reached the initial state in
one second and assuming that cellular machinery was functional, the ionic balances would have
also been restored. The holding potentials in the controls recordings did not change
significantly (Figure 122). The holing potential of cyanide was slightly depolarized by 9% but the
change was very small. The activity of cyanide had varied depending on the resting membrane
potential of the cell. Cyanide exposed to the cells with a resting membrane potential less than 38 mV caused the membrane potential to hyperpolarize and deplolarize in cells with resting
membrane potentials between -38 mV and -50 mV [111]. This result was in agreement with the
cyanide experiments perfomed on hippocampal pyrimidal neurons.
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During the first five minutes of exposure to Malonate, a slight decline in ATP levels and
changes in the intracellular ionic concentrations caused a decrease in the holding potential by
13% (Figure 122). Similar to the effects on peak amplitude, the holding potetnial of the cells
treated with 2DG alone and 2DG in combination with another drug had an immense effect. The
holding potential of 2DG, 2DG with cyanide and 2DG with malonate was lowered by 38%, 65%
and 88% (Figure 122). In accordance with the metabolic data, 2DG+cyanide treatement had an
extensive effect on AP.

Figure 122: Normalized initial holding potential of cells exposed to different metabolic inhibitors

5.9.1.3. Area of an action potential
The area under an action potential was also measured to characterize the drug effects
(Figure 123). The area in the control, 2DG, cyanide, malonate, 2DG+cyanide and 2DG+malonate
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had decreased to 96%, 51%, 90%, 82%, 25% and 34%. The treatment of the NG108-15 cell with
2DG and cyanide had the highest decline in the area. The area for malonate recording had
increased as the KATP channel was activated leading to a prolong depolarization of the action
potential.

Figure 123: Normalized area of an action potential of cells exposed to different metabolic inhibitors

5.9.1.4. Half-width at peak amplitude
The half width at peak amplitude (HWPA) varied in all conditions (Figure 124). The
HWPA for 2DG treated cells decreased as the peak was shortened. After five minutes, the half
width of the combinational treated 2DG and cyanide has increased due to elevated intracellular
calcium concentration. The calcium flux is usually responsible for the hump generated in the
action potential during depolarization. Combinational treatment with 2DG and malonate had
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no initial effect but reduced the HWPA after 5 minutes. Cyanide and malonate had showed no
significant effect on action potential peak height, holding potential and area of action potential.
Instead the HWPA of cells treated with cyanide and malonate showed a 20% and 19% decline in
amplitude. These results demonstrated that the changes in action potential are characteristic to
the pathway being inhibited.

Figure 124: Normalized action potential half-width at maximum peak height of cells exposed to different metabolic
inhibitors

5.9.2. Comparison of cellular ATP levels
Intracellular ATP levels act as indicators of cellular health. Since neurons are sensitive to
ATP levels, the effect of energy depletion on neuronal damage was studied [93]. Several cell
viability assays have been developed based on the determination of the cellular ATP levels. The
ATP levels in cells exposed to mitochondrial inhibitors, namely cyanide and malonate are
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reduced to 81% and 85% respectively (Figure 125).
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Figure 125: Percent ATP levels after 20 min exposure to metabolic inhibitors

Primary neuronal cells incubated with cyanide have been shown to lower the ATP level
to 33% [89] and the clonal pheochromocytoma PC12 cell line has also been shown to be
sensitive to cyanide [89]. Treatment of cells with 2DG had lowered cellular ATP levels to 45%.
The combinational treatment had the highest effect on NG108-15 cellular ATP levels. After a 20
min exposure ATP levels were reduced in 2DG with cyanide and 2DG with malonate treated
cells to 32 and 38% respectively. These results clearly indicated that NG108-15 cells were more
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sensitive to 2DG. Ray et al. have demonstrated that pre-treatment of NG108-15 cells with CoCl2
prevented the depletion of ATP during the combinational treatment with 2DG and cyanide [89].

5.10. Temporal proteomic analysis
Proteomics deals with the identification of protein expression profiles and their
interactions within the cell. Most proteins are not only expressed at various concentrations,
their activities also differ in the cell. A certain subset of proteins synthesized in the cell might be
inactive due to several rate limiting steps governing their activation. So, it is important to
chronically monitor the activities of these proteins and their interactions in a large network.
The overall goal of this dissertation is to be able to perform temporal proteomic analysis.

5.10.1. Heat map of predicted protein activities
The experimentally validated neuronal-metabolic model was able to predict the changes
in neuronal action potentials and cellular metabolism. The predicted activity of all the proteins
was analyzed to gain a deeper insight into the protein functions. The activities of the proteins
involved in the core metabolic pathways were analyzed at different time points. Figure 126
shows the changes in the proteins after a 10 minute exposure to metabolic perturbation. The
first column indicates the activity of proteins in a steady state. The activity of these proteins has
been normalized based on their activity. The activities of glycolytic proteins exposed to 2DG
were reduced and the mitochondrial enzyme activities were slightly increased which was in
accordance with the metabolic flux analysis of carbon (Figure 126).
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Figure 126: Heat map of cellular proteins activities exposed to different metabolic inhibitors after 10 min

The activity of glycerol-3 phosphate dehydrogenase (G3P shuttle) was also lowered as sufficient
amount of electrons were not generated due to a decline in cellular glycolysis. The lowered
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transport of electrons also resulted in decreased FADH2 oxidative phosphorylation. The activity
of phosphoribosyl pyrophosphate synthase (PRPPs) also decreased along with a decreased flux
into PPP.
Cyanide inhibited the mitochondrial respiration and caused a drop in oxidative
phosphotylation. The activity of F1F0 ATPase also deteriorated due to a lowered mitochondrial
potential. The activity of the F1F0 ATPase protein was compared between the malonate and
cyanide treatments. The inhibition of cellular respiration by cyanide increased the activity of
the TCA cycle as sufficient amounts of ATP were not being produced the by mitochondria.
Malonate had a mild effect on the TCA cycle and showed similar effects of cyanide induced
perturbations. The effect of the combinational treatment on protein activies was also
determined. The effect of 2DG and cyanide treatment had lowered protein activites in both the
pathways. Whereas, the treatment with 2DG and malonate had slighly lowered the glycolytic
activity compared to the 2DG and cyanide treatment. The activities of the metabolic proteins
were also lowered during 2DG and cyanide treatment wheres 2DG and malonate treatment had
a very low effect (Figure 126).
A snapshot of the protein activities after 60 minutes exposure to specific drugs was
analysed for changes in protein activites (Figure 127). Exposure to metabolic inhibitors varied
protein activities. Prolonged exposure to 2DG lowered the activity of all glycolytic proteins and,
specifically, reduced the actvity of phosphoglycerate kinase (PGK). The primary function of PGK
is to generate ATP by obtaining phosphate from 1,3 biphosphoglycerate.
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Figure 127: Heat map of cellular proteins activities exposed to different metabolic inhibitors after 60 min
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This is an important reaction where glycycolytic ATP is generated and inhibition could be a
viable option for cancer treatment. The acitvity of PRPPs also decreased as most of the carbon
ended up as lactate. Cyanide had lowered the activity of all glycolytic poteins by 1̴ 0% and
mitochondial TCA cycle proteins activities were lowered by ̴40%. Malonate effected protein
activities in both the glycolysis and mitochondrial pathways. The activity of G3P protein activity
was significantly decreased during malonate treatment as the transport of electrons from
glycolysis has decreased. The activities of all proteins decreased significantly after a 60 min
combinational treatment of 2DG+ cyanide and 2DG+malonate.

5.10.2. Time-dependent functional activities of proteins
The activation and inactivation of proteins occurs in a time-dependent manner. Current
proteomic tools lack the resolution to predict the changes in a large network simultaneously.
The model’s ability to chronically monitor functional changes in cellular protein activities of the
core metabolic pathways was demonstrated. Since the perturbations were induced using
cellular bioenergetic inhibitors, the activities of the proteins with respect to changes in cellular
ATP fluxes were investigated. The protein activities involved in carbon usage, ATP production
and usage are shown below (Figure 128, 129 and 130).
Temporal analysis of proteins involved in the cellular ATP consumption was determined
(Figure 128). The activities of proteins that depend on cellular ATP levels are ATP dependent
plasma membrane calcium transporter (Ca-ATPase), sodium-potassium ATPase (Na/K-ATPase),
phosphoribosyl

pyrophosphate

synthase

(PRPPS),

general

ATPase’s

(ATPase),

phosphofructokinase (PFK) and hexokinase (HK). The activities were normalized to the total ATP
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consumption. These protein activities were in agreement with the results obtained from the
metabolic flux analysis. Analysis of cellular proteins between treatments with 2DG, cyanide,
malonate, 2DG+Cyanide and 2DG+malonate was performed. Similar to the metabolic flux
analysis, the activities of the proteins decreased when the cells were exposed to 2DG alone or
combinational treatment involving 2DG.
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Figure 128: Predicted activities of Calcium ATPase (Ca-ATPase), Sodium-potassium-ATPase (Na/K-ATPase), phosphoribosyl pyrophosphate synthase (PRPPS),
general ATPases (ATPase), phosphofructokinase (PFK) and hexokinase (HK) during (A) control, (B) 2DG, (C) cyanide, (D) malonate, (E) 2DG+cyanide and (F)
2DG+malonate exposure. Their activities are normalized to total ATP usage by NG108-15
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The time dependent changes of the major proteins involved in determining carbon
fluxes is shown in Figure 129. Although all the enzymes are important in maintaining a proper
carbon flux throughout the cell, a few proteins were chosen to demonstrate the predictive
capabilities of the model. The activities of glucose transporter, pyruvate dehydrogenase,
monocarboxylate transporter and ribose-5 phosphate isomerase were analyzed. The glucose
transporter senses the intracellular concentration of glucose in the cell and imports glucose.
The monocarboxylate transporter (MCT) is responsible for transporting the intracellular lactate
outside. These transporters are diffusion based and exchange metabolites by sensing the
intracellular concentrations. The MCT’s have been shown to be highly active in cells with
elevated glycolysis especially in astrocytes and cancer cells. Pyruvate dehydrogenase
metabolizes the carbon entering the mitochondria so that it can be used in the TCA cycle.
Several inhibitors have been designed to impede the activity of these enzymes in order to
modulate and create a shift in cellular metabolism.
The temporal analysis of proteins engaged in ATP production is shown in Figure 130. The
major proteins involved in glycolytic ATP production are phosphoglycerate kinase (PGK) and
pyruvate kinase (PK). These enzymes have lowered significantly upon exposure to 2DG (figure
130 B). The PGK protein activity was completely inhibited after 60 min. The mitochondrial
proteins were still actively generating ATP. The combinational exposure of 2DG with cyanide
and malonate inhibited the protein activities completely. The protein activities were inhibited
on a different time scale by a different metabolic inhibitor. For example, PGK activity was
completely inhibited in 70 min when exposed to 2DG whereas the activity of the same enzyme
decreased much faster when exposed to a combinational treatment with 2DG and cyanide.
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Figure 129: Predicted activities of glucose transporter (GluT), pyruvate dehydrogenase (PDH), monocarboxylate transporter (MCT) and ribose-5-phosphate
isomerase (Ri5PI) during (A) control, (B) 2DG, (C) cyanide, (D) malonate, (E) 2DG+cyanide and (F) 2DG+malonate exposure. The protein activities are
normalized based on total carbon utilization in NG108-15 cell
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Figure 130: Predicted activities of phosphoglycerate kinase (PGK), pyruvate kinase (PK), succinyl CoA synthase (SCaS) and F-type ATP synthase (F1F0ATPase)
during (A) control, (B) 2DG, (C) cyanide, (D) malonate, (E) 2DG+cyanide and (F) 2DG+malonate exposure. The protein activities are normalized based on the
amount total amount of ATP generated by NG108-15 cell
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CHAPTER-6: CONCLUSIONS AND FUTURE WORK
6.1. Conclusions
Proteomics is a dynamic and rapidly growing field where many advances have occurred
during the past decade. Several high-throughput and high content screening technologies such
as MS have been developed but none of them have the capability to perform non-invasive
temporal analysis of cellular protein on a large-scale. The determination of protein activities
over time would enable us to better understand disease progression and also analyze
perturbations of pharmacologically active compounds. Pharmaceutical companies are in great
need of tools capable of characterizing perturbations induced by active compounds in cellular
networks. The work presented in this dissertation addresses this need with the development
and experimental validation of a novel in silico model capable of predicting the changes in
cellular protein activities and action potentials over time.
To accurately predict protein activities, a validated in silico model is a prerequisite.
Hence, the basal metabolism and cellular bioenergetics of NG108-15 cells were first
experimentally determined to validate the metabolic model. The analysis of cellular carbon
fluxes and ATP levels showed that metabolic pathways in a NG108-15 cell are reprogrammed.
The reconstructed metabolic module included the core metabolic pathways, namely, glycolysis,
pentose phosphate pathway, mitochondria and endoplasmic reticulum, which are essential to
study energy metabolism. The model calibration was accomplished using a parameter
estimation algorithm to simulate steady state by concurrently constraining the model to control
experimental data. The metabolic model produced an excellent fit to experimental data and
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predicted the activities of cellular proteins. A detailed analysis of cellular protein activities
revealed that NG108-15 cells are utilizing the ‘Warburg effect’.
A more realistic neuronal module was also constructed by incorporating additional ion
channels and exchangers to predict the membrane electrical properties of NG108-15 cell. The
electrophysiological readout from the NG108-15 cell was complex and deconvoluted by
employing a custom algorithm to estimate ion channel parameters and exchanger activities.
Deconvolution of the electrophysiological readout provided an excellent fit to voltage clamp
and current clamp recordings. This estimation of ion channel parameters was important as
these parameters determine ion fluxes. The developed neuronal module was coupled with a
metabolic model to build a more comprehensive neuronal-metabolic model. The coupled
neuronal-metabolic model accurately predicted cellular metabolic and neuronal protein
activities along with the changes in intracellular ionic and metabolite concentrations. The
model was capable of generating multiple action potentials over time. The neuronal module
also included a subcellular compartment, a distinct feature that provides a more physiological
representation of ionic fluxes during action potential generation in a neuron.
The predictive capability of the neuronal-metabolic activity was confirmed by performing
a series of known perturbations by inhibiting cellular proteins and simulating model behavior.
The model predictions were supported with experimental measurements. The proteins
involved in major energy producing pathways were perturbed. Initially, in silico perturbations of
glycolytic enzymes were analyzed. Glycolytic perturbations identified a significant effect on
cellular protein activities, leading to a decrease in carbon flux, cellular ATP levels and action
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potentials. The experimental determination of metabolic and neuronal activity to glycolysis
perturbations were in very good agreement with the model predictions. The glycolytic
inhibition lowered the activities of several proteins which lead to time-dependent changes in
neuronal AP.
The inhibition of mitochondrial protein activities was also evaluated by exposing cells to
cyanide and malonate. These mitochondrial inhibitors induced changes in metabolic and
electrophysiological activity and were measured experimentally and simulated using the
neuronal-metabolic model. The changes in neuronal APs predicted by the model were in good
agreement with the experimental recordings. In addition, the carbon and adenosine fluxes
were also in good agreement. The model predicted that the mitochondrial protein activity in
the NG108-15 cells was lower compared to the activity of glycolytic proteins. This lower
mitochondrial activity was reflected in metabolic and electrophysiological experiments where
no significant changes were found upon cyanide and malonate exposure. A combinational
perturbation in the neuronal-metabolic model showed that the sensitivity of the NG108-15 cells
could be enhanced. An experimental determination of neuronal electrophysiological recordings
and metabolic measurements showed that the model predictions were in good agreement.
Analysis of AP time series data revealed that the shape of APs varies based on the
pathway being inhibited. The characterization of these AP changes enabled the distinguishing of
the pathways being affected. The developed model also allowed temporal analysis of cellular
protein activities involved in core energy producing pathways. Thus, the developed model and
validated results demonstrate the use of a system biology driven electrophysiological model as
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an attractive platform for functional temporal proteomic analysis based on an
electrophysiology readout.

6.2. Future work
Future work could focus on extending the current model by incorporating additional
pathways representing all functional categories. The functional categories can be broadly
divided into 6 categories, namely, 1) energy metabolism, 2) biosynthesis of aminoacids, 3)
cellular processes, 4) fatty acid metabolism, 5) transcriptional regulation, 6) trasporters and
binding proteins [26]. Currently, the energy metabolism has been incorporated and tied to
neuronal actvitiy. A top-down model development approach has been followed that allows the
flexibility of incorporating any new functional modules later on.
The short-term future goals of the project could be to include cell-cycle to develop
nuclear-signaling process, followed by a more precise implementation of calcium handling. At
present the neuronal module is capable of predicting the ion concentration changes over time.
In future work, the incorporation of secondary messenger systems and its activation based on
altered ion concentrations would be useful to predict modifications in cellular activities. The
model would have to be adapted and validated for NG108-15 cells followed by
electrophysiological characterization, since time-scale of activities and corresponding AP peak
shapes could be different.
The long-term goal would be to include cellular process of functional categories listed
above and experimentally validate them followed by building a database of their effects. This
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would then enable analysis of APs after being treated with a compound to predict pathway
perturbations. For understanding disease progression or identification of long-term effects of a
drug, it is necessary to analyze APs on a longer time-scale. Long-term electrophysiological
recordings obtained from MEAs would have to be deconvoluted using a custom algorithm.
Although the resolutions of signals obtained from MEAs are not as high as compared to patchclamp electrophysiology, they could still be deconvoluted. In the event of complexity, other
viable approaches can be adapted. Recent advances in electrophysiological recordings have
enabled researchers to culture cells on carbon nanotubes [112] for achieving whole-cell
recordings on a longer time scale. But these techniques need to be validated confirming that no
other cellular mechanisms were triggered while using carbon nanotubes.
Further, advancement in model development would allow cellular APs to be measured
directly from a microfluidic system, followed by deconvolution of AP time-series to predict
protein-protein interaction and changes in protein activities for performing high-throughput,
non-invasive temporal proteomics.
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APPENDIX A: METABOLIC MODEL DIFFERENTIAL EQUATIONS
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Mitochondrial pyruvate

d(Pyrm)
1
=
∗ (v35 − v36)
dt
mitochondrial

Mitochondrial NAD

d(NADm)
1
=
∗ (−v36 – v39 – v40 – v44 + v49)
dt
mitochondrial

Acetyl-CoA

d(AcCoA)
1
=
∗ (v36 − v37)
dt
mitochondrial

Mitochondrial NADH

d(NADHm)
1
=
∗ (v36 + v39 + v40 + v44 – v49)
dt
mitochondrial

Oxaloacetate

d(OAA)
1
=
∗ (−v37 + v44)
dt
mitochondrial

Citrate

d(Cit)
1
=
∗ (v37 − v38)
dt
mitochondrial

Isocitrate

d(IsoCit)
1
=
∗ (v38 − v39)
dt
mitochondrial

α-Ketoglutarate

d(aKG)
1
=
∗ (v39 − v40)
dt
mitochondrial

Mitochondrial ADP

d(ADPm)
1
=
∗ (−v41 + v47 − v48)
dt
mitochondrial

Mitochondrial calcium

d(Cam)
1
=
∗ (v45 − v46)
dt
mitochondrial

Succinyl CoA

d(SucCoA)
1
=
∗ (v40 − v41)
dt
mitochondrial

Mitochondrial phosphate

d(Pim)
1
=
∗ (−v41 − v48 + v57)
dt
mitochondrial

Succinate

d(Suc)
1
=
∗ (v41 − v42)
dt
mitochondrial
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Mitochondrial ATP

d(ATPm)
1
=
∗ (v41 − v47 + v48)
dt
mitochondrial

Fumarate

d(Fum)
1
=
∗ (v42 − v43)
dt
mitochondrial

Malate

d(Mal)
1
=
∗ (v43 − v44)
dt
mitochondrial

Mitochondrial membrane potential

d(dPsi)
1
=
∗ (−2 ∗ v50 − v51 − v52 − v53 + v54 + v55 − v56)
dt
mitochondrial

Mitochondrial FAD

d(FAD)
1
=
∗ (−v42 − v64 + v65)
dt
mitochondrial

Mitochondrial FADH2

d(FADH2)
1
=
∗ (v42 + v64 − v65)
dt
mitochondrial

Endoplasmic reticulum calcium

d(Caer) 1
= ∗ (−v59 + v60 − v61)
dt
er

Cytosolic Glucose

d(Glc)
1
=
∗ (v1 − v2)
dt
cellular

Magnesium bound ATP

d(MgATP)
1
=
∗ (−v2 − v4 + v8 + v13 − v16 − v17 − v26 − v31 − v67 − v68)
dt
cellular

Glucose-6-phosphate

d(G6P)
1
=
∗ (v2 − v3 − v18)
dt
cellular

Magnesium bound ADP

d(MgADP)
1
=
∗ (v2 + v4 − v8 − v13 + v16 + v17 − v32 + v67 + v68)
dt
cellular

2,3-bisphosphoglycerate

d(BPG23)
1
=
∗ (v9 − v10 + v34)
dt
cellular

Magnesium

d(Mg)
1
=
∗ (v31 + v32 + v33 + v34)
dt
cellular
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Magnesium bound 2,3bisphosphoglycerate

d(MgBPG23)
1
=
∗ (−v34)
dt
cellular

Fructose 6-phosphate

d(F6P)
1
=
∗ (v3 − v4 + v25 + v27)
dt
cellular

AMP

d(AMP)
1
=
∗ (−v17 + v33)
dt
cellular

ATP

d(ATP)
1
=
∗ (v31 + v47)
dt
cellular

Fructose 1,6-biphosphate

d(F16BP)
1
=
∗ (v4 − v5)
dt
cellular

Magnesium bound AMP

d(MgAMP)
1
=
∗ (v26 − v33)
dt
cellular

Glyceraldehyde-3-phosphate

d(GAP)
1
=
∗ (v5 + v6 − v7 + v24 − v25 + v27)
dt
cellular

Dihydroxyacetone phosphate

d(DHAP)
1
=
∗ (v5 − v6)
dt
cellular

Cytosolic phosphate

d(Pi)
1
=
∗ (−v7 + v10 + v16 + v29 − v57 + v67 + v68)
dt
cellular

Cytosolic NAD

d(NAD)
1
=
∗ (−v7 + v14 + v64)
dt
cellular

1,3-bisphosphoglycerate

d(BPG13)
1
=
∗ (v7 − v8 − v9)
dt
cellular

Cytosolic NADH

d(NADH)
1
=
∗ (v7 − v14 − v64)
dt
cellular

3-Phosphoglycerate

d(PG3)
1
=
∗ (v8 + v10 − v11)
dt
cellular
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2-Phosphoglycerate

d(PG2)
1
=
∗ (v11 − v12)
dt
cellular

Phosphoenolpyruvate

d(PEP)
1
=
∗ (v12 − v13)
dt
cellular

Cytosolic pyruvate

d(Pyr)
1
=
∗ (v13 − v14 − v15 + v30 − v35)
dt
cellular

Cytosolic lactate

d(Lac)
1
=
∗ (v14 + v15 + v28)
dt
cellular

Cytosolic NADPH

d(NADPH)
1
=
∗ (−v15 + v18 + v19 − v20)
dt
cellular

Cytosolic NADP

d(NADP)
1
=
∗ (v15 − v18 − v19 + v20)
dt
cellular

ADP

d(ADP)
1
=
∗ (v17 + v32 − v47)
dt
cellular

6-phosphoglucono-δ-lactone

d(PGL)
1
=
∗ (v18 − v19)
dt
cellular

Ribuloase-5-phosphate

d(Ru5P)
1
=
∗ (v19 − v22 − v23)
dt
cellular

Glutathione disulphide

d(GSSG)
1
=
∗ (−v20 + v21)
dt
cellular

Glutathione

d(GSH)
1
=
∗ ( 2 ∗ v20 − −2 ∗ v21)
dt
cellular

Xyulose-5-phosphate

d(X5P)
1
=
∗ (v22 − v24 − v27)
dt
cellular

Ribose-5-phosphate

d(Ri5P)
1
=
∗ (v23 − v24 − v26)
dt
cellular
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Sedoheptulose 7-phosphate

d(S7P)
1
=
∗ (v24 − v25)
dt
cellular

Erythrose 4-phosphate

d(E4P)
1
=
∗ (v25 − v27)
dt
cellular

Phosphoribosyl pyrophosphate

d(PRPP)
1
=
∗ (v26 − v66)
dt
cellular

Cytosolic calcium

d(Ca)
1
=
∗ (−v45 + v46 + v59 − v60 + v61)
dt
cellular

Phosphatidylinositol 4,5-bisphosphate

D(PIP2)
1
=
∗ (−v58)
dt
cellular

Inositol triphosphate

d(IP3)
1
=
∗ (v58 − v62)
dt
cellular

Diacyl-glycerol

d(DAG)
1
=
∗ (v58 − v63)
dt
cellular

Extracellular glucose

d(Glce)
1
=
∗ (−v1)
dt
extracellular

Extracellular lactate

d(Lace)
1
=
∗ (−v28)
dt
extracellular

Extracellular phosphate

d(Pie)/dt = 1/extracellular ∗ (−v29)

Extracellular pyruvate

d(Pyre)
1
=
∗ (−v30)
dt
extracellular

193

APPENDIX B: METABOLIC MODEL FLUXES
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Glucose transporter
Vmaxgt
v1 =
∗
KmGlcout gt 1 +

Hexokinase

Glc
Vmax1hk
v2 =
∗(
)∗
Glc + KmGlchk KmMgATPhk

Glce −

Glc
Keqgt

Glce
Glc
Glce ∗ Glc
+
+
KmGlcout gt KmGlcingt KmGlcout gt ∗ KmGlcingt

Mg
MgADP
Vmax2hk
MgATP
– G6P ∗
Vmax1hk
KmMgATPMg hk
Keq hk
MgATP
Mg
Mg
(1 +
) (1 +
)+
+
KmMgATPhk
KmMgATPMg hk
KmMg hk
(
)
Mg
BPG23 + MgBPG23
BPG23 + MgBPG23
G6P
(1.55 +
) (1 +
)+
+ Mg
KmG6Phk
KmMg hk
KmBPG23hk
KmMghk ∗ KmMgBPG23hk
MgATP +

Glucosephosphate isomerase
G6P −
v3 = Vmaxgpi ∗

Phosphofructokinase

F6P
Keq gpi

G6P + KmG6Pgpi ∗ (1 +

F6P
)
KmF6Pgpi

F6P ∗ MgATP − F16BP ∗
v4 = Vmaxpfk ∗

MgADP
Keq pfk

(F6P + KmF6Ppfk ) ∗ (MgATP + KmMgATPpfk ) ∗
4

Mg
1+
KmMg pfk
ATP
1 + Lopfk ∗ (1 +
)∗
AMP + MgAMP
F6P
KmATPpfk
(1 +
) ∗ (1 +
)
KmAMPpfk
KmF6Ppfk
((
(
) ))

Aldolase
v5 =

Vmaxald
∗
KmF16BPald 1 +

DHAP
Keq ald
F16BP
GAP
GAP + KmGAPald
GAP
+
+ DHAP ∗
+ F16BP ∗
KmF16BPald KiGAPald
KmDHAPald ∗ KiGAPald
KmF16BPald ∗ KiiGAPald
F16BP − GAP ∗
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Triosephosphate isomerase
DHAP −
v6 = Vmaxtpi ∗

Glyceraldehyde
dehydrogenase

phosphate

v7 =

GAP
Keqtpi

DHAP + KmDHAPtpi ∗ (1 +

GAP
)
KmGAPtpi

Vmaxgapdh
KmNADgapdh ∗ KmGAPgapdh ∗ KmPigapdh

NADH
Keqgapdh
∗
NAD
GAP
Pi
NADH
BPG13
(1 +
) ∗ (1 +
) ∗ (1 +
) + (1 +
) ∗ (1 +
)−1
KmNADgapdh
KmGAPgapdh
KmPigapdh
KmNADHgapdh
KmBPG13gapdh
NAD ∗ GAP ∗ Pi − BPG13 ∗

Phosphoglycerate kinase
Vmaxpgk
v8 =
∗
KmMgADPpgk ∗ KmBPG13pgk (1 +

PG3
Keq pgk
MgADP
MgATP
BPG13
PG3
) ∗ (1 +
) + (1 +
) ∗ (1 +
)−1
KmMgADPpgk
KmBPG13pgk
KmMgATPpgk
KmPG3pgk
MgADP ∗ BPG13 − MgATP ∗

Bisphosphoglycerate mutase

BPG23 + MgBPG23
Keq bpgm
BPG23 + MgBPG23
1+
KmBPG23bpgm

BPG13 −
v9 = Kdbpgm ∗

Bisphosphoglycerate
phosphatase

PG3
Keq bpgp
v10 = Vmaxbpgp ∗
BPG23 + MgBPG23 + KmBPG23bpgp
BPG23 + MgBPG23 −
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Phosphoglycerate mutase
PG3 −
v11 = Vmaxpgm ∗

PG2
Keq pgm

PG3 + KmPG3pgm ∗ (1 +

PG2
)
KmPG2pgm

Enolase
v12 = Vmaxeno ∗

Pyruvate kinase

PG2 −

PEP
Keq eno

PG2 + KmPG2eno ∗ (1 +

PEP ∗ MgADP − Pyr ∗
v13 = Vmaxpk ∗

PEP
)
KmPEPeno

MgATP
Keq pk

ATP + MgATP 4
)
KmATPpk
(PEP + KmPEPpk ) ∗ (MgADP + KmMgADPpk ) ∗ 1 + Lopk ∗
4
4
PEP
F16BP
((1 +
) ) ∗ ((1 +
) )
KmPEPpk
KmF16BPpk )
(
(1 +

Lactate dehydrogenase (NADH)
v14 = Vmaxldh ∗ (Pyr ∗ NADH − Lac ∗

Lactate
(NADPH)

NAD
. Keq ldh )
[Lactate dehydrogenase (NADH)]

dehydrogenase
v15 = k ldh ∗ (Pyr ∗ NADPH − Lac ∗
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NADP
. Keq ldh )
[Lactate dehydrogenase (NADPH)]

ATPase
v16 = k ATPase ∗ MgATP

Adenylate kinase
Vmaxak
ADP
∗ (MgATP ∗ AMP − MgADP ∗
)
KmATPak ∗ KmAMPak
Keq ak
v17 = =
MgATP
MgADP + ADP
AMP
ADP
(1 +
) ∗ (1 +
)+
+ MgADP ∗ (
)
KmATPak
KmAMPak
KmADPak
(KmADPak )2

Glucose
dehydrogenase

phosphate
v18 =

G6P ∗ NADP − PGL ∗

Vmaxgpdh
∗
KmG6Pgpdh ∗ KmNADPgpdh
1 + NADP ∗

Phosphogluconate
dehydrogenase

Vmaxpgldh
v19 =
∗
KmPGL1pgldh ∗ KmNADPpgldh
(1 +

(

Glutathione reductase

GSSG ∗
v20 = Vmaxgr ∗

G6P
1 + KmG6P

gpdh

KmNADPgpdh

+

NADPH
Keq gpdh

ATP + MgATP
BPG23 + MgBPG23
NADPH
+
+
KmATPgpdh
KmNADPHgpdh
KmBPG23gpdh

NADPH
Keq pgldh
BPG23 + MgBPG23
ATP + MgATP
NADP
PGL
) ∗ (1 +
+
)+
+
KmNADPpgldh
KmPGL1pgldh
KmBPG23pgldh
KmATPpgldh
PGL
1+
KmPGL2pgldh
NADPH ∗
KmNADPHpgldh
)
PGL ∗ NADP − Ru5P ∗

(GSH)2
NADPH
NADP
−
∗
KmGSSGgr ∗ KmNADPHgr (KmGSH )2 KmNADPgr ∗ Keq gr
gr

1 + NADPH ∗
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GSSG
1 + KmGSSG

gr

KmNADPHgr

+

NADP
∗ (1 + GSH ∗
KmNADPgr

GSH
1 + KmGSH
KmGSHgr

gr

)

Glutathione oxidation
v21 = K go ∗ GSH

Phosphoribulose epimerase
Ru5P −
v22 = Vmaxpre ∗

Ru5P + KmRu5Ppre ∗ (1 +

Ribose phosphate isomerase
Ru5P −
v23 = Vmaxrpi ∗

Tranketolase (Ri5P)

X5P
Keq pre

Ri5P
Keq rpi

Ru5P + KmRu5Prpi ∗ (1 +

[Tranketolase (Ri5P)]. Vmaxtk ∗ ∗ Ri5P ∗ X5P −

v24 =

(

X5P
)
KmX5Ppre

Ri5P
)
KmRi5Prpi

GAP ∗ S7P
[Tranketolase (Ri5P)]. 𝐾𝑒𝑞𝑡𝑘

([Tranketolase (Ri5P)]. K1tk + Ri5P) ∗ X5P +
([Tranketolase (Ri5P)]. K2tk + [Tranketolase (Ri5P)]. K6tk ∗ S7P) ∗ Ri5P +
([Tranketolase (Ri5P)]. K3tk + [Tranketolase (Ri5P)]. K5tk ∗ S7P) ∗ GAP +
([Tranketolase (Ri5P)]. K4tk ∗ S7P + @[Tranketolase (Ri5P)]. K7tk ∗ X5P ∗ GAP)

)

Transaldolase
v25 = Vmaxta ∗

F6P
Keq ta
(K1ta + GAP) ∗ S7P + (K2ta + K6ta ∗ F6P) ∗ GAP + (K3ta + K5ta ∗ F6P) ∗ E4P + K4ta ∗ F6P +
K7ta ∗ S7P ∗ E4P
S7P ∗ GAP − E4P ∗
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Phosphoribosylpyrophosphate
synthetase

Ri5P ∗ MgATP − PRPP ∗
v26 = Vmaxprpps ∗

(KmATPprpps + MgATP) ∗ (KmRi5Pprpps + Ri5P)

[Transketolase (E4P)]Vmaxtk ∗ E4P ∗ X5P −
(
)
F6P
GAP ∗
[Transketolase (E4P)]Keq tk
v27 =
([Transketolase (E4P)]K1tk + E4P) ∗ X5P +
([Transketolase (E4P)]K2tk + [Transketolase (E4P)]K6tk ∗ F6P) ∗ E4P +
([Transketolase (E4P)]K3tk + [Transketolase (E4P)]K5tk ∗ F6P) ∗ GAP +
[Transketolase (E4P)]K4tk ∗ F6P +
[Transketolase (E4P)]K7tk ∗ X5P ∗ GAP
(
)

Transketolase (E4P)

Monocarboxylate transporter,
Lactate transport
v28 = Vmaxlt ∗ (Lace −

Phosphate transporter
plasma membrane

Lac
)
Keqlt

on
v29 = [Phosphate transport (Plasma membrane)]. Vmaxpt ∗ (Pie −

Pyruvate
transporter
plasma membrane

MgAMP
Keq prpps

Pi
. Keqpt )
[Phosphate transport (Plasma membrane)]

on
Pyr
v30 = [Pyruvate transport (Plasma membrane)]. Vmaxpt ∗ (Pyre − (
. Keq pt ))
[Pyruvate transport (Plasma membrane)]
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MgATP dissociation
v31 = EqMgATP ∗ (MgATP − Mg ∗

ATP
)
KdMgATP

v32 = EqMgADP ∗ (MgADP − Mg ∗

ADP
)
KdMgADP

MgADP dissociation

MgAMP dissociation
v33 = EqMgAMP ∗ (MgAMP − Mg ∗ AMP/KdMgAMP))

MgBPG23 dissociation
v34 = EqMgBPG23 ∗ (MgBPG23 − Mg ∗ BPG23/KdMgBPG23))

Pyruvate transport
(Mitochondrial membrane)
v35 = [Pyruvate transport (Mitochondrial membrane)]. Vmaxpt ∗ (Pyr −
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Pyrm
. Keqpt )
[Pyruvate transport (Mitochondrial membrane)]

Pyruvate dehydrogenase
v36 = k pdh ∗ (Pyrm −

AcCoA
) ∗ CoA ∗ NADm
K pdhEQ

Citrate synthase
v37 =

1+

Kcat cs ∗ Et cs
KmAcCoAcs KmOAAcs
KmOAAcs
+
+ KmAcCoAcs ∗
AcCoA
OAA
AcCoA ∗ OAA

Aconitase
v38 = Kfaco ∗ (Cit −

Isocitrate dehydrogenase

α-Ketoglutarate
dehydrogenase

v39 =

IsoCit
)
Keq aco

Kcat idh Et idh
KmIsoCit idh nidh
(
)
Hm
kH2idh
KmNADidh
NADHm
IsoCit
1+(
)+(
)+
ADPm
Cam + NADm ∗ (1 + KiNADHidh ) +
kH1idh
Hm
(1 +
) ∗ (1 +
)
KaADPidh
KaCaidh
NADHm
1+
KmIsoCit idh nidh KmNADidh
KiNADHidh
(
)
∗
∗
ADPm
Cam
IsoCit
NADm
(1 +
) ∗ (1 +
)
KaADPidh
KaCaidh
(
)

v40 =

Kcat akgdh Et akgdh
KmNADakgdh nakgdh
KmaKGakgdh
(
)
NADm
aKG
1+
+
Mgm
Mgm
Cam
Cam
(1 +
) ∗ (1 +
) (1 +
) ∗ (1 +
)
KaMg akgdh
KaCaakgdh
KaMg akgdh
KaCaakgdh
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Succinyl CoA lyase
v41 = Kfscl ∗ (SucCoA ∗ ADPm − Suc ∗ ATPm ∗

CoA
)
Keq scl

Succinate dehydrogenase
v42 =

Kcat sdh ∗ Et sdh
KmSucsdh
OAA
Fum
1+
∗ (1 +
) ∗ (1 +
)
Suc
KiOAAsdh
KiFumsdh

Fumarate hydratase
v43 = Kffh ∗ (Fum −

Malate dehydrogenase
v44 = Kcat mdh Et mdh (
1+

Mal
)
Keqfh

1
+ koffset)
Hm
Hm2
+
kH1mdh kH1mdh ∗ kH2mdh

1
kH3mdh
kH4mdh 2
(1 +
+ kH3mdh ∗
)
Hm
Hm
∗
KmMalmdh
OAA
KmNADmdh KmMalmdh
OAA
KmNADmdh
1+
∗ (1 +
)+
+
∗ (1 +
)∗(
)
Mal
KiOAAmdh
NADm
Mal
KiOAAmdh
NADm
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Calcium uniporter

Vmaxuni ∗ (

v45 =
(1 +

Ca 4
) +(
Ktrans

Ca
Ca 3
) ∗ (1 +
)
Ktrans
Ktrans

L
2F(dPsi − dPsio)
dPsi − dPsio
∗ (1 − exp (−2F
))
)∗
R∗T
R∗T
Ca nauni
(1 +
)
Kact

Sodium-Calcium exchanger

(Vmaxex ∗ exp (bF
v46 =
(1 +

Adenine nucleotide
translocator
v47 = Vmaxant ∗

dPsi − dPsio
Cam
)∗(
))
R∗T
Ca

KNa nex
KCa
) ∗ (1 +
)
Na
Cam

ADPm
dPsi
∗ exp (−F ∗
)
0.0225 ∗ ADP ∗ ATPm
R∗T
ATP
dPsi
ADPm
(1 + 0.05 ∗
∗ exp (−h ∗ F ∗
)) ∗ (1 + 0.36 ∗
)
0.45 ∗ ADP
R∗T
0.05 ∗ ATPm
1 − 0.018 ∗ ATP ∗

F1F0 ATPase

dPsiB
Cm − ADPm
)) ∗ KF1 ∗
−
R∗T
ADPm ∗ Pim
dpH
R∗T∗
+ dPsi
Cm − ADPm
F
(pa − pc2 ∗ KF1 ∗
) ∗ exp (3F ∗
)
ADPm ∗ Pim
R∗T
(100 ∗ pa + pc1 ∗ exp (3F ∗

v48 = −rhoF1 ∗

(

)
Cm − ADPm
dPsiB
(1 + p1 ∗ KF1 ∗
) ∗ exp (3F ∗
)+
ADPm ∗ Pim
R∗T
dpH
R∗T∗
+ dPsi
Cm − ADPm
F
(p2 + p3 ∗ KF1 ∗
) ∗ exp (3F ∗
)
ADPm ∗ Pim
R∗T
(
)
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Oxidative phosphorylation
(ra + rc1 ∗ exp (6F

dpH
R∗T∗
+ dPsi
dPsiB
NADHm
F
)) ∗ KNADH ∗ sqrt (
) − ra ∗ exp (g ∗ 6F
)+
R∗T
NADm
R∗T

rc2 ∗ KNADH ∗ sqrt (
v49 = 0.5 ∗ rhoNADH ∗

(

NADHm
dPsiB
(1 + r1 ∗ KNADH ∗ sqrt ( NADm )) ∗ exp (6F R ∗ T ) +
dpH
R∗T∗
+ dPsi
NADHm
F
(r2 + r3 ∗ KNADH ∗ sqrt ( NADm )) ∗ exp (g ∗ 6F
)
R∗T
(
)

dPsi (Calcium uniporter)

(

Vmaxuni
v50 =
∗
Cmito
(1 +

Ca 4
) +(
Ktrans

Ca
Ca 3
) ∗ (1 +
)
Ktrans
Ktrans

L
2F(dPsi − dPsio)
dPsi − dPsio
∗ (1 − exp (−2F
))
)∗
R∗T
R∗T
Ca nauni
(1 +
)
Kact

dPsi (Sodium-Calcium
exchanger)
Vmaxex
v51 =
Cmito

dPsi (Adenine nucleotide
translocator)

dpH
R∗T∗
+ dPsi
NADHm
F
) ∗ exp (g ∗ 6F
)
NADm
R∗T

(exp (bF
(1 +

dPsi − dPsio
Cam
)∗(
))
R∗T
Ca

KNa nex
KCa
) ∗ (1 +
)
Na
Cam

ADPm
dPsi
1 − 0.018 ∗ ATP ∗
∗ exp (−F ∗
)
Vmaxant
0.0225
∗
ADP
∗
ATPm
R
∗T
v52 =
∗
ATP
dPsi
ADPm
Cmito
(1 + 0.05 ∗
∗ exp (−h ∗ F ∗
)) ∗ (1 + 0.36 ∗
)
0.45 ∗ ADP
R∗T
0.05 ∗ ATPm
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)

dPsi (F1F0 ATPase)
100 ∗ pa ∗ (1 + KF1
3 ∗ rhoF1
v53 = − (
)∗
Cmito

dpH
R∗T∗
+ dPsi
Cm − ADPm
F
) − (pa + pb) ∗ exp (3F
)
ADPm ∗ Pim
R∗T

Cm − ADPm
dPsiB
(1 + p1 ∗ (KF1 ADPm ∗ Pim)) ∗ exp (3F R ∗ T ) +
dpH
R∗T∗
+ dPsi
Cm − ADPm
F
(p2 + p3 (KF1 ADPm ∗ Pim)) ∗ exp (3F
)
R∗T
(
)

dPsi (Oxidative
phosphorylation NADH)

ra ∗ KNADH ∗ sqrt (
v54 =

6 ∗ rhoNADH
∗
Cmito

(

dPsi (Oxidative
phosphorylation FADH2)

dpH
R∗T∗
+ dPsi
NADHm
F
) − (ra + rb) ∗ exp (g ∗ 6 ∗ F ∗
)
NADm
R∗T

NADHm
dPsiB
(1 + r1 ∗ KNADH ∗ sqrt ( NADm )) ∗ exp (6 ∗ F ∗ R ∗ T ) +
dpH
R∗T∗
+ dPsi
NADHm
F
(r2 + r3 ∗ KNADH ∗ sqrt ( NADm )) ∗ exp (g ∗ 6 ∗ F ∗
)
R∗T

ra ∗ KFADH2 ∗ sqrt (
v55 =

4 ∗ rhoFADH2
∗
Cmito

)

dpH
R∗T∗
+ dPsi
FADH2
F
) − (ra + rb) ∗ exp (g ∗ 4F
)
FAD
R∗T

FADH2
dPsiB
(1 + r1 ∗ KFADH2 ∗ sqrt ( FAD )) ∗ exp (4F R ∗ T ) +
dpH
R∗T∗
+ dPsi
FADH2
F
(r2 + r3 ∗ KFADH2 ∗ sqrt ( FAD )) ∗ exp (g ∗ 4F
)
R∗T
(
)

dPsi (Leak)
v56 = gh ∗
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R∗T∗

dpH
+ dPsi
F
Cmito

Phosphate transport
(Mitochondrial membrane)
v57 = [Phosphate transport (Mitochondrial membrane)]. Vmaxpt ∗ (Pi −

Pim
. Keq pt )
[Phosphate transport (Mitochondrial membrane)]

Phospholipase C
v58 = (PLC ∗ (Vmaxplc ∗

PIP2
))
KmPIP2plc + PIP2

ER calcium leak
v59 = (kLeak ∗ (Caer − Ca)) ∗ er

ER calcium pump
v60 = (kPump ∗ Ca) ∗ cellular

ER calcium channel
v61 = (Lchannel + Pchannel ∗ (IP33 ) ∗
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Ca3
) ∗ (Caer − Ca)
(IP3 + KmIP3channel )3 ∗ (Ca + KmCachannel )3

IP3 consumption
v62 = kIP3 ∗ IP3

DAG consumption
v63 = kDAG ∗ DAG

G3P shuttle
v64 = VmaxG3P ∗ FAD ∗ NADH

Oxidative phosphorylation
FADH2

(ra + rc1 ∗ exp (4F

dpH
R∗T∗
+ dPsi
dPsiB
FADH2
F
)) ∗ KFADH2 ∗ sqrt (
) − ra ∗ exp (g4F
)+
R∗T
FAD
R∗T

rc2 ∗ KFADH2 ∗ sqrt (
v65 = 0.5 ∗ rhoFADH2 ∗

(

dpH
R∗T∗
+ dPsi
FADH2
F
) ∗ exp (g ∗ 4 ∗ F ∗
)
FAD
R∗T

FADH2
dPsiB
(1 + r1 ∗ KFADH2 ∗ sqrt ( FAD )) ∗ exp (4F R ∗ T ) +
dpH
R∗T∗
+ dPsi
FADH2
F
(r2 + r3 ∗ KFADH2 ∗ sqrt ( FAD )) ∗ exp (g ∗ 4F
)
R∗T
(
)
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)

Sink for protein synthesis
v66 = Vmaxproteinsyn ∗ PRPP

Na/K-ATPase
1

v67 =
(

((1 +

2

KmK
KmNa 3
KATP
) ) ∗ ((1 +
) ) ∗ ((1 +
))
Ke
Na
MgATP
)

Ca-ATPase
v68 =

209

1
𝐾𝑚
KATP
(1 + ( Ca𝐶𝑎 )) ∗ (1 + (MgATP))

APPENDIX C: METABOLIC MODEL PARAMETERS
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Description

Symbol

Value

Units

Ref

Faraday constant

F

96480

C mol-1

[59]

Activation constant

Kact

0.00038

mM

[59]

Kd for translocated Ca+2

Ktrans

0.019

mM

[59]

Keq for conformational transitions in uniporter

L

110

-

[59]

Gas constant

R

8.3145

V C mol-1 0K-1

[59]

Temperature

T

302.15

0

[59]

Vmax uniport Ca+2 transport

Vmax_uni

0.625

uM s-1

[59]

Offset membrane potential

dPsio

0.091

Volts

[59]

Uniporter activation cooperativity

na_uni

2.8

-

[59]

Antiporter Ca+ constant

KCa

0.000375

mM

[59]

Antiporter Na+ constant

KNa

9.4

mM

[59]

Vmax of Na+/Ca+2 antiporter

Vmax_ex

9 ∗ 10−7

mM s-1

Fitted

dPsi dependence on Na+/Ca+2 antiporter

b

0.5

-

[59]

Na+/Ca+2 antiporter cooperativity

n_ex

3

-

[59]

Maximal rate of ANT

Vmax_ant

0.005

mM

[59]
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K

Description

Symbol

Value

Units

Ref

Fraction of ΔdPsi

h

0.5

-

[59]

Total sum of mitochondrial adenine nucleotides

Cm

2.5

mM

Fitted

Equilibrium constant of ATP hydrolysis

KF1

1.71e+06

-

[59]

Phase boundary potential

dPsiB

0.05

V

[59]

pH gradient across the inner membrane

dpH

-0.6

pH units

[59]

Sum of products of rate constants

p1

1.346e-08

-

[59]

Sum of products of rate constants

p2

7.739e-07

-

[59]

Sum of products of rate constants

p3

6.65e-15

-

[59]

Sum of products of rate constants

pa

1.656e-05

s-1

[59]

Sum of products of rate constants

pc1

9.651e-14

s-1

[59]

Sum of products of rate constants

pc2

4.585e-14

s-1

[59]

Concentration of electron carriers (respiratory
complexes II-III-IV)

rhoF1

0.003

mM

Fitted

Equilibrium constant of respiration

KNADH

1.35e+18

-

[59]

Correction factor for voltage

g

0.85

-

[59]

Sum of products of rate constants

r1

2.077e-18

-

[59]
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Description

Symbol

Value

Units

Ref

Sum of products of rate constants

r2

1.728e-09

-

[59]

Sum of products of rate constants

r3

1.059e-26

-

[59]

Sum of products of rate constants

ra

6.394e-10

s-1

[59]

Sum of products of rate constants

rc1

2.656e-19

s-1

[59]

Sum of products of rate constants

rc2

8.632e-27

s-1

[59]

Concentration of electron carriers (respiratory
complexes I-III-IV)

rhoNADH

0.005

mM

[59]

Inner membrane capacitance

Cmito

1.812

mM V-1

[59]

Sum of products of rate constants

pb

2.023e-05

s-1

[59]

Sum of products of rate constants

rb

1.762e-13

s-1

[59]

Equilibrium constant of FADH2 oxidation

KFADH2

5.497e+13

-

[59]

Concentration of electron carriers (respiratory
complexes II-III-IV)

rhoFADH2

0.06

mM

Fitted

Ionic conductance of the inner membrane

gh

0.01

mM s-1 V-1

[59]

Equilibrium constant for PDH

K_pdh_EQ

8.0

-

[75]

Rate constant G3P shuttle

Vmax_G3P

0.031

s-1

Fitted

Rate constant for protein synthesis/degradation

Vmax_proteinsyn

3.084

s-1

Fitted
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Description

Symbol

Value

Units

Ref

Michaelis constant for ATP in NaK-ATPase

KATP

5

mM

Fitted

Michaelis constant for K+ in NaK-ATPase

KmK

3.5

mM

[78]

Michaelis constant for Na in NaK-ATPase

KmNa

10

mM

[78]

Equilibrium constant of glucose transporter

Keq_gt

0.25

-

[58]

Michaelis constant for forward glucose transporter

KmGlcin_gt

6.9

mM

[58]

Michaelis constant for reverse glucose transporter

KmGlcout_gt

1.7

mM

[58]

Maximal rate of glucose transporter

Vmax_gt

0.0953

mM s-1

Fitted

Equilibrium constant of HK

Keq_hk

3900

mM

[58]

Michaelis constant for HK

KmBPG23_hk

2.7

mM

[58]

Michaelis constant for HK

KmG6P_hk

0.0045

mM

[58]

Michaelis constant for HK

KmGlc_hk

0.1

mM

[58]

Michaelis constant for HK

KmMgATPMg_hk

1.14

mM

[58]

Michaelis constant for HK

KmMgATP_hk

1.44

mM

[58]

Michaelis constant for HK

KmMgBPG23_hk

3.44

mM

[58]

Michaelis constant for HK

KmMg_hk

1.02

mM

[58]
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Description

Symbol

Value

Units

Ref

Maximal rate of HK

Vmax1_hk

0.045

mM s-1

Fitted

Maximal rate of HK

Vmax2_hk

1.1067

mM s-1

[58]

Equilibrium constant of GPI

Keq_gpi

0.3925

-

[58]

Michaelis constant for GPI

KmF6P_gpi

0.071

mM

[58]

Michaelis constant for GPI

KmG6P_gpi

0.182

mM

[58]

Maximal rate for GPI

Vmax_gpi

2.652

mM s-1

Fitted

Equilibrium constant of PFK

Keq_pfk

1e+05

mM

[58]

Michaelis constant for PFK

KmAMP_pfk

0.033

mM

[58]

Michaelis constant for PFK

KmATP_pfk

0.01

mM

[58]

Michaelis constant for PFK

KmF6P_pfk

0.1

mM

[58]

Michaelis constant for PFK

KmMgATP_pfk

0.068

mM

[58]

Michaelis constant for PFK

KmMg_pfk

0.44

mM

[58]

Lo for PFK

Lo_pfk

0.001072

-

[58]

Maximal rate of PFK

Vmax_pfk

0.6779

mM s-1

Fitted

Equilibrium constant of ALD

Keq_ald

0.114

mM

[58]
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Description

Symbol

Value

Units

Ref

Inhibition constant for ALD

KiGAP_ald

0.0572

mM

[58]

Inhibition constant for ALD

KiiGAP_ald

0.176

mM

[58]

Michaelis constant for ALD

KmDHAP_ald

0.0364

mM

[58]

Michaelis constant for ALD

KmF16BP_ald

0.0071

mM

[58]

Michaelis constant for ALD

KmGAP_ald

0.1906

mM

[58]

Maximal rate of ALD

Vmax_ald

0.2857

mM

Fitted

Equilibrium constant of TPI

Keq_tpi

0.0407

mM

[58]

Michaelis constant for TPI

KmDHAP_tpi

0.838

mM

[58]

Michaelis constant for TPI

KmGAP_tpi

0.428

mM

[58]

Maximal rate of TPI

Vmax_tpi

15.4784

mM s-1

[58]

Equilibrium constant of GADPH

Keq_gapdh

0.000192

mM

[58]

Michaelis constant for GADPH

KmBPG13_gapdh

0.0035

mM

[58]

Michaelis constant for GADPH

KmGAP_gapdh

0.005

mM

[58]

Michaelis constant for GADPH

KmNADH_gapdh

0.0083

mM

[58]

Michaelis constant for GADPH

KmNAD_gapdh

0.05

mM

[58]
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Description

Symbol

Value

Units

Ref

Michaelis constant for GADPH

KmPi_gapdh

3.9

mM

[58]

Maximal rate of GADPH

Vmax_gapdh

12.197

mM s-1

Fitted

Equilibrium constant of PGK

Keq_pgk

1455

mM

[58]

Michaelis constant for PGK

KmBPG13_pgk

0.002

mM

[58]

Michaelis constant for PGK

KmMgADP_pgk

0.35

mM

[58]

Michaelis constant for PGK

KmMgATP_pgk

0.48

mM

[58]

Michaelis constant for PGK

KmPG3_pgk

1.2

mM

[58]

Maximal rate of PGK

Vmax_pgk

14.184

mM s-1

Fitted

Dissociation constant of bPGM

Kd_bpgm

215.5866

Fitted

[58]

Equilibrium constant of bPGM

Keq_bpgm

1e+05

mM

[58]

Michaelis constant for bPGM

KmBPG23_bpgm

0.04

mM

[58]

Equilibrium constant of bPGM

Keq_bpgp

1e+05

mM

[58]

Michaelis constant for bPGM

KmBPG23_bpgp

0.2

mM

[58]

Maximal rate of bPGM

Vmax_bpgp

0.0015

mM s-1

Fitted

Equilibrium constant of PGM

Keq_pgm

0.145

mM

[58]
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Description

Symbol

Value

Units

Ref

Michaelis constant for PGM

KmPG2_pgm

1

mM

[58]

Michaelis constant for PGM

KmPG3_pgm

5

mM

[58]

Maximal rate of PGM

Vmax_pgm

5.673

mM s-1

Fitted

Equilibrium constant of ENO

Keq_eno

1.7

mM

[58]

Michaelis constant for ENO

KmPEP_eno

1

mM

[58]

Michaelis constant for ENO

KmPG2_eno

1

mM

[58]

Maximal rate of ENO

Vmax_eno

4.255

mM s-1

Fitted

Equilibrium constant of PK

Keq_pk

13790

mM

[58]

Michaelis constant for PK

KmATP_pk

3.39

mM

[58]

Michaelis constant for PK

KmF16BP_pk

0.005

mM

[58]

Michaelis constant for PK

KmMgADP_pk

0.474

mM

[58]

Michaelis constant for PK

KmPEP_pk

0.225

mM

[58]

Lo for PK

Lo_pk

19

-

[58]

Maximal rate of PK

Vmax_pk

1.617

mMs-1

Fitted

Equilibrium constant of LDH (Lactate
dehydrogenase-NADH)

Keq_ldh

9090

mM

[58]
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Description

Symbol

Value

Units

Ref

Maximal rate of LDH (NADH)

Vmax_ldh

104.99

mM s-1

[58]

Equilibrium constant of LDH (Lactate
dehydrogenase-NADPH)

Keq_ldh

32

mM

[58]

Maximal rate of LDH (NADPH)

k_ldh

2

mM s-1

[58]

Maximal rate of ATPase

k_ATPase

0.015

mM s-1

Fitted

Equilibrium constant of AK

Keq_ak

0.25

mM

[58]

Michaelis constant for AK

KmADP_ak

0.11

mM

[58]

Michaelis constant for AK

KmAMP_ak

0.08

mM

[58]

Michaelis constant for AK

KmATP_ak

0.09

mM

[58]

Maximal rate of AK

Vmax_ak

46

mM s-1

Fitted

Equilibrium constant of GPDH

Keq_gpdh

2000

mM

[58]

Michaelis constant for GPDH

KmATP_gpdh

0.749

mM

[58]

Michaelis constant for GPDH

KmBPG23_gpdh

2.289

mM

[58]

Michaelis constant for GPDH

KmG6P_gpdh

0.0667

mM

[58]

Michaelis constant for GPDH

KmNADPH_gpdh

0.00312

mM

[58]

Michaelis constant for GPDH

KmNADP_gpdh

0.00367

mM

[58]
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Description

Symbol

Value

Units

Ref

Maximal rate of GPDH

Vmax_gpdh

0.108

mM s-1

Fitted

Equilibrium constant of PGLDH

Keq_pgldh

141.7

mM

[58]

Michaelis constant for PGLDH

KmATP_pgldh

0.154

mM

[58]

Michaelis constant for PGLDH

KmBPG23_pgldh

0.12

mM

[58]

Michaelis constant for PGLDH

KmNADPH_pgldh

0.0045

mM

[58]

Michaelis constant for PGLDH

KmNADP_pgldh

0.018

mM

[58]

Maximal rate of PGLDH

Vmax_pgldh

1.05

mM s-1

Fitted

Michaelis constant for PGLDH

KmPGL1_pgldh

0.01

mM

[58]

Michaelis constant for PGLDH

KmPGL2_pgldh

0.058

mM

[58]

Equilibrium constant of Glutathione reduction

Keq_gr

1.04

mM

[58]

Michaelis constant for Glutathione reduction (GR)

KmGSH_gr

20

mM

[58]

Michaelis constant for GR

KmGSSG_gr

0.0652

mM

[58]

Michaelis constant for GR

KmNADPH_gr

0.00852

mM

[58]

Michaelis constant for GR

KmNADP_gr

0.07

mM

[58]

Maximal rate of GR

Vmax_gr

3

mM s-1

[58]
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Description

Symbol

Value

Units

Ref

Rate constant for Glutathione oxidation (GO)

K_go

0.01

mM

[58]

Equilibrium constant of GO

Keq_pre

2.7

mM

[58]

Michaelis constant for PRE

KmRu5P_pre

0.19

mM

[58]

Michaelis constant for PRE

KmX5P_pre

0.5

mM

[58]

Maximal rate of PRE

Vmax_pre

3.0894

mM s-1

Fitted

Equilibrium constant of RPI

Keq_rpi

3

mM

[58]

Michaelis constant for RPI

KmRi5P_rpi

2.2

mM

[58]

Michaelis constant for RPI

KmRu5P_rpi

0.78

mM

[58]

Maximal rate of RPI

Vmax_rpi

0.4866

mM

Fitted

Constant for Tranketolase (Ri5P)

K1_tk

0.4177

mM

[58]

Constant for Tranketolase (Ri5P)

K2_tk

0.3055

mM

[58]

Constant for Tranketolase (Ri5P)

K3_tk

12.432

mM

[58]

Constant for Tranketolase (Ri5P)

K4_tk

0.00496

mM

[58]

Constant for Tranketolase (Ri5P)

K5_tk

0.41139

mM

[58]

Constant for Tranketolase (Ri5P)

K6_tk

0.00774

mM

[58]
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Description

Symbol

Value

Units

Ref

Constant for Tranketolase (Ri5P)

K7_tk

48.8

mM

[58]

Equilibrium constant of Tranketolase (Ri5P)

Keq_tk

1.05

mM

[58]

Maximal rate of Tranketolase (Ri5P)

Vmax_tk

0.0157

mM

Fitted

Constant for Transaldolase (TA) (Ri5P)

K1_ta

0.00823

mM

[58]

Constant for TA (Ri5P)

K2_ta

0.04765

mM

[58]

Constant for TA (Ri5P)

K3_ta

0.1733

mM

[58]

Constant for TA (Ri5P)

K4_ta

0.006095

mM

[58]

Constant for TA (Ri5P)

K5_ta

0.8683

mM

[58]

Constant for TA (Ri5P)

K6_ta

0.4653

mM

[58]

Constant for TA (Ri5P)

K7_ta

2.524

mM

[58]

Equilibrium constant of TA (Ri5P)

Keq_ta

1.05

mM

[58]

Maximal rate of Transaldolase (Ri5P)

Vmax_ta

0.01813

mM s-1

Fitted

Equilibrium constant of PRPPS

Keq_prpps

1e+05

mM

[58]

Michaelis constant for PRPPS

KmATP_prpps

0.03

mM

[58]

Michaelis constant for PRPPS

KmRi5P_prpps

0.57

mM

[58]

222

Description

Symbol

Value

Units

Ref

Maximal rate of PRPPS

Vmax_prpps

0.001

mM s-1

Fitted

Constant for Transketolase (E4P)

K1_tk

0.00184

mM

[58]

Constant for Transketolase (E4P)

K2_tk

0.3055

mM

[58]

Constant for Transketolase (E4P)

K3_tk

0.0548

mM

[58]

Constant for Transketolase (E4P)

K4_tk

0.0003

mM

[58]

Constant for Transketolase (E4P)

K5_tk

0.0287

mM

[58]

Constant for Transketolase (E4P)

K6_tk

0.122

mM

[58]

Constant for Transketolase (E4P)

K7_tk

0.215

mM

[58]

Equilibrium constant of Transketolase (E4P)

Keq_tk

1.2

mM

[58]

Maximal rate of Transketolase (E4P)

Vmax_tk

0.0157

mM s-1

Fitted

Equilibrium constant of LT

Keq_lt

0.5

mM

[58]

Maximal rate for LT

Vmax_lt

0.0015

mM s-1

Fitted

Equilibrium constant of phosphate transport
(Plasma membrane)

Keq_pt

1

mM

[58]

Maximal rate of phosphate transport (Plasma
membrane)

Vmax_pt

3.3333

mMs-1

Fitted

Equilibrium constant of pyruvate transport (Plasma
membrane)

Keq_pt

1

mM

Fitted
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Description

Symbol

Value

Units

Ref

Maximal rate of pyruvate transport (Plasma
membrane)

Vmax_pt

0.0003

mM

Fitted

Equilibrium constant of MgATP

EqMgATP

3.3333 ∗ 105

s-1

[58]

Dissociation constant for MgATP

KdMgATP

0.072

mM

[58]

Equilibrium constant of MgADP

EqMgADP

3.3333 ∗ 105

s-1

[58]

Dissociation constant for MgADP

KdMgADP

0.76

mM

[58]

Equilibrium constant of MgAMP

EqMgAMP

3.3333 ∗ 105

s-1

[58]

Dissociation constant for MgAMP

KdMgAMP

16.64

mM

[58]

Equilibrium constant of MgBPG23

EqMgBPG23

3.3333 ∗ 105

s-1

[58]

Dissociation constant for MgBPG23

KdMgBPG23

1.667

mM

[58]

Equilibrium constant of pyruvate transport (Mito
membrane)

Keq_pt

2

-

Fitted

Maximal rate of pyruvate transport (Mito
membrane)].

Vmax_pt

0.04

s-1

Fitted

Rate constant of PDH

k_pdh

1.2

-

[75]

Concentration of CS

Et_cs

0.0258

mM

Fitted

Catalytic constant of CS

Kcat_cs

3.2

s-1

[59]

Michaelis constant for AcCoA

KmAcCoA_cs

0.0126

mM

[59]
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Description

Symbol

Value

Units

Ref

Michaelis constant for OAA

KmOAA_cs

0.00063

mM

[59]

Equilibrium constant of ACO

Keq_aco

2.22

-

[59]

Forward rate constant of ACO

Kf_aco

12.5

s-1

[59]

Concentration of IDH

Et_idh

0.007

mM

Fitted

Activation constant by ADP

KaADP_idh

0.062

mM

[59]

Activation constant for Ca+2

KaCa_idh

0.00141

mM

[59]

Rate constant of IDH

Kcat_idh

16.3

s-1

[59]

Inhibition constant by NADH

KiNADH_idh

0.19

mM

[59]

Michaelis constant for isocitrate

KmIsoCit_idh

1.52

mM

[59]

Michaelis constant for NAD

KmNAD_idh

0.923

mM

[59]

Ionization constant of IDH

kH1_idh

8.1e-05

mM

[59]

Ionization constant of IDH

kH2_idh

5.98e-05

mM

[59]

Hill coefficient of IDH

n_idh

2

-

[59]

Concentration of α-KGDH

Et_akgdh

0.0323

mM

Fitted

Activation constant for Ca+2

KaCa_akgdh

0.00127

mM

[59]
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Description

Symbol

Value

Units

Ref

Activation constant for Mg+2

KaMg_akgdh

0.0308

mM

[59]

Rate constant of KGDH

Kcat_akgdh

5

s-1

[59]

Michaelis constant for NAD

KmNAD_akgdh

38.7

mM

[59]

Michaelis constant for αKG

KmaKG_akgdh

1.94

mM

[59]

Hill coefficient of KGDH for αKG

n_akgdh

1.2

-

[59]

Equilibrium constant of SL

Keq_scl

3.115

-

[59]

Forward rate constant of SL

Kf_scl

0.127

mM-1 s-1

[59]

Concentration of SDH

Et_sdh

0.0323

mM

Fitted

Rate constant of SDH

Kcat_sdh

1

s-1

[59]

Inhibition constant by fumarate

KiFum_sdh

1.3

mM

[59]

Inhibition constant by oxalacetate

KiOAA_sdh

0.15

mM

[59]

Michaelis constant for succinate

KmSuc_sdh

0.03

mM

[59]

Equilibrium constant of FH

Keq_fh

1

-

[59]

Forward rate constant for FH

Kf_fh

1.83

s-1

[59]

Total MDH enzyme concentration

Et_mdh

0.001

mM

Fitted
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Description

Symbol

Value

Units

Ref

Rate constant of MDH

Kcat_mdh

27.75

s-1

[59]

Inhibition constant by oxalacetate

KiOAA_mdh

0.0015

mM

[59]

Michaelis constant for malate

KmMal_mdh

1.493

mM

[59]

Michaelis constant for NAD+

KmNAD_mdh

0.2244

mM

[59]

Ionization constant of MDH

kH1_mdh

1.131e-05

mM

[59]

Ionization constant of MDH

kH2_mdh

26.7

mM

[59]

Ionization constant of MDH

kH3_mdh

6.68e-09

mM

[59]

Ionization constant of MDH

kH4_mdh

5.62e-06

mM

[59]

pH-independent term in the pH activation factor of
MDH

koffset

0.0399

-

[59]

Equilibrium constant of phosphate transport (Mito
membrane)

Keq_pt

20

-

Fitted

Maximal rate of phosphate transport (Mito
membrane)

Vmax_pt

5.002

s-1

Fitted

Michaelis constant for PLC

KmPIP2_plc

0.00045

mM

[74]

Maximum flux across PMCA

Vmax_plc

0.001

mM s-1

[74]

Maximal rate of IP3 production

kPump

20

s-1

[74]

Dissociation constant of IP3 sites on IP3R

KmIP3_channel

0.001

mM

[74]
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Description

Symbol

Value

Units

Ref

Ca2+ leak from ER to cytoplasm

L_channel

0.00093

s-1

[74]

Maximal total permeability of IP3 channels

P_channel

66.6

s-1

[74]

Dissociation constant of Ca2+-activation sites on
IP3R

KmCa_channel

0.0004

mM

[74]

Half maximal inhibitory concentration for 2DG

2DG IC50

23.34

mM

Fitted

Half maximal inhibitory concentration for cyanide

CYN IC50

0.005

mM

Fitted

Half maximal inhibitory concentration for malonate

MAL IC50

24.17

mM

Fitted
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Description

Symbol

Value (mM)

Mitochondrial pyruvate

Pyrm

0.0032449

Mitochondrial NAD

NADm

10

Acetyl-CoA

AcCoA

0.00013565

Mitochondrial NADH

NADHm

5.4748e-07

Oxaloacetate

OAA

0.0046568

Citrate

Cit

0.025474

Isocitrate

IsoCit

0.054419

α-Ketoglutarate

aKG

0.00060511

Mitochondrial ADP

ADPm

0.27199

Mitochondrial calcium

Cam

0.00013734

Succinyl CoA

SucCoA

0.3477

Mitochondrial phosphate

Pim

19.99

Succinate

Suc

0.00078309

Mitochondrial ATP

ATPm

2.228

Fumarate

Fum

0.037381
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Description

Symbol

Value (mM)

Malate

Mal

0.030819

Mitochondrial FAD

FAD

5.25

Mitochondrial FADH2

FADH2

3.2402e-05

Endoplasmic reticulum calcium

Caer

0.044987

Mitochondrial membrane potential

dPsi

0.12203

Cytosolic Glucose

Glc

5.8843

Magnesium bound ATP

MgATP

0.20011

Glucose-6-phosphate

G6P

0.0014076

Magnesium bound ADP

MgADP

0.070602

2,3-bisphosphoglycerate

BPG23

0.31498

Magnesium

Mg

1.0641

Magnesium bound 2,3-bisphosphoglycerate

MgBPG23

0.20106

Fructose 6-phosphate

F6P

0.00050133

AMP

AMP

0.071164

ATP

ATP

0.013541
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Description

Symbol

Value (mM)

Fructose 1,6-biphosphate

F16BP

0.06041

Magnesium bound AMP

MgAMP

0.0045507

Glyceraldehyde-3-phosphate

GAP

0.016302

Dihydroxyacetone phosphate

DHAP

0.40075

Cytosolic phosphate

Pi

0.9999

Cytosolic NAD

NAD

0.062889

1,3-bisphosphoglycerate

BPG13

7.4997e-05

Cytosolic NADH

NADH

0.0026113

3-Phosphoglycerate

PG3

0.036012

2-Phosphoglycerate

PG2

0.0045566

Phosphoenolpyruvate

PEP

0.0056698

Cytosolic pyruvate

Pyr

0.02099

Cytosolic lactate

Lac

1.4259

Cytosolic NADPH

NADPH

3.0797e-07

Cytosolic NADP

NADP

0.004
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Description

Symbol

Value (mM)

ADP

ADP

0.050427

6-phosphoglucono-δ-lactone

PGL

0.00032077

Ribuloase-5-phosphate

Ru5P

0.02701

Glutathione disulphide

GSSG

1.4447

Glutathione

GSH

0.225

Xyulose-5-phosphate

X5P

0.072808

Ribose-5-phosphate

Ri5P

0.079043

Sedoheptulose 7-phosphate

S7P

0.00085122

Erythrose 4-phosphate

E4P

0.00045071

Phosphoribosyl pyrophosphate

PRPP

3.4337e-05

Cytosolic calcium

Ca

0.00012546

Phosphatidylinositol 4,5-bisphosphate

PIP2

2000

Inositol triphosphate

IP3

3.7369e-12

Diacyl-glycerol

DAG

3.7369e-12

Extracellular glucose

Glce

25
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Description

Symbol

Value (mM)

Extracellular lactate

Lace

3.3388e-05

Extracellular phosphate

Pie

1

Extracellular pyruvate

Pyre

1.1601e-07

Extracellular potassium

Ke

5.4

Extracellular calcium

Cae

1.8

Extracellular magnesium

Mge

0.8

Extracellular sodium

Nae

130.2

CoA

CoA

0.02

Mitochondrial proton

Hm

2.5e-05

Mitochondrial magnesium

Mgm

0.4
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